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A set of mild conditions for the pentafluorophenylation of carbonyl compounds employing 
copper-bisphosphine catalysis have been developed. The optimised conditions allow access 
to a wide range of pentafluorophenyl benzyl alcohols in high yields. The reaction of aliphatic 
aldehydes and particularly electrophilic ketones to give products in moderate yields is also 
disclosed. 
 
An investigation into the reactivity of β-fluoroalkyl-α,β-unsaturated carbonyl compounds was 
conducted. Asymmetric copper hydride reduction of β-fluoroalkyl-α,β-unsaturated ketones 
was found to preferentially give the allylic alcohol product resulting from 1,2 attack in up to 
62% ee. Reaction of β-fluoroalkyl-α,β-unsaturated esters under similar conditions gave the 
product of conjugate reduction in higher enantiomeric excess; up to 99% was observed. 
Rhodium-catalysed arylation of β-fluoroalkyl-α,β-unsaturated ketones was also found to give 
the product of direct carbonyl attack. Conditions for the racemic reaction are described along 
with those for the enantioselective reaction of methyl ketones in up to 74% ee. Ruthenium 
catalysed arylation of β-fluoroalkyl-α,β-unsaturated aldehydes employing Me-Bipam as 
ligand gave the desired secondary allylic alcohols in good yields and good to excellent 




1.    Introduction 
 
The incorporation of fluorine into an organic molecule often has a profound effect on its 
chemical, physical and biological properties.1 It has been estimated that 30-40% of 
agrochemicals and 20% of pharmaceuticals currently on the market contain fluorine. 





Fluorine is a small atom with a very high electronegativity and it is this combination of 
properties which means that the introduction of fluorine atoms into commercial compounds is 
often highly advantageous.2 There are three common reasons for introducing fluorine into a 
compound of interest. Firstly, fluorine can increase the bioavailability of a drug molecule by 
blocking metabolically labile sites, thus preventing oxidation by liver enzymes such as 
cytochrome P450. An example of this application is Ezetimibe.3 SCH48461 is a moderately 
potent compound with an ED50 of 2.2 mgkg
-1 (Scheme 1.2). During the development of 
Ezetimibe, two fluorine atoms were introduced into SCH48461 in order to prevent oxidation 
of the aromatic rings. This contributed greatly towards the much improved potency of the 







Fluorine (as such an electronegative element) can also be used to increase the bioavailability 
of a drug molecule by decreasing the basicity and thus increasing membrane permeability. 
This is illustrated by work carried out on selective 5HT1D receptor ligands (Scheme 1.3).
4 
The introduction of a single fluorine atom into the starting compound led to a decrease in pKa 
from 9.7 to 8.7 with a significant increase in bioavailability being observed, along with a 
small decrease in potency. The difluorinated analogue was also synthesised and had a pKa of 




Fluorine substituents can also increase the binding affinity of a compound by strengthening 
other interactions through a change in the molecular conformation,5 or by interacting with a 
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protein itself.6 Fluorine can have a strong effect on molecular conformations due to the low 
energy of the σ*C-F antibonding orbital (itself a consequence of the highly polarised nature of 
the bond) which leads to its ready participation in hyperconjugation. As a result, fluorine 
displays an anomeric effect and a gauche effect. Whilst fluorine is generally believed to form 
only weak hydrogen bonds,7 both dipole-dipole and charge-dipole interactions have been 
described. The protein tyrosine kinase 1B inhibitors shown in Scheme 1.4 are only effective 
when the fluorine atoms are present. Evidence from X-ray crystallography and kinetic studies 
suggests that this is due to direct interactions between the fluorine atoms and the active site of 





Naturally occurring fluorine-containing compounds are extremely rare.8 As a result, 
organofluorines are almost always accessed by organic synthesis (although enzymes that can 
perform transformations upon fluorinated compounds have also been discovered9). Despite 
the need for procedures for the synthesis of fluorinated compounds, methodology for the 
introduction of fluorine-containing functional groups into molecules is currently surprisingly 
limited. Hence, the most common strategy to access organofluorines is through the 
functionalisation of commercially available fluorinated building blocks. However, this 
approach is itself limited by the types of fluorinated building blocks available. 
 
New methods for the introduction of fluorine-containing functional groups in a mild, 








2. Copper-Bisphosphine-Initiated Pentafluorophenylation 
of Aldehydes and Ketones 
 
2.1   Introduction 
 
Pentafluorophenyl compounds are of utility in medicinal chemistry,10 electron-transport 
devices,11 light-emitting diodes,12 printing,13,14 liquid crystal displays15 and fluorous biphasic 
ligands.16  
 
In principle, a simple approach for the introduction of pentafluorophenyl groups is the 
addition of a nucleophilic pentafluorophenyl synthon to an aldehyde or ketone, and this 
strategy has been accomplished by the use of pentafluorophenyllithium17 or the Grignard 
reagent.18 The yields for these processes are variable, but are generally rather poor. Another 
drawback is their incompatibility with sensitive functionality. 
 
The successful application of trifluoromethyl(trimethylsilane) to the trifluoromethylation of a 
range of functionalities has led to a recent increase in the use of silicon-based reagents for the 
introduction of other fluorine-containing functional groups.19 Advantages of such reagents 
are their stability, non-toxicity and relatively low cost. Fluoroalkyl silanes do not themselves 
react with electrophiles at an appreciable rate. However, the silicon centre is highly 
susceptible to nucleophilic attack, giving rise to a pentavalent silicon complex, which can 
transfer the fluoroalkyl group to a suitable electrophile.  
 
2.1.1    Pentafluorophenylation with (Pentafluorophenyl)trimethylsilane 
 
The first report of a pentafluorophenylation reaction utilising 
(pentafluorophenyl)trimethylsilane (1) was by Gilman and co-workers in 1970.20 They 
reported that 1 reacted with benzaldehyde (2a) to form the desired pentafluorophenyl alcohol 
derivative after heating the two together at 165 °C for 4 days and hydrolysing the resulting 
trimethylsiloxy derivative (Equation 2.1). Although the obtained yield of 62% is 






In 1972, Ishikawa and Isobe described an improved method for the reaction of 
polyhalogenophenyltrimethylsilanes with benzaldehyde, employing substoichiometric 
quantities of potassium fluoride in DMF as an initiator (Scheme 2.1).21 Their reactions went 
to completion after only a few minutes and although they do not report the reaction of 1 itself 
in this manner, the yields for the silane reagents that they do report are similar to that 





It is highly likely that the mechanism for this process is analogous to that for the reaction of 
Ruppert’s reagent with aldehydes (Scheme 2.2). The activation of 1 by the fluoride anion 
proceeds as has been previously described and the polyhalogenophenyl group is transferred to 
the electrophilic carbon of the carbonyl group to generate an alkoxide adduct (6). The affinity 
of the silicon atom in 1 for the anionic oxygen of the alkoxide leads to the formation of 
another pentavalent silicon complex (7). The polyhalogenophenyl group is then transferred 
from this complex to the electrophilic carbon of a carbonyl group, generating another 
molecule of 6 and the desired product (8). The cycle can continue until all of the carbonyl 





Significantly improved yields (87% for 5a) were reported by Hiyama and co-workers by 
changing the activator to tris(dimethylamino)sulfonium difluorotrimethylsilicate (TASF) and 
the solvent to THF.22 The use of a potassium cyanide-18-crown-6 complex as the initiator has 
also been reported.23 Here, the reaction has been applied to a much wider range of aldehyde 






The authors also describe an attempt to extend the scope to include enolisable ketones. 






In a later publication,24 the same authors describe just one non-enolisable ketone substrate for 
which the pentafluorophenylation reaction using 1 was successful: trifluoroacetophenone 
(Equation 2.2). Other non-enolisable substrates such as octofluoroacetophenone and tbutyl 





Much research has been carried out recently by Dilman’s group into reactions of silicon-
based pentafluorophenyl reagents with C=N bonds. The products in all of these cases are α-
pentafluorophenyl-substituted amines, although the required starting materials vary.  Their 
first report describes the synthesis of pentafluorophenylmethylamines 14 through a silicon 
Mannich reaction (Scheme 2.5).25 Screening of silicon reagents revealed that 1 is not 
nucleophilic enough to be used in this reaction and MeOSi(C6F5)3 (15) was selected instead. 
The scope of the reaction was explored, changing both the carbonyl and amine component, 






A few months later, the authors published an alternative method, which allows the synthesis 
of products with quaternary carbon centres (Scheme 2.6).26 This was not possible under the 
previous conditions, due to the lack of reactivity of ketones. Here, the substrates were 
preformed enamines, and MeSi(C6F5)3 (16) was found to be the preferred 
pentafluorophenylating agent. Acetic acid was employed to generate an iminium acetate from 
the enamine and the reaction then proceeded as before.  














































Dilman next reported the use of salicylaldehyde (18) in the silicon Mannich reaction 
(Scheme 2.7).27 The adjacent hydroxyl group allows the reaction to take place under the 
original conditions but using MeSi(C6F5)3 as the pentafluorophenylsilyl derivative. This 
reagent is preferred to MeOSi(C6F5)3 as it is easier to prepare and less sensitive to hydrolysis. 
The mechanism proposed by the authors is given in Scheme 2.7. Reaction of salicylaldehyde 
with MeSi(C6F5)3 generates the silyl ether (19), which in turn reacts with the amine to 
generate a zwitterionic species (20). The pentafluorophenyl group is then transferred 
intramolecularly from silicon to the electrophilic carbon of the iminium cation. After 


























































Aldehydes without a neighbouring hydroxyl group were also shown to undergo reaction with 
TMS-protected amines and a less expensive silicon-based pentafluorophenylating reagent, 
C6F5SiF3 (22, Scheme 2.8).
28 However, yields did not exceed 27% until a Lewis base, such as 
lithium acetate, was added into the reaction mixture. The authors attributed this observation 
to the generation of F3SiOSiMe3 as a product of the reaction, as it can form an acetal with the 
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benzaldehyde starting material, thus preventing further reaction. The addition of a Lewis base 





Finally, in 2008, Dilman and co-workers reported the first use of 1 itself in these reactions.29 
This method requires the initial generation of iminium ions either from imines or from the 
reaction of aldehydes and amines in situ, as before. The pentafluorophenylating agent 1 was 
then added along with a Lewis base, the most effective of which was found to be potassium 
fluoride or sodium acetate (Scheme 2.9). The yields for this process are generally excellent 





Preformed imines can also be pentafluorophenylated to generate α-pentafluorophenyl-
substituted amines (Scheme 2.10).30 Here, fluorotris(pentafluorophenyl)silane (24), a silicon-
based reagent that is more sensitive towards Lewis-base activation than 1, was used. With 
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this reagent, even chloride anions, which are not particularly nucleophilic, could mediate the 
reaction of 24 with non-activated imines. The optimised conditions for the reported reaction 
employed 2,2,2-trifluoroethanol, chlorotrimethylsilane and heating under reflux in 
acetonitrile. A wide range of imine substrates underwent reaction in this manner to provide 
high yields of the desired product (14) in under one hour. Diaryl imines required a higher 
concentration of chloride ions, supplied by benzyltriethylammonium chloride, for the reaction 





The proposed mechanism for this process is given in Scheme 2.11. The reaction of 
chlorotrimethylsilane with the alcohol generates anhydrous HCl, which subsequently 
protonates the imine to give an iminium cation. The chloride anion then associates with the 
silicon atom of 24 generating a pentavalent silicon complex, which transfers a 
pentafluorophenyl group to the electrophilic carbon of the iminium ion. Two equivalents of 







When Dilman and co-workers reported the trifluoromethylations of salicyl aldimines31 and N-
benzoylhydrazones32 using Ruppert’s reagent, TMSCF3, the methods were also applied to the 
introduction of the pentafluorophenyl group (Scheme 2.12). Both of these methods employ 
complexation of a Lewis acid as a means of increasing the electrophilicity of an imine. The 
authors observe that the problem with this approach is that fluoroalkyl silanes require Lewis 
basic activation and if a Lewis acid is added to the reaction mixture, this activation will not 
occur. The solution was found to be intramolecular chelation with an adjacent hydroxyl 
group. In this manner, the authors achieved the pentafluorophenylation of salicyl aldimines 
and N-benzoylhydrazones in excellent yields using boron trifluoride and sodium acetate as 






Enamines have also been pentafluorophenylated using the commercially available 
pentafluorophenylating agent 1.33 Again, the method used was developed by Dilman and co-
workers for use with Ruppert’s reagent and extended to 1 (Scheme 2.13). The report 
describes the synthesis of α-pentafluorophenylated amines using 1 and a carboxylic acid. The 
first step of this reaction is shown in Scheme 2.13. The carboxylic acid can protonate the 
enamine to generate an iminium cation and a carboxylate anion. The carboxylate anion then 






This methodology has been extended further to include the pentafluorophenylation of β-
aminoacrylates (Scheme 2.14).34 However, in this case, (C6F5)3SiF was used to transfer the 
C6F5 group and a stronger acid, such as HCl generated in situ from an alcohol and 
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chlorotrimethylsilane, is required. The yields for this process vary greatly depending upon the 
substituents on the enamine. For example, when R2 is a phenyl group, yields decrease 
significantly relative to those obtained when there is a methyl substituent in that position. 
































The development of methods for the use of fluoroalkyl silane reagents in conjugate additions 
has proved to be much more difficult and reports are very limited. However, in 2008 Dilman 
reported the conjugate pentafluorophenylation of an arylidene malononitrile 27 requiring 
stoichiometric sodium acetate in DMF (Equation 2.3).35 Whilst this is the only example 





In summary, (pentafluorophenyl)trimethylsilane is a versatile reagent and can be used in the 
nucleophilic pentafluorophenylation of a range of C=N electrophiles. However, the 
corresponding reactions of carbonyl compounds are less common. Existing studies of the 
pentafluorophenylation of aldehydes using 1 contain limited descriptions of substrate scope 
and there is only one example of the successful reaction of a ketone. A more detailed 
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evaluation of the scope of the pentafluorophenylation of aldehydes and ketones using 1 under 
mild conditions and employing relatively non-toxic reagents is therefore warranted.     
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2.2   Results and Discussion 
 
As we have seen, (pentafluorophenyl)trimethylsilane has been employed in the 
pentafluorophenylation of C=N bonds using a variety of methods, whilst the corresponding 
reactions with carbonyl compounds are less common. On this basis, we have carried out a 
more detailed evaluation of the scope of pentafluorophenylation of aldehydes and ketones 
using 1 under user-friendly conditions. 
 
In considering potential reagents to promote carbonyl pentafluorophenylation using 1, we 
were prompted to examine copper-dppe complexes, in view of their successful use in 
combination with the Ruppert-Prakash reagent for the trifluoromethylation of aldehydes 
(Scheme 2.15)36 and the direct silylation of bisactivated cyclopropenes conducted within the 









For our initial investigations, benzaldehyde (2a) was employed as a test substrate. The results 












1 Cu(OAc)2 10 THF >95 1.5 
2 Cu(acac)2 10 THF 90 21 
3 Cu(OAc)2 5 THF 80 6 




It is interesting to observe that the use of toluene in this reaction gave minimal (<5%) 
conversions despite its use by Shibata and co-workers36 in their analogous 
trifluoromethylation procedure (Entry 4). The conditions that were selected as effective for 
carbonyl pentafluorophenylation as a result of this screening were Cu(OAc)2 (10 mol%), 
dppe (10 mol%) and TMSC6F5 (1.1 equiv) in THF at room temperature. After the reaction 
had stopped progressing, as observed by TLC analysis, a solution of HCl was added to 




Table 2.2 presents the results of pentafluorophenylation of a range of unsaturated aldehydes 




Table 2.2 Yields stated are of isolated product. a Conversion as determined by 1H and 19F NMR. 
 
The yields obtained for the reaction of aromatic aldehydes (2a-i) were generally good. 
Substitution at any ring position was well tolerated and substrates containing electron-
withdrawing substituents (particularly in ortho positions e.g. 2d and 2f) were shown to give 
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increased yields of isolated product (4d and 4f). On the other hand, substrates containing 
alkoxy substituents on the aromatic rings (2g-i) were shown to give lower conversions. 
Heating reactions that did not complete gave no more desired product and after prolonged 
periods of heating, degradation of starting materials and products began to be observed. 
Increasing catalyst loading and increasing the concentration of the reaction mixture also 
failed to increase the quantity of desired product that formed. 
 
Heteroaromatic aldehydes were more problematic. 2-Furancarboxaldehyde (2n) showed only 
20% conversion and 1-methylindole-2-carboxaldehyde (2l) gave less than 5% of the desired 
product. Again, increasing the reaction temperature failed to give an improvement in the 
observed conversion. The reaction of 2-pyridinecarboxaldehyde (2k) resulted in a complex 
mixture of products with no starting material remaining after only 5 minutes of reaction. No 
desired product was isolated from the crude reaction mixture. However, 4-
pyridinecarboxaldehyde (2j) did provide the desired product 4j in 62% yield, while 2-
thiophenecarboxaldehyde (2m) gave 4m in 38% yield. 
 
Trans-cinnamaldehyde was used as an example of an α,β-unsaturated aldehyde substrate. 
Conversions were found to be poor for this substrate as well, giving a 42% yield. As in 
previous examples, heating failed to give an improvement, but did lead to the appearance of 
side-products, which were not identified. No formation of the conjugate addition product was 
observed.  
 
Aliphatic aldehydes were found to be very reactive under the optimised conditions and 
complete consumption of starting material was generally observed after a reaction time of 
only fifteen minutes. However, these reactions also provided a number of unidentified side 
products resulting in greatly decreased isolated yields (34% for 4q). Decreasing the reaction 
temperature to −78 °C offered some improvement in minimising side-product formation, but 
isolated yields of the products 4q-4s (Table 2.3) remain modest due to varying levels of 
decomposition. Slow addition of the (pentafluorophenyl)trimethylsilane reagent or of the 





Table 2.3 Yields given are of isolated product. 
 
Extension of this protocol to more challenging ketone substrates was then explored. With 
enolisable ketones, such as acetophenone, only conversion into the corresponding 






With benzophenone, a non-enolisable substrate, no reaction was obtained. However, more 
electrophilic ketones such as ethyl pyruvate and 4-nitrobenzophenone did lead to the desired 
products 12b and 12c, respectively, though in modest yields (Table 2.4). 
 
 
Table 2.4 Yields given are of isolated product. 
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Other conditions were also attempted for the pentafluorophenylation of ketones, including the 
use of such Lewis acids as Ti(OiPr)4, and MgF2, as well as tetrabutylammonium 
triphenyldifluorosilicate (TBAT). Various solvents and temperatures were tried with 
activators in both catalytic and stoichiometric quantities. No significant amount of 
pentafluorophenylation of acetophenone was observed under any of the conditions tried. 
 
The reaction of an enantiomerically pure aldehyde was investigated to ascertain whether any 
diastereoselectivity was observed under the optimised conditions. Unfortunately, as for all 
aliphatic aldehydes, a large amount of degradation products were obtained along with only a 
14% yield of isolated product even when the reaction was conducted at -78 °C. The 





The exact role of Cu(OAc)2 and dppe in promoting carbonyl pentafluorophenylation is not 
clearly understood at this stage. However, our current hypothesis is that the Cu(OAc)2-dppe 
complex merely serves to initiate an autocatalytic process in direct analogy to mechanisms 
proposed for carbonyl trifluoromethylation using the Ruppert-Prakash reagent (TMSCF3). 









































As it is not believed that the copper is involved in the reaction mechanism beyond the release 
of an acetate anion, developing a set of conditions for the enantioselective reaction using 
copper-bisphosphine catalysis was unlikely to be as simple as employing a chiral 
bisphosphine ligand. However, a brief screen of chiral non-racemic bisphosphine ligands 
(including Josiphos, BINAP and Chiraphos) was conducted under the optimised conditions in 
order to determine if any enantioselectivity was observed. For none of the ligands employed 
was any enantiomeric excess obtained, although the amount of conversion to product did 
differ from one ligand to another. This result agrees with a report by Shibata38 on his group’s 
attempts to carry out an asymmetric trifluoromethylation reaction using Ruppert’s reagent 
and copper-bisphosphine catalysis. 
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2.3   Conclusions 
 
In summary, we have developed a set of mild conditions for the pentafluorophenylation of 
carbonyl compounds using copper-bisphosphine initiation of 
(pentafluorophenyl)trimethylsilane. The conditions work well for aromatic aldehydes and 
give modest product yields for the reaction of aliphatic aldehydes and particularly 
electrophilic ketones.39 Attempts to carry out the reaction asymmetrically through the use of 
chiral bisphosphine ligands failed to give any enantioselectivity.  
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2.4    Experimental 
 
General Information 
All reactions were carried out under a nitrogen atmosphere in oven-dried apparatus. THF and 
toluene were dried and purified by passage through activated alumina columns using a 
solvent purification system from www.glasscontoursolventsystems.com. All commercially 
available reagents were used as received. Thin layer chromatography (TLC) was performed 
on Merck DF-Alufoilien 60F254 0.2 mm precoated plates. Product spots were visualized by 
UV light at 254 nm, and subsequently developed using potassium permanganate solution. 
Flash column chromatography was carried out using silica gel (Fisher Scientific 60Å particle 
size 35-70 micron) employing the method of Still and co-workers.40 Melting points were 
recorded on a Gallenkamp melting point apparatus and are uncorrected. Infra-red spectra 
were recorded on a Jasco FT/IR-460 Plus instrument as a thin film on sodium chloride plates 
or as a Nujol mull. 1H NMR spectra were recorded on a Bruker DMX500 (500 MHz) 
spectrometer or a Bruker DPX360 (360 MHz) spectrometer. Chemical shifts (δ) are quoted in 
parts per million (ppm) downfield of tetramethylsilane, using residual protonated solvent as 
internal standard (CDCl3 at 7.27 ppm; CD3OD at 4.84 ppm). Abbreviations used in the 
description of resonances are: s (singlet), d (doublet), t (triplet), q, (quartet), app (apparent), 
br (broad). Coupling constants (J) are quoted to the nearest 0.1 Hz. Proton-decoupled 13C 
NMR spectra were recorded on a Bruker DPX360 (90.6 MHz) spectrometer or a Bruker 
ARX250 (62.9 MHz) spectrometer. Chemical shifts (δ) are quoted in parts per million (ppm) 
downfield of tetramethylsilane, using deuterated solvent as internal standard (CDCl3 at 77.0 
ppm; CD3OD at 49.05 ppm). Assignments were made using the DEPT sequence with 
secondary pulses at 90° and 135°. 19F NMR spectra were recorded on a Bruker ARX250 (235 
MHz) spectrometer. Chemical shifts are reported in parts per million (ppm) downfield of 
CFCl3, using fluorobenzene as internal standard (C6H5F at –113.2 ppm). High-resolution 
mass spectra were recorded on a Finnigan MAT 900 XLT spectrometer or a Finnigan MAT 
95XP spectrometer at the EPSRC National Mass Spectrometry Service Centre, University of 






General Procedure A for Pentafluorophenylation of Aldehydes and Ketones 
 
A solution of Cu(OAc)2 (18.2 mg, 0.10 mmol) and dppe (39.8 mg, 0.10 mmol) in THF (3 
mL) was stirred at room temperature for 30 min. The appropriate aldehyde or ketone (1.00 
mmol) was then added, followed by TMSC6F5 (210 µL, 1.10 mmol) over 0.5 min and the 
reaction was stirred at room temperature until complete consumption of the carbonyl 
compound as observed by TLC analysis, or until no further reaction progress could be seen. 
(In the case of aliphatic aldehydes, the mixture was cooled to −78 °C before the addition of 
TMSC6F5 and the reaction was thereafter maintained at −78 °C.)  The reaction was quenched 
with 1 mL HCl solution (~ 1M in MeOH/H2O, made up by diluting 8.2 mL of 37% HCl up to 
100 mL with MeOH) and the mixture was stirred at room temperature for 1 h. The mixture 
was filtered through a short plug of SiO2 using EtOAc (ca. 50 mL) as eluent, and the filtrate 
was concentrated in vacuo. Purification of the residue by column chromatography afforded 
the desired alcohol.    
 
General Procedure B for Pentafluorophenylations of Aldehydes and Ketones 
The procedure was identical to General Procedure A, except that the appropriate aldehyde or 
ketone were stirred together with the solution of Cu(OAc)2 and dppe for 30 min prior to the 
addition of TMSC6F5. 
 
General Procedure C for Pentafluorophenylations of Aldehydes and Ketones 
This procedure was identical to procedure A except that the workup was altered as follows: 
When the reaction had stopped progressing as observed by TLC analysis, 1 mL of HCl (~ 1M 
in MeOH/H2O, made up by diluting 8.2 mL of 37% HCl up to 100 mL with MeOH) was 
added and the mixture was stirred for 1 h. The solvent was removed in vacuo and the 
resulting mixture was partitioned between saturated aqueous NaHCO3 solution (20 mL) and 
CH2Cl2 (20 mL). The aqueous layer was separated and extracted with CH2Cl2 (20 mL x 3), 
and the combined organic layers were dried (MgSO4) and concentrated in vacuo. Purification 







The title compound was prepared according to General Procedure A from 
benzaldehyde (102 µL, 1.00 mmol) for a reaction time of 2 h and purified 
by column chromatography (10% EtOAc/hexane) to give a colourless oil, which solidified to 
a white solid upon standing (210 mg, 77%). Rf = 0.32 (10% EtOAc/hexane); m.p. 38-41 °C 
(lit22 m.p. 49 °C); IR (Nujol) 3252 (OH), 1654, 1522, 1504, 1456, 1302, 1120, 994, 945, 699 
cm-1; 1H NMR (360 MHz, CDCl3) δ 7.39-7.32 (5H, m, ArH), 6.22 (1H, s, CHOH), 3.32 (1H, 
br, OH); 13C NMR (62.9 MHz, CDCl3) δ 144.6 (2 x C, dm, J = 241.9 Hz), 140.7 (C, dm, J = 
241.0 Hz), 140.4 (C), 137.6 (2 x C, dm, J = 253.2 Hz), 128.7 (2 x CH), 128.2 (CH), 125.3 (2 
x CH), 116.8 (C, t, J = 17.0 Hz), 67.4 (CH); 19F NMR (235 MHz, CDCl3) δ –143.1 (2F, dd, J 
= 21.7, 7.6 Hz, ArF), –154.6 (1F, t, J = 21.2 Hz, ArF), –161.5 (2F, ddd, J = 21.7, 21.2, 7.6 
Hz, ArF); HRMS (EI) Exact mass calcd for C13H7F5O [M
+]: 274.0412, found: 274.0413. 
 
 Naphthalen-1-ylpentafluorophenylmethanol  (4b)  
The title compound was prepared according to General Procedure A 
from 1-naphthaldehyde (136 µL, 1.00 mmol) for a reaction time of 4 h 
and purified by column chromatography (10% EtOAc/hexane) to give white crystals (250 
mg, 77%). Rf = 0.23 (10% EtOAc/hexane); m.p. 104-107 °C; IR (Nujol) 3321 (OH), 1651, 
1522, 1500, 1119, 1082, 992, 940, 798, 776 cm-1; 1H NMR (360 MHz, CDCl3) δ 8.07 (1H, 
dd, J = 8.3, 1.8 Hz, ArH), 7.91 (1H, dd, J = 7.6, 1.8 Hz, ArH) 7.87 (1H, d, J = 8.3 Hz, ArH), 
7.63 (1H, d, J = 7.2 Hz, ArH), 7.60-7.46 (3H, m, ArH), 6.89 (1H, s, CHOH), 2.87 (1H, br, 
OH); 13C NMR (90.6 MHz, CDCl3) δ 144.9 (2 x C, dm, J = 249.4 Hz), 140.8 (C, dm, J = 
254.8 Hz), 137.6 (2 x C, dm, J = 253.5 Hz), 134.8 (C), 133.7 (C), 130.2 (C), 129.3 (CH), 
128.9 (CH), 126.7 (CH), 125.9 (CH), 125.0 (CH), 123.8 (CH), 122.5 (CH), 115.9 (C, t, J = 
14.4 Hz), 65.0 (CH); 19F NMR (235 MHz, CDCl3) δ –142.1 (2F, dd, J = 21.4, 7.2 Hz, ArF), –
154.3 (1F, t, J = 21.2 Hz, ArF), –161.4 (2F, ddd, J = 21.4, 21.2, 7.2 Hz, ArF); HRMS (EI) 
Exact mass calcd for C17H9F5O [M
+]: 324.0568, found: 324.0570. 
 
Pentafluorophenyl-m-tolylmethanol  (4c)  
The title compound was prepared according to General Procedure A 
from m-tolualdehyde (118 µL, 1.00 mmol) for a reaction time of 3 h 
and purified by column chromatography (10% EtOAc/hexane) to give white crystals (280 


















1608, 1522, 1502, 1301, 1118, 1045, 992, 955 cm-1; 1H NMR (360 MHz, CDCl3) δ 7.27 (1H, 
dd, J = 7.6, 7.6 Hz, ArH), 7.20 (1H, s, ArH), 7.19 (1H, d, J = 7.6 Hz, ArH), 7.14 (1H, d, J = 
7.6 Hz, ArH) 6.19 (1H, s, CHOH), 2.85 (1H, br, OH), 2.37 (3H, s, ArCH3); 
13C NMR 
(90.6 MHz, CDCl3) δ 144.6 (2 x C, dm, J = 249.2 Hz), 140.7 (C, dm, J = 254.6 Hz), 140.5 
(C), 138.6 (C), 137.6 (2 x C, dm, J = 253.3 Hz), 129.0 (CH), 128.6 (CH), 126.0 (CH), 122.3 
(CH), 117.0 (C, t, J = 15.2 Hz), 67.6 (CH), 21.4 (CH3); 
19F NMR (235 MHz, CDCl3) δ –
143.1 (2F, dd, J = 21.8, 7.6 Hz, ArF), –154.9 (1F, t, J = 21.3 Hz, ArF), –161.6 (2F, ddd, J = 
21.8, 21.3, 7.6 Hz, ArF); HRMS (EI) Exact mass calcd for C14H9F5O [M





The title compound was prepared according to General Procedure B from 
2-nitrobenzaldehyde (151 mg, 1.00 mmol) for a reaction time of 3 h and 
purified by column chromatography (10% EtOAc/hexane) to give a yellow oil (281 mg, 
88%). Rf = 0.17 (10% EtOAc/hexane); IR (film) 3438 (OH), 1654, 1611, 1578, 1503 (NO2), 
1347 (NO2), 1304, 1119, 996, 951 cm
-1; 1H NMR (360 MHz, CDCl3) δ 8.09 (1H, d, J = 8.3 
Hz, ArH), 8.06 (1H, d, J = 8.3 Hz, ArH) 7.75 (1H, t, J = 7.7 Hz, ArH), 7.54 (1H, t, J = 7.7 
Hz, ArH), 6.81 (1H, s, CHOH), 3.35 (1H, br, OH); 13C NMR (62.9 MHz, CDCl3) δ 146.6 
(C), 145.1 (2 x C, dm, J = 255.2 Hz), 140.7 (C, dm, J = 249.7 Hz), 135.8 (C), 134.9 (2 x C, 
dm, J = 248.0 Hz), 133.8 (CH), 129.1 (CH), 128.7 (CH), 125.1 (CH), 115.6 (C, t, J = 14.8 
Hz), 63.9 (CH); 19F NMR (235 MHz, CDCl3) δ –141.5 (2F, dd, J = 21.0, 6.8 Hz, ArF), –
153.6 (1F, t, J = 20.7 Hz, ArF), –161.5 (2F, ddd, J = 21.0, 20.7, 6.8 Hz, ArF); m/z: No mass 
ion peaks observed under a range of mass spectroscopic techniques. 
 
 (4-Bromophenyl)pentafluorophenylmethanol  (4e)  
The title compound was prepared according to General Procedure B 
from 4-bromobenzaldehyde (185 mg, 1.00 mmol) for a reaction time of 
4 h and purified by column chromatography (10% EtOAc/hexane) to give yellow crystals 
(236 mg, 67%). Rf = 0.26 (10% EtOAc/hexane); m.p. 60-63 °C; IR (Nujol) 3318 (OH), 1653, 
1525, 1501, 1403, 1123, 1075, 1012, 993, 946 cm-1; 1H NMR (360 MHz, CDCl3) δ 7.35 (2H, 
d, J = 8.4, ArH), 7.13 (2H, d, J = 8.4 Hz, ArH), 6.04 (1H, d, J = 5.4 Hz, CHOH), 3.04 (1H, d, 
J = 5.4 Hz, OH); 13C NMR (90.6 MHz, CDCl3) δ 144.6 (2 x C, dm, J = 249.4 Hz), 141.0 (C, 













CH), 122.2 (C), 116.3 (C, t, J = 14.3 Hz), 66.8 (CH); 19F NMR (235 MHz, CDCl3) δ –143.0 
(2F, dd, J = 21.4, 7.4 Hz, ArF), –153.9 (1F, t, J = 21.1 Hz, ArF), –161.1 (2F, ddd, J = 21.4, 
21.1, 7.4 Hz, ArF); HRMS (EI) Exact mass calcd for C13H6BrF5O [M
+]: 351.9517, found: 
351.9516. 
 
 (2,6-Dichlorophenyl)pentafluorophenylmethanol  (4f)  
The title compound was prepared according to General Procedure B from 
2,6-dichlorobenzaldehyde (175 mg, 1.00 mmol) for a reaction time of 5.5 
h and purified by column chromatography (8% EtOAc/hexane) to give pale yellow crystals 
(288 mg, 84%). Rf = 0.27 (10% EtOAc/hexane); m.p. 74-77 °C; IR (Nujol) 3298 (OH), 1651, 
1582, 1565, 1523, 1495, 1439, 1120, 999, 939 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.34 (2H, 
d, J = 8.0 Hz, ArH), 7.23 (1H, t, J = 8.0 Hz, ArH),  6.83 (1H, d, J = 9.1 Hz, CHOH), 3.91 
(1H, d, J = 9.1 Hz, OH); 13C NMR (62.9 MHz, CDCl3) δ 144.8 (2 x C, dm, J = 253.3 Hz), 
140.6 (C, dm, J = 254.4 Hz), 137.5 (2 x C, dm, J = 252.9 Hz), 134.8 (C), 134.7 (2 x C), 130.1 
(CH), 129.4 (2 x CH), 114.7 (C, t, J = 11.9 Hz), 67.7 (CH) ; 19F NMR (235 MHz, CDCl3) δ –
141.7 (2F, dd, J = 22.2, 7.1 Hz, ArF), –155.0 (1F, t, J = 21.5 Hz, ArF), –162.3 (2F, ddd, J = 





The title compound was prepared according to General Procedure C 
from m-anisaldehyde (122 µL, 1.00 mmol) for a reaction time of 17 h 
and purified by column chromatography (10% EtOAc/hexane) to give a colourless oil (210 
mg, 69%). Rf = 0.18 (10% EtOAc/hexane); IR (film) 3486 (OH), 2360, 1652, 1606, 1588, 
1503, 1274, 1228, 1038, 988 cm-1; 1H NMR (360 MHz, CDCl3) δ 7.27 (1H, dd, J = 8.1, 7.9 
Hz, ArH), 6.98 (1H, br, ArH), 6.92 (1H, d, J = 7.9 Hz, ArH),  6.84 (1H, dd, J = 8.1, 2.5 Hz, 
ArH), 6.18 (1H, s, CHOH), 3.81 (3H, s, OCH3), 3.40 (1H, br, OH); 
13C NMR (90.6 MHz, 
CDCl3) δ 159.8 (C), 142.2 (C), 144.6 (2 x C, dm, J = 252.4 Hz), 140.8 (C, dm, J = 257.3 Hz), 
137.6 (2 x C, dm, J = 253.4 Hz), 129.7 (CH), 117.5 (CH), 113.2 (CH), 111.2 (CH), 116.8 (C, 
t, J = 14.8 Hz), 67.2 (CH), 55.1 (CH3); 
19F NMR (235 MHz, CDCl3) δ –143.0 (2F, dd, J = 
21.9 Hz, 7.7 Hz, ArF), –154.7 (1F, t, J = 21.3 Hz, ArF), –161.5 (2F, ddd, J = 21.9 Hz, 21.3 
Hz, 7.7 Hz, ArF); HRMS (EI) Exact mass calcd for C14H9F5O2 [M

















The title compound was prepared according to General Procedure C 
from 4-pyridinecarboxaldehyde (95 µL, 1.00 mmol) for a reaction time 
of 17 h and purified by column chromatography (60% EtOAc/hexane) to give yellow crystals 
(170 mg, 62%). Rf = 0.23 (10% EtOAc/hexane); m.p. 140°C (decomp); IR (Nujol) 3063 
(OH), 1651, 1606, 1504, 1414, 1377, 1346, 1222, 1121, 996 cm-1; 1H NMR (500 MHz, 
CD3OD) δ 8.74 (2H, br, ArH), 7.61 (2H, br, ArH), 6.25 (1H, s, CHOH); 
13C NMR 
(90.6 MHz, CD3OD) δ 153.2 (2 x CH), 149.9 (2 x CH), 146.4 (2 x C, dm, J = 249.3 Hz), 
142.5 (C, dm, J = 252.8 Hz), 139.1 (2 x C, dm, J = 251.6 Hz), 118.3 (C, t, J = 14.9 Hz), 65.7 
(CH), one quaternary peak not detected; 19F NMR (235 MHz, CD3OD) δ –142.3 (2F, dd, J = 
19.8, 6.8 Hz, ArF), –155.3 (1F, t, J = 19.6 Hz, ArF), –162.6 (2F, ddd, J = 19.8, 19.6, 6.8 Hz, 
ArF); HRMS (ESI) Exact mass calcd for C12H7NOF5 [M+H]
+: 276.0442, found: 276.0444. 
 
 (Pentafluorophenyl)thiophen-2-ylmethanol (4m)  
The title compound was prepared according to General Procedure C from 
2-thiophenecarboxaldehyde (92 µL, 1.00 mmol) for a reaction time of 4 h 
and purified by column chromatography (5% EtOAc/hexane) to give yellow crystals (107 
mg, 38%). Rf = 0.37 (10% EtOAc/hexanes); m.p. 54-56 °C; IR (Nujol) 3247 (OH), 1654, 
1522, 1501, 1302, 1234, 1169, 1117, 992, 939 cm-1; 1H NMR (360 MHz, CDCl3) δ 7.18 (1H, 
dd, J = 5.0, 1.0 Hz, ArH), 6.83 (1H, dd, J = 5.0, 3.5 Hz, ArH), 6.78 (1H, d, J = 3.5 Hz, ArH), 
6.24 (1H, d, J = 7.8 Hz, CHOH), 3.10 (1H, d, J = 7.8 Hz, OH); 13C NMR (90.6 MHz, CDCl3) 
δ 144.6 (2 x C, dm, J = 249.8 Hz), 144.1 (C), 140.0 (C, dm, J = 255.1 Hz), 137.6 (2 x C, dm, 
J = 253.9 Hz) 127.0 (CH), 126.0 (CH), 124.9 (CH), 116.3 (C, t, J = 14.8 Hz), 64.3 (CH); 19F 
NMR (235 MHz, CDCl3) δ –143.0 (2F, dd, J = 21.6, 7.6 Hz, ArF), –154.0 (1F, t, J = 21.1 Hz, 
ArF), –161.2 (2F, ddd, J = 21.6, 21.1, 7.6 Hz, ArF); HRMS (EI) Exact mass calcd for 
C11H5F5OS [M




The title compound was prepared according to General Procedure A from 
trans-cinnamaldehyde (126 µL, 1.00 mmol) for a reaction time of 5 h and 
purified by column chromatography (10% EtOAc/hexane) to give a white solid (127 mg, 




















1498, 1124, 1095, 991, 966, 944, 695 cm-1; 1H NMR (360 MHz, CDCl3) δ 7.41-7.26 (5H, m, 
ArH), 6.69 (1H, d, J = 15.8 Hz, PhCH=C), 6.52 (1H, ddt, J = 15.8, 6.8, 1.5 Hz, PhCH=CH), 
5.75 (1H, d, J = 6.8 Hz, CHOH), 2.48 (1H, br, OH); 13C NMR (90.6 MHz, CDCl3) δ 144.7 (2 
x C, dm, J = 249.3 Hz), 141.2 (C, dm, J = 248.3 Hz), 137.6 (2 x C, dm, J = 253.3 Hz), 135.6 
(C), 132.9 (CH), 128.7 (2 x CH), 128.5 (CH), 127.3 (CH), 126.7 (2 x CH), 116.0 (C, m), 66.9 
(CH); 19F NMR (235 MHz, CDCl3) δ –143.4 (2F, dd, J = 21.8, 7.8 Hz, ArF), –154.8 (1F, t, J 
= 21.2 Hz, ArF), –161.6 (2F, ddd, J = 21.8, 21.2, 7.8 Hz, ArF); HRMS (EI) Exact mass calcd 
for C15H9F5O [M
+]: 300.0568, found: 300.0565. 
 
 1-Pentafluorophenyl-3-phenyl-propan-1-ol (4q)  
The title compound was prepared according to General Procedure C from 
hydrocinnamaldehyde (132 µL, 1.00 mmol) for a reaction time of 2.5 h at 
–78 °C and purified by column chromatography (10% EtOAc/hexane) to give a white solid 
(132 mg, 44%). Rf = 0.22 (10% EtOAc/hexane); m.p. 70-72 °C; IR (Nujol) 3195 (OH), 2359, 
1651, 1521, 1497, 1455, 1304, 1124, 1020, 968 cm-1; 1H NMR (360 MHz, CDCl3) δ 7.32-
7.26 (2H, m, ArH), 7.23-7.17 (3H, m, ArH), 5.07 (1H, t, J = 7.9 Hz, CHOH), 2.88-2.80 (1H, 
m, CH2CH2), 2.66 (1H, ddd, J = 14, 9.2, 6.9 Hz, CH2CH2), 2.37 (1H, dddd, 14, 9.2, 7.9, 5.6 
Hz, CH2CH2), 2.21 (1H, br, OH), 2.21-2.11 (1H, m, CH2CH2); 
13C NMR (90.6 MHz, CDCl3) 
δ 144.7 (2 x C, dm, J = 247.8 Hz), 140.5 (C, dm, J = 254.4 Hz), 140.4 (C), 137.5 (2 x C, dm, 
J = 253.0 Hz), 128.5 (2 x CH), 128.3 (2 x CH), 126.2 (CH), 116.9 (C, t, J = 15.4 Hz), 65.8 
(CH), 38.2 (CH2), 32.1 (CH2); 
19F NMR (235 MHz, CDCl3) δ –143.8 (2F, dd, J = 22.0, 8.0 
Hz, ArF), –155.1 (1F, t, J = 21.4 Hz, ArF), –161.8 (2F, ddd, J = 22.0, 21.4, 8.0 Hz, ArF); 
HRMS (EI) Exact mass calcd for C15H11F5O [M
+]: 302.0725, found: 302.0726. 
 
 2-Methyl-1-pentafluorophenylpropan-1-ol (4r)  
The title compound was prepared according to General Procedure C from 
isobutyraldehyde (91 µL, 1.00 mmol) for a reaction time of 3 h at –78 °C 
and purified by column chromatography (8% EtOAc/hexane) to give white crystals (107 mg, 
45%). Rf = 0.26 (10% EtOAc/hexanes); m.p. 39-41 °C; IR (Nujol) 3243 (OH), 1652, 1522, 
1502, 1302, 1145, 1112, 1043, 995, 967 cm-1; 1H NMR (360 MHz, CDCl3) δ 4.62 (1H, d, J = 
9.2 Hz, CHOH), 2.37 (1H, br, OH), 2.16 (1H, m, (CH3)2CH), 1.14 (3H, d, J = 6.6 Hz, CH3), 
0.79 (3H, d, J = 6.8 Hz, CH3); 
13C NMR (62.9 MHz, CDCl3) δ 144.6 (2 x C, dm, J = 245.1 















72.4 (CH), 34.2 (CH), 19.2 (CH3), 18.7 (CH3); 
19F NMR (235 MHz, CDCl3) δ –143.0 (2F, 
dd, J = 22.1, 7.9 Hz, ArF), –155.4 (1F, t, J = 20.8 Hz, ArF), –162.0 (2F, ddd, J = 22.0, 22.0, 
7.8 Hz, ArF); HRMS (EI) Exact mass calcd for C10H9F5O [M
+]: 240.0568, found: 240.0565. 
 
 2,2-Dimethyl-1-pentafluorophenylpropan-1-ol  (4s)  
The title compound was prepared according to General Procedure C from 
trimethylacetaldehyde (109 µL, 1.00 mmol) for a reaction time of 3 h at –
78 °C and purified by column chromatography (10% EtOAc/hexane) to give a colourless oil 
(141 mg, 56%). Rf = 0.38 (10% EtOAc/hexane); IR (film) 3512 (OH), 2363, 1652, 1522, 
1498, 1330, 1121, 1064, 990, 959 cm-1; 1H NMR (360 MHz, CDCl3) δ 4.78 (1H, s, CHOH), 
2.47 (1H, br, OH), 1.00 (9H, t, J = 1.5 Hz, tBu); 13C NMR (90.6 MHz, CDCl3) δ 144.8 (2 x 
C, dm, J = 255.5 Hz), 140.2 (C, dm, J = 253.7 Hz), 137.4 (2 x C, dm, J = 253.0 Hz), 115.3 
(C, t, J = 16.1 Hz), 75.6 (CH), 37.2 (C) 25.5 (3 x CH3); 
19F NMR (235 MHz, CDCl3) δ –
139.4 (2F, dd, J = 22.6, 7.4 Hz, ArF), –155.4 (1F, t, J = 20.8 Hz, ArF), –162.2 (2F, m, ArF); 
m/z: No mass ion peaks observed under a range of mass spectroscopic techniques. 
 
 2-Hydroxy-2-pentafluorophenylpropionic acid ethyl ester (12b)  
The title compound was prepared according to General Procedure C 
from ethyl pyruvate (111 µL, 1.00 mmol) for a reaction time of 23 h and 
purified by column chromatography (10% EtOAc/hexane) to give a 
colourless oil (87 mg, 31%). Rf = 0.24 (10% EtOAc/hexanes); IR (film) 3484 (OH), 2988, 
2923, 1743 (C=O), 1655, 1526, 1495, 1252, 1138, 988 cm-1; 1H NMR (360 MHz, CDCl3) δ 
4.34-4.25 (2H, m, CH2CH3), 4.08 (1H, br, OH), 1.91 (3H, t, J = 3.1 Hz, CCH3), 1.27 (3H, t, J 
= 7.1 Hz, CH2CH3); 
13C NMR (90.6 MHz, CDCl3) δ 174.3 (C), 145.7 (2 x C, dm, J = 251.0 
Hz), 140.9 (C, dm, J = 255.5 Hz), 137.7 (2 x C, dm, J = 253.2 Hz), 116.0 (C, t, J = 12.4 Hz), 
73.3 (C), 63.2 (CH2), 26.2 (CH3, t, J = 5.7 Hz), 13.8 (CH3); 
19F NMR (235 MHz, CDCl3) δ –
139.8 (2F, ddd, J = 19.8, 6.1, 3.1 Hz, ArF), –154.1 (1F, t, J = 20.7 Hz, ArF), –162.0 (2F, ddd, 
J = 20.7, 19.8, 6.1 Hz, ArF); m/z: No mass ion peaks observed under a range of mass 
spectroscopic techniques. 
 
(4-Nitrophenyl)(pentafluorophenyl)phenylmethanol (12c)  
The title compound was prepared according to General Procedure B 























16 h, but with the following workup procedure: 1 mL of HCl (~ 1M in MeOH/H2O) was 
added and the mixture was heated under reflux for 5 h. The solvent was removed in vacuo 
and the resulting mixture was partitioned between saturated aqueous NaHCO3 solution (20 
mL) and CH2Cl2 (20 mL). The aqueous layer was separated and extracted with CH2Cl2 (20 
mL x 3), and the combined organic layers were dried (MgSO4) and concentrated in vacuo. 
Purification by column chromatography (10% EtOAc/hexane) to gave a pale yellow oil (191 
mg, 48%). Rf = 0.29 (10% EtOAc/hexanes); IR (film) 3538 (OH), 3063, 1650, 1606, 1522 
(NO2), 1487, 1349 (NO2), 1112, 994, 701 cm
-1; 1H NMR (360 MHz, CDCl3) δ 8.18 (2H, d, J 
= 9.0 Hz, ArH), 7.50 (2H, d, J = 9.0 Hz, ArH), 7.43-7.41 (3H, m, ArH), 7.30-7.28 (2H, dd, J 
= 6.6, 3.0 Hz, ArH), 3.81 (1H, t, J = 4.5 Hz, OH); 13C NMR (90.6 MHz, CDCl3) δ 151.2 (C), 
147.5 (C), 145.0 (2 x C, dm, J = 249.5 Hz), 143.1 (C), 141.0 (C, dm, J = 256.5 Hz), 138.0 (2 
x C, dm, J = 254.4 Hz), 128.9 (CH), 128.8 (2 x CH), 128.1 (2 x CH), 126.4 (2 x CH), 123.2 
(2 x CH), 119.8 (C, t, J = 11.1 Hz), 80.1 (C); 19F NMR (235 MHz, CDCl3) δ –136.4 (2F, ddd, 
J = 20.3, 5.6, 4.5 Hz, ArF), –153.0 (1F, tt, J = 21.4, 2.8 Hz, ArF), –160.7 (2F, ddd, J = 21.4, 
20.3, 5.6 Hz, ArF); HRMS (EI) Exact mass calcd for C19H10F5NO3 [M
+]: 395.0575, found: 
395.0574.  
 
 (4R)-2,2-Dimethyl-1,3dioxolane-4-carbaldehyde (2u)41  
The title compound was prepared according to a literature procedure.41 To a 
suspension of silica-supported sodium periodate (6.0 g) in CH2Cl2 (15 mL), 
was added 1,2:5,6-di-O-isopropylidene-D-mannitol (0.79 g, 3 mmol) in CH2Cl2 (15 mL).The 
mixture was allowed to stur at room temoerature for 1 hour. The periodate was removed by 
filtration and washed with CHCl3 (3 x 30 mL). The reaction mixture was concentrated in 
vacuo to give the named compound as a colourless oil (0.53 g, 68%), which was used without 
further purification. 1H NMR (360 MHz, CDCl3) δ 9.66 (1H, d, J = 1.8 Hz, O=CH), 4.34 
(1H, ddd, J = 7.2, 4.7, 1.8 Hz, CHCHO), 4.12 (1H, dd, J = 13.3, 7.2 Hz, CH2), 4.06 (1H, dd, 




The title compound was prepared according to General Procedure B from 
2u (130 mg, 1.00 mmol) for a reaction time of 16 h starting at −78 °C and 
warming gradually to room temperature, but with the following workup procedure: TBAF 
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(1.0M in THF, 1 mL) was added and the mixture was stirred at room temperature for 90 
minutes. Saturated NaHCO3 solution (20 mL) was added and the mixture was extracted with 
CH2Cl2 (3 x 20 mL), dried (MgSO4) and concentrated in vacuo. The residue was purified by 
column chromatography (15% EtOAc/hexane) to give a colourless oil (43 mg, 14%, 1.2:1 dr) 
Major diastereomer: 1H NMR (360 MHz, CDCl3) δ 4.91 (1H, d, J = 12.2 Hz, CHOH), 4.49-
4.39 (1H, m, CH2), 4.17 (1H, d, J = 3.6 Hz, OH), 4.12 (1H, dd, J = 10.4, 10.1 Hz, CH2), 3.80 
(1H, d, J = 5.4 Hz, CH), 1.39 (3H, s, CH3), 1.31 (3H, s, CH3); 
19F NMR (235 MHz, CDCl3) δ 
–143.2 (2F, ddd, J = 22.3, 6.3, 5.4 Hz, ArF), –154.6 (1F, tt, J = 20.0, 5.4 Hz, ArF), –162.1 
(2F, ddd, J = 22.3, 20.0, 6.3 Hz, ArF). 
Minor diastereomer: : 1H NMR (360 MHz, CDCl3) δ 4.97 (1H, d, J = 9.4 Hz, CHOH), 4.49-
4.39 (1H, m, CH2), 4.17 (1H, d, J = 1.4 Hz, OH), 4.01 (1H, dd, J = 12.6, 9.4 Hz, CH2), 3.76 
(1H, d, J = 5.3 Hz, CH), 1.52 (3H, s, CH3), 1.38 (3H, s, CH3); 
19F NMR (235 MHz, CDCl3) δ 
–142.1 (2F, ddd, J = 22.0, 6.9, 2.4 Hz, ArF), –154.1 (1F, tt, J = 21.2, 2.4 Hz, ArF), –162.1 
(2F, ddd, J = 22.0, 21.2, 6.9 Hz, ArF). 
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3. Enantioselective Synthesis of Fluoroalkylated 
Stereocentres 
 
3.1   Introduction 
 
With the exception of the fluorine atom itself, the trifluoromethyl group is the most common 
fluorine-containing functional group used in medicinal chemistry.43 Some examples of 
commercial products containing trifluoromethyl stereocentres are given in Scheme 3.1. 






There are complementary approaches to the enantioselective synthesis of chiral 
fluoroalkylated species: direct enantioselective fluoroalkylation, or the asymmetric 
elaboration of a prochiral fluoroalkylated molecule.   
 
3.1.1 Direct Enantioselective Trifluoromethylation 
 
In recent years, direct trifluoromethylation has become a rapidly growing field. The 
introduction of a trifluoromethyl group into a molecule differs from the introduction of single 
fluorine atoms, as it is a carbon−carbon bond-forming reaction. However, methods that are 
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applicable for the introduction of methyl groups are rarely compatible with the 
trifluoromethyl group. This makes direct trifluoromethylation a unique challenge. 
 
There are three broad categories of direct trifluoromethylation, each with its own difficulties. 
These are radical, electrophilic and nucleophilic trifluoromethylations. Direct nucleophilic 
trifluoromethylation is by far the most developed of these fields and it is in this area that the 
current literature on the development of asymmetric trifluoromethylation reactions is focused 
upon.  
 
The trifluoromethyl anion is intrinsically unstable and readily undergoes α-elimination of 
fluoride to generate difluorocarbene. As a result, it is necessary to stabilise trifluoromethyl 
anion equivalents and the most common method for this is the use of a metal centre. In 1984, 
Ruppert reported the synthesis of (trifluoromethyl)trimethylsilane (32).44 Five years later, the 
reagent was first used by Prakash to trifluoromethylate carbonyl compounds45 and since then 
it has been used extensively in nucleophilic trifluoromethylation reactions.  
 
Ruppert’s reagent is used very regularly in trifluoromethylation reactions as a result of its 
stability, non-toxicity and relatively low cost. TMSCF3 does not itself react with 
electrophiles. However, the silicon centre is highly susceptible to nucleophilic attack, giving 
rise to a pentavalent silicon complex, which can transfer the CF3 group to a suitable 
electrophile. Other fluoroalkyl or fluoroaryl silane reagents can be used in the same manner 
to introduce fluorine-containing functional groups such as the pentafluoroethyl, 
heptafluoropropyl, or pentafluorophenyl (vide supra) groups. 
 
The mechanism for this reaction is shown in Scheme 2.2 for the pentahalogenophenyl 
analogues. Examples of nucleophilic activators that have been employed with Ruppert’s 
reagent in trifluoromethylation reactions are TBAF,45 KOtBu45 and CsF.46 Logically, the use 
of chiral activators for Ruppert’s reagent would seem to be an excellent strategy for 
asymmetric nucleophilic trifluoromethylation. Indeed, there have been many reports of such 
an approach to the trifluoromethylation of carbonyls, with varying levels of success. One 
example which shows particular promise was reported by Shibata in 2007.47 A chiral 
quaternary ammonium bromide is employed in conjunction with tetramethylammonium 
fluoride to synthesise trifluoromethyl alcohols from ketones (Scheme 3.2). Three substrates 
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are trifluoromethylated with ees greater than 90% and there are a further 10 examples with 





This methodology has also been extended to the trifluoromethylation of azomethine imines in 
the first example of the enantioselective nucleophilic trifluoromethylation of C=N bonds.48 
The enantiomeric excesses are even higher than those obtained for alkyl aryl ketones with 10 






Although much less common than nucleophilic examples, there have been reports of 
enantioselective electrophilic trifluoromethylations. Most of these gave very disappointing 
enantioselectivities and/or required expensive or non-commercial trifluoromethyl sources. By 
far the most impressive example to date of an enantioselective electrophilic 
trifluoromethylation is that published by Macmillan and co-workers in 2010.49 This approach 
employs Togni’s reagent (39), a hypervalent iodonic trifluoromethylation reagent, along with 
a Lewis acid and an organocatalyst to carry out the enantioselective α-trifluoromethylation of 
aldehydes. The reaction works well for a wide range of aldehyde substrates and the 






The proposed mechanism for this reaction is given in Scheme 3.5. Togni’s reagent undergoes 
Lewis acid-catalysed cleavage of the I−O bond to generate 43, a highly electrophilic 
iodonium salt. Compound 43 will then react with the enamine species (42), generated by the 
condensation of the aldehyde substrate with the organocatalyst, from the least sterically 
hindered face, to form 44. Reductive elimination at the iodine centre then generates the 
desired C−CF3 bond with retention of stereochemistry. Hydrolysis of the iminium ion will 































































The only example in the literature of an effective enantioselective radical 
trifluoromethylation also comes from the MacMillan group.50 In 2009, they published their 
first report of the enantioselective α-trifluoromethylation of aldehydes using photoredox 
organocatalysis (Scheme 3.6). An organocatalyst is used as above to generate a chiral 
enamine, which is selectively attacked at the least hindered face by a trifluoromethyl radical. 
The trifluoromethyl radical is generated through the use of visible light in conjuction with 
Ir(ppy)2(dtb-bpy)
+ (46). Again, the conditions are tolerant of a range of functionalities and 





Despite the significant level of interest in enantioselective trifluoromethylation reactions, 
there is still a lack of general methods that consistently give high yields and ee values. There 
are also limited motifs for which the above synthetic approaches can be used. For example, 
the direct asymmetric trifluoromethylation approach has not been used to synthesise 
molecules with all-carbon quaternary stereocentres. One possible method for the generation 
of all-carbon stereocentres is through a conjugate addition reaction. However, the conjugate 
addition of Ruppert’s reagent has only been described in limited cases for particularly 
reactive substrates35,51 and there has never been a report of an enantioselective version.   
 
In these cases, the most commonly used method is the asymmetric elaboration of prochiral 
trifluoromethyl alkenes. Reviews on the reactions of prochiral trifluoromethyl substrates have 
been published52 and, as such, we will limit ourselves here to the most relevant substrates to 
this work: β-fluoroalkyl-α,β-unsaturated carbonyls.  
 
3.1.2 Asymmetric Elaboration of β-Fluoroalkyl-α,β-Unsaturated Carbonyl 
Compounds 
 
The great utility of α,β-unsaturated carbonyl compounds is due to presence of two reactive 
sites. Although this can cause problems initially due to the requirement for careful control of 
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regiochemistry, it can allow for simple further elaboration of the molecule leading to a rapid 
increase in complexity. The introduction of a trifluoromethyl substituent into the β-position 
of such substrates allows for the asymmetric synthesis of a fluorinated stereocentre through 
conjugate addition or the synthesis of a chiral fluoroalkylated allylic alcohol through a 1,2-
addition. 
 
There are several examples of asymmetric reactions on β-trifluoromethyl-α,β-unsaturated 
carbonyl compounds. 
 
3.1.2.1    Asymmetric Reduction of β-Trifluoromethyl-α,β-Unsaturated Carbonyl 
Compounds 
 
In 2006, the group of Sodeoka described an asymmetric palladium-catalysed conjugate 
reduction of enones.53 One of the examples from this publication is the reduction of (Z)-47a, 
a β-trifluoromethyl enone to give 48a as product in 85% yield with a good 84% enantiomeric 
excess (Equation 3.1). The reaction proceeds through the generation of Pd-H from ethanol 





Szőllősi reported attempts to carry out an asymmetric palladium-catalysed conjugate 
reduction of fluorinated α,β-unsaturated carboxylic acids.54 Unfortunately, although these 
substrates were found to be reactive under a range of conditions, the enantioselectivity 
remained low (Equation 3.2). The reaction was also found to lack generality, as application 






An improved result was disclosed by Alimardanov and co-workers in the following year.55 
Their catalyst system used rhodium in conjunction with a chiral Walphos ligand to give the 
desired product in quantitative yield with an enantiomeric excess of >99%. However, as this 
reaction was developed as part of a process-scale synthesis, there is only one substrate 
example in this publication (Equation 3.3).   
 
























Another rhodium-catalysed reduction was reported by Benhaim and co-workers.56 In this 
case, the substrates were tetrasubstituted β-trifluoromethyl-α-dehydroamino esters. The effect 
of the ligand employed was found to differ from substrate to substrate. The optimum ligand 
found for substrates with an aryl group attached directly to the double bond (Ph-BPE) was 
different from that required when this was not the case (TCFP). As such, there were two 
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different sets of optimised conditions employed to obtain high yields and excellent 
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Konno and co-workers have described the enantioselective synthesis of compounds with an 
allylic trifluoromethyl stereocentre starting from β-trifluoromethyl-α,β-unsaturated ketones.57 
Their approach commenced with the asymmetric reduction of the carbonyl moiety, followed 
by mesylation or acetylation of the product thus formed (56) to give a leaving group. The 
optically active mesyl or acetyl compounds (57 and 58) were then subjected to a palladium-
catalysed formate reduction to give the corresponding product, 59 (Scheme 3.8). The initial 
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reduction was carried out using Noyori’s BINAL-H reagent. For the two examples described, 
enantiomeric excesses of 88% and 76% were obtained. No loss of ee occurred during the 
mesylation or acetylation step. However, the palladium-catalysed formate reduction step did 
result in a significant decrease in ee for substrate 59b.     
 
(E)-47a : R = Me






THF, –78 °C, 2h
56a : 88% ee






57 : R2 = Ms (88% ee)







or PPh3 (for 58) (10 mol%)
Pd2 (dba)3 CHCl3 (2.5 mol%)
DMF, 80 °C, 2h
59a : 83% ee







Reductions are not the only type of asymmetric reaction that have been reported for these 
substrates. Conjugate additions of various carbon nucleophiles have also been described. 
 
3.1.2.2    Enantio- and Diastereoselective Conjugate Additions to β-
Trifluoromethyl-α,β-Unsaturated Carbonyl Compounds and Sulfoxides 
 
As we have seen, several enantioselective reductions of β-trifluoromethyl α,β-unsaturated 
carbonyl compounds exist. In contrast, the vast majority of the conjugate addition of carbon 
nucleophiles to these substrates that give chiral products are carried out diastereoselectively. 
This can be through the use of a chiral auxiliary or by reaction with an enantiomerically pure 
nucleophile.  
 
Similarly to unsaturated carbonyl compounds, unsaturated sulfoxides, sulfones and 
sulfonamides make excellent substrates for conjugate addition reactions. An additional 
benefit to using such compounds is that sulfoxides can be chiral and, as such, 
diastereoselective reactions can be carried out on these substrates to generate trifluoromethyl 
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stereocentres stereoselectively. Ishikawa has reported the Michael reaction of 3,3,3-trifluoro-
1-propenyl phenyl sulfoxide with a range of enolates.58 The diastereoselectivities were very 
high in cases when the enolate was derived from a methyl ketone (Scheme 3.9). The 
diastereoselectivity of this reaction is explained by an 8-membered ring transition state in 
which the p-Tol group occupies a pseudo-equatorial position, thus decreasing the steric clash 
with R1 (Figure 3.1). However, control over the relative positioning of the trifluoromethyl 
stereocentre and the additional stereocentre formed when R2 ≠ H was much poorer. This is 
likely to be due to poor selectivity in enolate formation from 10. The major product is that 
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The group of Bravo have shown that α-(fluoroalkyl)-β-sulfinylenamines can undergo reaction 
with a range of nitrogen, oxygen or carbon-based nucleophiles.59 Unfortunately, the measured 
diastereoselectivities were 1:1 for all examples (Scheme 3.10). The reaction of these 
substrates with sulfur nucleophiles, such as thiophenol, did not give the desired product; 
reduction of the sulfoxide group to the sulfide was observed. In a further publication by the 
same authors, the introduction of a CN nucleophile (63d) was also shown to work well, 





Better selectivity is often observed when α,β-unsaturated carbonyl compounds are used. In 
particular, several diastereoselective or enantioselective conjugate additions to 4,4,4-
trifluorocrotonate substrates and their derivatives have been reported. The first example was 
described by Yamazaki and co-workers in 1995.61 Two stereocentres (one of which bears a 
trifluoromethyl substituent) could be created by the conjugate addition of chiral 
oxazolidinone-containing enolates to ethyl 4,4,4-trifluorocrotonate, often with excellent 







A third stereocentre could be generated if the ester employed was changed from an ethyl to 
an allylic group.62 In a one-pot procedure, the conjugate addition reaction was followed by 
the addition of TMSCl to generate ketene silyl acetal, 68, which underwent an Ireland-
Claisen rearrangement to give 69 (Scheme 3.12). Addition of PdCl2(PhCN)2 at this point 
prevented the generation of unwanted side-products. The product was obtained selectively as 
a single diastereomer, although variable amounts of the ester formed after the initial 






The same group have also reported the reaction of chiral 4,4,4-trifluorocrotonimide substrates 
with organocopper reagents.63 Excellent yields were obtained for a range of nucleophiles, 
although the diastereomeric excesses were variable (Scheme 3.13). In some cases, the 






The conjugate addition of a Ni(II) complex of a chiral Schiff base (made from glycine and a 
chiral benzophenone) to ethyl 4,4,4-trifluorocrotonate has also been reported (Scheme 
3.14).64 Interestingly, if the reaction was halted after 30 seconds, the isolated yield obtained 
was only 64%, but the diastereomeric ratio was excellent (97:3), whereas after 23 hours 
reaction time, the isolated yield increased to 97%, but the diastereomeric ratio became much 
poorer (81:19). This suggested that the reaction was reversible and the amount of the 





Another set of nucleophiles that have been reported in the diastereoselective conjugate 
additions of chiral compounds to 4,4,4-trifluorocrotonates, are N-sulfinyl nitroamines.65 After 
the conjugate addition, the sulfinyl group was removed with TFA, followed by purification 
by chromatography using SCX ion exchange resin. The desired nitropiperidone products are 






All of the conjugate additions described thus far have been diastereoselective reactions of 
chiral molecules. However, the group of Konno have described the enantioselective rhodium-
catalysed arylation and alkenylation of β-trifluoromethyl-α,β-unsaturated carbonyl 
compounds with boronic acids.66 Excellent yields and enantioselectivities were obtained for a 
range of aryl boronic acids, although reaction with alkenylboronic acids gave somewhat 
lower ee values (Scheme 3.16). The methodology was also successfully extended to an 




























































Another example of an enantioselective conjugate addition in which β-trifluoromethyl-α,β-
unsaturated compounds have been reported is the Friedel-Crafts reaction. In 2010, Shibata 
described the enantioselective reaction of pyrroles with a β-trifluoromethyl acrylate under 
chiral Lewis acid catalysis (Scheme 3.17).67 Yields and enantioselectivities were excellent 
and the utility of the products was demonstrated in the synthesis of trifluorinated heliotridane, 










































































83a 84  
Scheme 3.17 
 
The above reactions show that conjugate addition to fluoroalkylated unsaturated carbonyl 
compounds can be an effective approach to the synthesis of chiral fluorinated molecules. 
However, there are still many unexplored possibilities for these unsaturated substrates, such 
as the enantioselective synthesis of quaternary stereocentres or reactions that do not require 
chiral auxiliaries to give high ees.  
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3.1.2.3    Asymmetric Cycloadditions of β-Trifluoromethyl-α,β-Unsaturated 
Sulfones and Nitroalkenes 
 
Another class of reactions that has been applied to β-trifluoromethyl-α,β-unsaturated carbonyl 
compounds to selectively give a trifluoromethyl-bearing stereocentre is the cycloaddition 
reaction.  
 
The first such example was revealed by Carretero in 2007.68 A β-trifluoromethyl vinyl 
sulfone reacted with an azomethine ylid in a 1,3-dipolar cycloaddition reaction under copper 
(I)-Taniaphos catalysis to give pyrrolidine 87 in moderate yield and enantiomeric excess 





Another 1,3-dipolar cycloaddition has been reported by Zanda.69 Here, the reaction of a β-
trifluoromethyl nitroalkene with a chiral nitrone gave trifluoromethylated isoxazolidines in a 





Cycloadditions on unsaturated trifluoromethylated substrates have been shown as a method 
for the synthesis of chiral fluorinated materials by which several stereocentres can be 
controlled at once. 
 
Although a number of enantioselective reactions have been carried out on β-trifluoromethyl 
α,β-unsaturated compounds, there is still plenty of scope for new methodology employing 
these substrates to give chiral trifluoromethylated products. For example, the synthesis of 
quaternary stereocentres through conjugate addition or the development of more general 





4.    Copper-Hydride Reductions of β-Fluoroalkyl-α,β-
Unsaturated Carbonyl Compounds 
 
4.1.  Introduction 
 
The enantioselective formation of C-H bonds can be achieved through conjugate reductions. 
CuH is a mild source of hydride, which has shown versatility in highly regioselective and 
enantioselective conjugate reductions of α,β-unsaturated acceptors. Reviews of copper-
catalysed reductions have been published.70  
 
4.1.1    Conjugate CuH Reductions of α,β-Unsaturated Carbonyl 
Compounds 
 
The most significant development in the field of CuH reduction chemistry was the discovery 
of the synthetic potential of Stryker’s reagent in 1988.71 Stryker’s reagent is [(PPh3)CuH]6, a 
hexamer in which the Cu-H species is stabilised by phosphine ligands. There are several 
different reported methods for the synthesis of the reagent, but, in general, the rigorous 
exclusion of air is necessary and Stryker’s reagent must be stored under inert conditions. 
Scheme 4.1 illustrates the effectiveness of Stryker’s reagent in the selective reduction of α,β-



























Scheme 4.1 a0.16 equiv Stryker’s reagent used. 
 
Although Stryker’s reagent was originally reported as a stoichiometric reductant, possibilities 
for its employment in much more atom-economic catalytic processes were realised very 
early.72 Stryker reports that the reaction of 2-cyclohexen-1-one with a substoichiometric 
quantity of [(PPh3)CuH]6 in benzene or toluene under 80 psi of hydrogen resulted in slow 
conversion to cyclohexanone as the sole product. They also describe the in-situ generation of 
CuH by stirring CuOtBu and PPh3 in toluene. At a hydrogen pressure of 200 psi, the reaction 
occurred more rapidly, but over-reduction to cyclohexanol was observed.   
 
The extreme air-sensitivity of CuOtBu is a major disadvantage of the system. Cu(OAc)2·H2O 
has been found to act as a convenient alternative.73 Another improvement in recent years has 
been the development of silanes as a source of stoichiometric hydride. Silanes are generally 
inexpensive and environmentally benign and several have been reported in CuH reductions; 
the most popular being polymethylhydrosiloxane (PMHS), tetramethyldisiloxane (TMDS), 
Fleming’s silane (PhMe2SiH) and phenylsilane. 
 
The reductions can be made enantioselective if the triphenylphosphine ligands are replaced 
with chiral non-racemic bisphosphines. The earliest asymmetric reports came from the group 
of Buchwald. In 1999, the group reported the enantioselective conjugate reduction of α,β-
unsaturated esters in excellent yields and enantiomeric excesses employing PMHS as the 
hydride source and p-tol-BINAP as the ligand (Scheme 4.2).74 Two equivalents of ligand per 
metal centre were used as this was shown to give higher ees, although experiments 
employing p-tol-BINAP ligands of different enantiomeric purities showed that the active 






The proposed catalytic cycle for the conjugate reductions is given in Scheme 4.3.70(a) The 
copper hydride species 96 generated in-situ reacts with a molecule of the substrate to form a 
π-complex 97. The hydride is then delivered to the β-carbon to give the copper enolate 98, 
which undergoes metathesis with the stoichiometric source of hydride via transition state 99 





In 2000, the same group reported the enantioselective reduction of β-alkyl cyclopentanones 
under the same conditions (Scheme 4.4).75 Again, enantiomeric excesses were excellent. The 
amount of PMHS used had to be restricted to 1.05 equivalents as any excess led to over-






This chemistry has also found application in the dynamic kinetic resolution of 
cyclopentenones.76 High diastereomeric ratios and enantiomeric excesses were obtained for a 
number of 2,4-dialkylcyclopent-2-enones (Scheme 4.5). Scheme 4.6 shows the reasoning 
behind the authors’ choice of conditions for this resolution. As illustrated in Scheme 4.3, 
conjugate reduction of the enone generates a copper enolate. In the presence of a silane, σ-
bond metathesis occurs to give a silyl enol ether product 106. Under basic conditions, rapid 
racemisation of the starting material at the stereocentre α to the carbonyl will occur, but the 
product, as a silyl enol ether, will not undergo epimerisation. Screening revealed that the 
optimised conditions required stoichiometric NaOtBu as the base and PMHS as hydride 
source. tBuOH was required in order to speed up epimerisation to match the rate of conjugate 
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Scheme 4.6 
 
The scope of the reaction has also been extended to cover α,β-unsaturated lactones and 
lactams (Equation 4.1).78 The authors also disclose the use of bulky alcohols to accelerate 
catalyst turnover. This increase in turnover rate not only decreases reaction times, but also 






Up to this point, all of the catalytic reductions of enones that had been described were only 
effective for cyclic substrates. The first report of the CuH conjugate reduction of acyclic 
enones in high yields and enantiomeric excesses was published by Lipshutz in 2003.79 
Various bisphosphine ligands were employed, with those in the Josiphos class exhibiting the 





Acyclic unsaturated esters have also been reduced in excellent yields and enantioselectivities 
(Scheme 4.8).80 A catalyst loading as low as 0.1 mol% of Stryker’s reagent could be 
























































Catalytic asymmetric conjugate reductions have also been applied to substrates containing a 
heteroatom on the β–carbon of the alkene as an approach to the synthesis of novel β-
azaheterocyclic acid derivatives (Scheme 4.9).81 A range of β-amino-substituted α,β-
unsaturated esters were reduced in excellent yields and high enantiomeric excesses under 
conditions that did not require rigorous exclusion of air or moisture (a calcium sulphate guard 
tube was used). Substrates with bulky substituents in the β-position, such as 109c, required 
long reaction times in order to go to completion. As moisture reacts competitively with the 
silanes, 6-10 equivalents of PMHS was used in these cases. This reaction has been utilised in 






Another subset of α,β-unsaturated esters for which asymmetric CuH reductions have been 
reported are those with a β-silyl substituent.83 Yields and enantiomeric excesses reported are 
generally above 90% although the reaction times required are higher than those for other 





Enones and enoates are not the only unsaturated substrates that have been shown to undergo 
asymmetric copper hydride reductions. There have also been reports of the reduction of 
nitroalkenes84 and α,β-unsaturated nitriles,85 sulfones86 and phosphonates.87  
 
Within the Lam group, it has been shown that 2-alkenylheteroarenes are excellent substrates 
for asymmetric conjugate reduction chemistry.88 Very high yields and ees were obtained for 
substrates with varying heterocycles and with a range of substituents in the β-positions 
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(Scheme 4.11). Control experiments carried out on 3- and 4-alkenylheteroarenes have shown 







Whilst in all the above examples conjugate reduction was observed, it is also possible to carry 




4.1.2    Asymmetric Copper-Catalysed Hydrosilylations of Carbonyl 
Compounds and Imines 
 
The first published example of the application of the above described enantioselective CuH 
reduction chemistry conditions to carbonyl compounds was described by Lipshutz in 2001.89 
A range of aromatic ketones underwent hydrosilylation in excellent yields with high 
enantiomeric excesses (Scheme 4.13). With (R)-3,5-xylyl-MeO-BIPHEP as ligand and 
PMHS as hydride source at −50 ºC, ligand loadings as low as 0.005% allowed complete 





At about the same time, the group of Riant published an asymmetric reduction of alkyl aryl 
ketones catalysed by a copper fluoride complex (Scheme 4.14).90 (S)-BINAP was selected as 
a suitable chiral ligand and phenylsilane was preferred as hydride source, although cheaper 
reagents such as PMHS could be used if slower reaction rates were acceptable. Interestingly, 
this methodology used oxygen to accelerate the reaction, thus allowing decreased catalyst 
loadings to be employed. Yields are excellent for all examples shown and enantiomeric 
excesses are good to excellent with the exception of α-ketoester or dialkyl ketone substrates 





Heteroaromatic ketones have also been reduced asymmetrically using copper hydride 
catalysis.91 Pyridine, furan, thiazole and isoxazole substrates all underwent reaction under 
optimised conditions to give desired product in excellent yields and highly promising 
enantioselectivities (Scheme 4.15). Surprisingly, despite these successes, the pyrrole and 
thiophene equivalents did not give any conversion, even at room temperature. The reasons for 




























































In 2005, Chan published a set of conditions for the asymmetric hydrosilylation of ketones, 
which combines the excellent enantioselectivities given by Lipshutz’s conditions and the air 
and moisture stability of Riant’s approach.92 The authors also extended the substrate scope to 
include substituted benzophenones, although enantiomeric excesses for these examples were 





Riant has also published a detailed study on the effects of temperature and ligand structure in 
these enantioselective hydrosilylation reactions.93 The authors discovered that strongly 
electron-donating bisphosphine ligands gave an accelerated reaction rate, but (S)-BINAP 
remained the ligand that gave the highest enantiomeric excess. The effect of temperature on 
ee was found to be more complicated. With (S)-BINAP or (R)-MeO-BIPHEP as ligand, there 
was a linear decrease in enantiomeric excess as the temperature was decreased until −40 °C at 
which point a minima was observed. A small increase in ee was then observed as the 
temperature was further decreased. This behaviour suggests that a change in mechanism 
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occurs at −40 °C. However, when a bulkier ligand ((R)-DTBM-MeO-BIPHEP) was 
employed, a linear increase in enantioselectivity was seen as the temperature was decreased. 


















































Monodentate ligands have also been reported in asymmetric copper-catalysed 
hydrosilylations.94 The optimised conditions gave generally high yields and enantiomeric 
excesses for the reduction of aryl alkyl ketones (Scheme 4.18). Extending the reaction to 







A kinetic resolution of chiral secondary alcohols using copper hydride chemistry has been 
described by the group of Oestreich.95 Their approach uses silanes which are stereogenic at 
the silicon centre. Scheme 4.19 shows the logic behind the design of this resolution. If the 
stereogenic silane, 120, reacts preferentially with one enantiomer of alcohol 121 to form one 
diastereomer of 122 then the opposite alcohol enantiomer will remain and be 
enantioenriched. Reductive cleavage of the Si-O bond would allow the silane reagent to be 







Optimised conditions for the resolution are shown in Scheme 4.20. The yields of both 
obtained products are excellent across 7 racemic alcohol starting materials and ees are good, 






Other applications of asymmetric hydrosilylation chemistry are given in a publication by the 
group of Lipshutz,96 which displays the utility of this methodology through its use in the 






In 2010, Lipshutz published the first example of a selective, asymmetric 1,2 reduction of 
enones using CuH chemistry (Scheme 4.22).97 A range of α-substituted enones were 
hydrosilylated in excellent yields with excellent enantiomeric excesses to give chiral allylic 
alcohols. The switch in selectivity for these substrates is believed to be due to the α-

























































Whilst all of the work described above employs chiral phosphorus ligands, other ligand 
classes can be used. In particular, NHCs have been shown to work extremely well in this 
chemistry.98 However, there are currently no examples of the application of chiral NHCs in 
copper hydride reductions.  
  
There has also been one report of the asymmetric hydrosilylation of imines under copper 
catalysis.99 A phosphinyl residue was used as the substituent on nitrogen for several reasons. 
Firstly, these derivatives are easy to form and give a single isomer (E) at the C=N bond. It 
was also expected that the presence of the phosphorus would decrease the strength of the Cu-
N bond in the intermediate formed after reduction, thus accelerating the rate of catalyst 
turnover. Optimisation of reaction conditions showed that TMDS was the best silane source, 
whilst (R)-DTBM-SEGPHOS gave the best enantiomeric excesses as ligand. A range of 
imines were reduced under these conditions to give the desired products with excellent yields 





Until recently, the mechanism of Cu-catalysed hydrosilylations was assumed to be similar to 
the proposed conjugate reduction mechanism (Scheme 4.3). However, a recent publication by 
Nikonov has cast significant doubts on this as a likely mechanism.100 Using deuterium-
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labelling experiments, the authors have shown that the hydride is transferred directly from the 
silicon species and not from the copper centre. On the other hand, the copper is required for 
the reaction to proceed. No alternative mechanism is proposed, but it is likely that the 
transition state involves both the silicon species and the copper-ligand complex. Further work 
is required for a full understanding of the mechanism of these hydrosilylation reactions. 
 
As we have seen, CuH reduction chemistry is a flexible method for the enantioselective 
synthesis of molecules from carbonyl compounds, whether α,β-unsaturated or not. 
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4.2   Results and Discussion 
 
4.2.1    Enantioselective Copper-Catalysed Reductions of β-Fluoroalkyl-
α,β-Unsaturated Ketones 
 
As we have seen, β-fluoroalkyl-α,β-unsaturated carbonyl compounds have been shown to be 
effective prochiral substrates in the asymmetric synthesis of chiral fluoroalkyl-containing 
compounds. However, the majority of conjugate additions carried out upon fluorinated 
enones have employed chiral auxiliaries. This makes such processes less atom-economic and 
requires additional steps for the addition and removal of the auxiliary. A more efficient 
approach could be developed through the use of asymmetric catalytic methodology. To this 
end, we have conducted an exploration of the reactivity of β-fluoroalkyl-α,β-unsaturated 
carbonyl compounds under established asymmetric metal-catalysed procedures. 
 
The initial aim of this project was to develop a set of conditions for the asymmetric Cu-
catalysed conjugate reduction of β-fluoroalkyl enones selectively generating a new 





Firstly, a selection of β-fluoroalkyl enones (Scheme 4.24) were synthesised from the 
commercially available fluoroalkyl ketones using Wittig chemistry. The reactions were 
conducted at reflux. Whilst the reactions go to completion within an acceptable time at lower 
temperatures, better selectivity of double bond geometry (up to >19:1) was obtained at reflux. 




















































Scheme 4.24 Yields shown are those of the isolated major isomer. 
 
A method was then required for the identification of the geometry of the major isomer in each 
case. In order to achieve this, a 1H-19F HOESY (Heteronuclear Overhauser Effect 
Spectroscopy) NMR experiment was employed. This technique shows through-space 
correlations between protons and fluorine atoms. The signal indicated in Figure 4.1 was 






Enone 129a was then subjected to some standard copper hydride reduction conditions. Initial 
conditions for the attempted reduction of 129a were Cu(OAc)2·H2O (10 mol%), (±)-BINAP 
(10 mol%), tetramethyldisiloxane (TMDS) as reductant (4 equiv), and tBuOH (4 equiv) in 
toluene at room temperature. To our surprise, the only obtained product was that of 1,2-
reduction rather than the expected 1,4-reduction (Equation 4.3). Before the report published 
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by Lipshutz in 2010, there was no literature precedent for the direct Cu-catalysed reduction of 
carbonyl compounds in the presence of a conjugated double bond. Therefore, it was decided 
that this reaction warranted further investigation and screening for high enantiomeric excess. 
The products of the 1,2-reduction are chiral fluoroalkylated allylic alcohols. As there is a vast 
amount of established methodology for the manipulation of chiral allylic alcohols, it was 





Before extensive screening was conducted, a substrate with a less bulky group than phenyl in 
the β-position (129b) was also tested in the reduction, as steric hindrance seemed a likely 
explanation for the switch in selectivity.  Under the same conditions, 129b was found to give 
90% of the 1,2 reduction product, 133b, and 10% of the 1,4 reduction product, 130b 
(Equation 4.4). A control reaction also showed that in the absence of the copper catalyst, no 





Optimisation of the reaction conditions then began with the major aim being the development 
of an asymmetric reaction. The first reaction parameter that was explored was the chiral 




Table 4.1 Signs in parenthesis are those of the optical rotation. 
 
An interesting observation made during ligand screening is that enantiomeric excesses 
decreased (sometimes very significantly) upon the employment of bulkier ligands within a 
certain class. For example, (S)-SEGPHOS gave an ee of 64%, whilst the much more hindered 
(S)-DM-SEGPHOS gave only 37%. Another, smaller, decrease in enantioselectivity (to 33%) 
was seen when the larger-still (S)-DTBM-SEGPHOS was used. (S)-SEGPHOS and (R)-
BINAP were found to give the same ee value (although with the opposite enantiomers being 
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predominant) of 64%. None of the other bisphosphine ligands screened offered any 
improvement in this value. No reaction was observed when nitrogen-based ligands were 
tested.  
 
Further screening of reaction conditions was carried out using (R)-BINAP as ligand. When 
the temperature was decreased to 0 °C, no improvement in enantiomeric excess was 
observed. Changing the copper source, solvent and the reductant employed often had an 
effect on conversions and reaction rates, but also failed to significantly increase the ee. 
However, the reaction was found to be cleaner when PMHS was used. The ee under these 
conditions was 68% and this was the highest that was observed during screening. Upon scale-
up, extremely low isolated yields were observed with PMHS as hydride source. Switching to 
phenylsilane gave much improved yields, but a slightly decreased ee. The best conditions that 





Other substrates were also tested under these conditions (Scheme 4.26). The enantiomeric 
excesses measured were found to be much lower when ketones other than methyl ketones 
were reduced. It is likely that this is a result of the decreased steric discrimination between 
the two sides of the ketone. Patterns were also observed with the ratio of 1,2- to 1,4-product 
obtained. For methyl ketone substrates (129a, 129c and 129f), no 1,4-product was seen. For 
129e with a bulky aryl substituent both adjacent to the carbonyl and in the β-position, only 
1,2-product was obtained. However, for 129b which has a much smaller methyl group at the 
β-position, as well as a phenyl ring adjacent to the carbonyl, there was a 3:1 ratio of 1,2- to 
1,4-reduction. 129d, which has these characteristics in conjunction with an electron-donating 
substituent on the aromatic ring making the ketone less electrophilic, gave a 1:1.6 ratio of 



























































Scheme 4.26 Yields given are those of isolated product. Reactions were conducted on 0.5 mmol of 
unsaturated ketone. a Isolated as a mixture with 134. 
 
Whilst complete conversion to reduction product was seen for all other substrates tested, a 
side-product (from which the reduction product was found to be inseparable) was observed 
for 129c that constitutes 25% of the reaction mixture. This product, difluoroalkene 134, is 





There are a few reports in the literature of reductive defluorinations catalysed by metal 
species, specifically organocopper reagents101,63 or samarium iodide.102 For example, the 
group of Otaka have reported the synthesis of phosphopeptide mimics employing the 
organocopper-catalysed reductive defluorination of γ-difluoro-α,β-unsaturated carbonyl 






A mechanism for this process has been proposed (Scheme 4.28).103 A single electron transfer 
from the copper species generates radical 138, which forms 139 through the addition of 
another molecule of the copper reagent. Interaction of the copper with a fluorine atom then 





It is not known why this product should be formed from 129c and not for the other ketones, 
but a possible explanation is that an initial co-ordination to the sulphur atom of the thiophene 
moiety encourages the initial single electron transfer or the addition of copper into the 







A possible transition state for the 1,2-reduction is given in Scheme 4.30. Evidence from the 
work of Nikonov100 suggests that both the copper hydride complex and silane are involved in 
the transition state. Co-ordination of the copper hydride species to the oxygen (at the least 
hindered lone pair) could activate the carbonyl group towards attack from the silane. The si 





At this point, as no further improvement to the enantiomeric excesses was being observed for 
the 1,2-reduction, we returned to our original aim of generating the fluoroalkyl stereocentre 
by 1,4-reduction. In order to achieve this, we investigated the reaction of β-fluoroalkyl α,β-
unsaturated esters. 
4.2.2    Enantioselective Copper-Catalysed Reductions of β-Fluoroalkyl-
α,β-Unsaturated Esters 
 
The lower electrophilicity of esters relative to ketones was expected to encourage the 1,4-
reduction over the 1,2-reduction in the reaction of β-fluoroalkyl-α,β-unsaturated esters under 
copper hydride conditions.  
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The first requirement was the synthesis of the substrates. In most cases, a straightforward 
Wittig reaction could be conducted as it had been for the synthesis of ketone substrates. A 
total of ten compounds were made in this way (Scheme 4.31). 
 
 
Scheme 4.31 Yields are those of isolated major isomer. 
 
Two cyclic substrates were also synthesised. A Von-Pechmann cyclisation from 






145l was synthesised by an ester formation reaction on the commercially available phenol 























Initial screening was mostly conducted on 145b. Ligands were investigated first (Scheme 
4.32). Josiphos gave complete conversion to product, but the enantiomeric excess measured 
was a disappointing 70%. (R)-BINAP gave an ee of 93%, but 50% of the starting material 
remained. (S)-SEGPHOS showed promise, giving complete conversion and an excellent ee, 





Decreasing the reaction temperature to 0 °C with Josiphos as ligand gave an increase in 
enantiomeric excess to 86%. Changing the reaction solvent to toluene had no effect on the 
conversion or the ee value obtained when Josiphos was used as the ligand. However, when 
(R)-BINAP was employed with toluene as solvent, complete conversion to desired product 
was observed and the enantiomeric excess was an excellent 99%. Conducting the reaction on 






One other substrate for which the reduction was successful with the above conditions was 
145k giving complete conversion and an ee of 86% (Equation 4.8). For this substrate, (R)-






Unfortunately, when these conditions were extended to other substrates, numerous problems 
were encountered. Whilst complete or near complete conversion to the desired products was 
obtained for almost all starting materials with the optimised conditions from Equation 4.7, 
enantiomeric excesses could not be measured for some due to a lack of effective racemic 
assay conditions. Multiple chiral HPLC and GC columns were tested, but no separation of the 
enantiomers was observed for those products shown in Scheme 4.33. The use of Pirkle’s 
reagent to obtain a chiral NMR assay was also found to be unsuccessful. Derivatisation of the 
products to give compounds for which the enantiomers can be resolved is a potential solution. 
Care must be taken with such an approach, however, as the conditions used to obtain 






The enantiomeric excess obtained for the reduction of 149e with (R)-BINAP as ligand was a 
good 94%. Unfortunately, for this substrate, an additional product was also formed (150, 
Figure 4.3), which was inseparable from the desired product. This side product is formed 
through a Cu-F interaction leading to β-elimination (see 4.2.1). Traces (<<5%) of this product 
are observed with other substrates. The reasons for the large increase in the amount of 
difluoroalkene product in this case are unknown, although the thiophene containing ketone 
(129c) was also found to give increased amounts of the elimination product in the 1,2 
reduction (vide supra). The exact quantity of this side-product obtained varies depending 





The final set of substrates for which problems were observed are 145h and 145j. 145j was 
subjected to the optimised conditions with varying ligands and monitored by GC analysis. 
After 2 hours reaction time with (R)-SEGPHOS as ligand at 0 °C, only 10% conversion into 
desired product was observed and the enantiomeric excess was measured as a promising 
74%. However, after 22 hours, complete conversion to the reduced product was seen, but 
with an ee of 36% of the opposite enantiomer (Scheme 4.34). The more reactive, electron-
deficient, substrate 145h was exposed to the same conditions. After 45 minutes at room 
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temperature, the conversion was already at 35% with an ee value of 78%. No starting 
material remained after two hours, but the ee had significantly decreased to 13%. 
 
145j 149j
2 h: 10% conv, 74% ee











45 min: 35% conv, 78% ee










Early consideration on the possible cause of the change in enantioselectivity as the reaction 
progressed for these substrates produced several possibilities which were explored in turn. 
Firstly, it is possible that the gradual build-up in the reaction mixture of compounds 151, 152 
and 153 (Figure 4.4) was affecting the course of the reaction (153 can be observed by GC-
MS as the reaction progresses). This species is formed by the reaction of either the hydride 
source itself, or the silyl enol ether intermediate, 154 (Figure 4.4), with the proton source, 
tbutanol. Other silanes containing only one hydride group (Et3SiH and (EtO)3SiH) were tested 
in the reaction, but gave only a trace of the desired product. PMHS was also tried and gave 
35% conversion with an ee of only 20%. This possible explanation was finally ruled out 
when the reaction was conducted in the absence of tbutanol. Whilst the reaction of 145h was 
slower without the proton source, complete conversion to the desired product was still 








(%) ee (%) 
PhSiH3 >95 13 
PMHS 35 20 
Et3SiH <5 - 
(EtO)3SiH <5 - 
a
PhSiH3 >95 21 
Table 4.2 
aNo tBuOH was added 
 
Another possible explanation for the changing enantiomeric excess as the reaction progresses 
is a selective degradation of one enantiomer in the chiral environment of the reaction mixture. 
This is unlikely to be the cause due to good isolated yields of the desired reduction product 
(70% for 149h and 76% for 149j when the reaction was carried out racemically employing 
(±)-BINAP).  
 
As there are only two small differences between these substrates and 145b for which the 
reaction worked well and completed in high enantiomeric excess, it stands to reason that one 
of these changes is responsible for the poorer enantioselectivity. One is the presence of a 
para-substituent on the aromatic ring in the β-position and the other is a methyl ester in place 
of the benzyl. 145f was synthesised to investigate the effect of the ester group. Under the 
same reaction conditions with (R)-SEGPHOS as ligand again, an ee of 28% was obtained, 






Further screening was carried out on these compounds in the hope that more results would 
shed some light on the cause of these ee issues. Whilst some improvement was observed 
upon screening other ligands (BINAP gave complete conversion and 60% ee for 149j), the 
enantiomeric excesses still remained disappointing (Equation 4.10). Whilst decreasing the 
reaction temperature from room temperature to 0 °C had a positive effect on the 
enantioselectivity (13% to 42% for 149h with >95% conversion), decreasing the temperature 





Using PMHS as a reaction solvent instead of just as a hydride source gave increased ee 
values (59% for 149j and 72% for 149h). Unfortunately, the conversions obtained were low 
as no improvement was seen on those values obtained with PMHS as a reagent (37% for 149j 
and 53% for 149h, Scheme 4.35). Interestingly, with PMHS as solvent, the ee value 
remained roughly the same throughout the reaction with the value for 149h being 68% at 
36% conversion. With the aim of increasing these conversions, phenylsilane was added as a 
hydride source whilst PMHS remained as solvent. This gave a small increase in conversion 
(up to 47% for 149j), whilst the ee remained almost the same. Using phenylsilane itself as 






Whilst the results for this reaction were initially highly promising and it does work extremely 
well for some substrates (145b and 145k), problems with extending the methodology to other 




4.3   Conclusions and Future Work 
 
The reactivity of β-fluoroalkyl-α,β-unsaturated carbonyl compounds under copper-hydride 
reduction conditions was studied. Whilst most unsaturated ketones underwent 1,2-reduction, 
the unsaturated esters were found to reduce in the 1,4 sense. Screening for enantioselectivity 
for the ketone substrates gave moderate enantiomeric excesses of up to 62% for methyl 
ketones, but the results were found to be much poorer with bulkier groups. The 1,4-reduction 
was found to work extremely well for some substrates giving ees of up to 99%, but the 
reaction was found to be of limited generality and therefore of limited use as a synthetic 
strategy. Problems were encountered with obtaining racemic assays for several substrates 
meaning that enantiomeric excesses could not be measured.  
Possible solutions to the problems observed with this chemistry mostly involve the 
investigation of alternative catalyst systems (both metal and ligand) for conjugate reduction. 
The potential utility of the products (containing as they do a fluoroalkyl-bearing stereocentre) 
would make this a worthwhile endeavour.   
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4.4    Experimental 
 
General Information 
All reactions were carried out under a nitrogen atmosphere in oven-dried apparatus. THF, 
toluene and dichloromethane were dried and purified by passage through activated alumina 
columns using a solvent purification system. All commercially available reagents were used 
as received. Thin layer chromatography (TLC) was performed on Merck DF-Alufoilien 
60F254 0.2 mm precoated plates. Product spots were visualized by UV light at 254 nm, and 
subsequently developed using potassium permanganate or vanillin as appropriate. Flash 
column chromatography was carried out using silica gel (Fisher Scientific 60Å particle size 
35-70 micron) employing the method of Still and co-workers.40 Melting points were recorded 
on a Gallenkamp melting point apparatus and are uncorrected. Infra-red spectra were 
recorded on a Jasco FT/IR-460 Plus instrument as a thin film or as a dilute solution in CHCl3, 
or on a Shimadzu IRAffinity-1 instrument as a thin film or as a solid. 1H NMR spectra were 
recorded on a Bruker AVA500 (500 MHz) spectrometer, a Bruker AVA400 (400 MHz) 
spectrometer, a Bruker ARX250 (250 MHz) or a Bruker DPX360 (360 MHz) spectrometer. 
Chemical shifts (δ) are quoted in parts per million (ppm) downfield of tetramethylsilane, 
using residual protonated solvent as internal standard (CDCl3 at 7.27 ppm; CD3OD at 4.84 
ppm). Abbreviations used in the description of resonances are: s (singlet), d (doublet), t 
(triplet), q, (quartet), app (apparent), br (broad). Coupling constants (J) are quoted to the 
nearest 0.1 Hz. Proton-decoupled 13C NMR spectra were recorded on a Bruker DPX360 (90.6 
MHz) spectrometer or a Bruker AVA500 (125.8 MHz) spectrometer. Chemical shifts (δ) are 
quoted in parts per million (ppm) downfield of tetramethylsilane, using deuterated solvent as 
internal standard (CDCl3 at 77.0 ppm; CD3OD at 49.05 ppm). Assignments were made using 
the DEPT sequence with secondary pulses at 90° and 135°. Proton-decoupled 19F NMR 
spectra were recorded on a Bruker ARX250 (235 MHz) spectrometer or a Bruker AVA400 
(376 MHz). Chemical shifts are reported in parts per million (ppm) downfield of CFCl3, 
using fluorobenzene as internal standard (C6H5F at –113.2 ppm). High-resolution mass 
spectra were recorded using electrospray ionisation (ES), electron impact ionisation (EI) or 
atmospheric solids analysis probe (ASAP) techniques on a Finnigan MAT 900 XLT 
spectrometer or a Finnigan MAT 95XP spectrometer or a Thermofisher LTQ Orbitrap XL 
spectrometer at the EPSRC National Mass Spectrometry Service Centre, University of Wales, 
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Swansea or using electron impact ionisation on a Finnigan MAT 900 spectrometer at the 
University of Edinburgh. Low-resolution mass spectra were recorded using electron impact 
ionisation on an Agilent 7890A GC fitted with a 5975C MS detector. Optical rotations were 
performed on an Optical Activity POLAAR 20 polarimeter. Chiral HPLC analysis was 
performed on an Agilent 1100 instrument using 4.6 x 250 mm columns. Chiral GC analysis 
was performed on an Agilent 7890A instrument. 
 
Preparation of α,β-Unsaturated Ketone Substrates 
 





A solution of the appropriate 2-bromoester or 2-bromoketone (1.0 equiv) in toluene (1.3 M 
solution) was added dropwise over 10 min to a solution of triphenylphosphine (1.0 equiv) in 
toluene (1.3 M solution). The reaction mixture was stirred at room temperature for 18 h, and 
the resulting phosphonium salt was filtered and oven-dried. The phosphonium salt was used 
without further purification. 
Na2CO3 (1.5 equiv) was added to a suspension of the phosphonium salt in H2O and CH2Cl2 
(1:1, 0.17 M with respect to phosphonium salt). The mixture was stirred at room temperature 
for 18 h and then transferred to a separating funnel. The organic layer was separated and the 
aqueous layer was extracted with CH2Cl2 (3 x 20 mL). The combined organic layers were 





-phosphanylidene)ethan-1-one (132a)105  
 The title compound was prepared according to General Procedure A from 2-
bromoacetophenone (3.98 g, 20.0 mmol) and the resultant ylide (5.80 g, 76%) displayed 
















from 2-bromo-4’-methoxyacetophenone (4.58 g, 20.0 mmol) and the resultant ylide (6.38 g, 








The title compound was prepared according to General Procedure A from 
2-bromo-4’-chloroacetophenone (4.70 g, 20.0 mmol) and the resultant ylide (6.31 g, 76%) 






The title compound was prepared according to General Procedure A from 
benzyl bromoacetate (6.2 mL, 40 mmol) and the resultant ylide (15.28 g, 93%) displayed 
spectral data was consistent with those described previously.108  
 
General Procedure B: Wittig Reaction of Trifluoromethyl Ketones 
 
The appropriate perfluoroalkyl ketone (1.0 equiv) was added in one portion to a solution of 
the appropriate ylid (1.1 equiv) in THF (0.2 M solution) and the reaction mixture was heated 
under reflux until complete consumption of the ketone as observed by TLC analysis, or until 
no further reaction progress could be seen. The reaction mixture was concentrated in vacuo 
and the residue was triturated thoroughly with hexane. After removal of the hexane in vacuo, 





The title compound was prepared according to General Procedure B from 
(acetylmethylene)triphenylphosphorane (5.30 g, 16.5 mmol) and trifluoroacetophenone (2.1 
mL, 15 mmol) for 6 hours and purified by column chromatography eluting with 10% 
EtOAc/hexane to give the major E-isomer (the unpurified mixture contained a >19:1 E:Z 
ratio of isomers) as a yellow oil (2.76 g, 92%). Spectral data was found to be consistent with 
that previously reported.57 Rf = 0.52 (20% EtOAc/hexane); IR (CDCl3) 3350, 1711 (C=O), 













7.22 (3H, m, ArH), 7.16-7.12 (2H, m, ArH), 6.56 (1H, q, J = 1.4 Hz, C=CH), 1.73 (3H, s, 
CH3); 
13C NMR (125.8 MHz, CDCl3) δ 199.2 (C), 139.0 (C, q, J = 30.9 Hz), 132.5 (CH, q, J 
= 4.9 Hz), 130.7 (C), 129.9 (CH), 129.0 (2 x CH2), 128.7 (2 x CH2), 122.8 (C, q, J = 274.8 
Hz), 30.4 (CH3); 




The title compound was prepared according to General Procedure B from 
132a (4.20 g, 11 mmol) and trifluoroacetone (0.90 mL, 10 mmol) for 15 hours and purified 
by column chromatography eluting with 10% EtOAc/hexane to give the major E-isomer (the 
unpurified mixture contained a >19:1 E:Z ratio of isomers) as a yellow oil (1.15 g, 54%). 
Spectral data was found to be consistent with that previously reported.109 Rf = 0.50 (20% 
EtOAc/hexane); IR (CDCl3) 3064, 2929, 1680 (C=O), 1598, 1316, 1295, 1232, 1180, 1128, 
706 cm-1; 1H NMR (360 MHz, CDCl3) δ 7.96-7.93 (2H, m, ArH), 7.65-7.60 (1H, m, ArH), 
7.54-7.49 (2H, m, ArH), 7.25-7.23 (1H, m, C=CH), 2.16 (3H, d, J = 1.5 Hz, CH3); 
13C NMR 
(90.6 MHz, CDCl3) δ 191.1 (C), 139.2 (C, q, J = 30.3 Hz), 137.1 (C), 133.8 (CH), 128.9 (2 x 
CH), 128.5 (2 x CH), 125.7 (CH, q, J = 5.3 Hz, C=CH), 123.4 (C, q, J = 274.0 Hz), 12.8 
(CH3); 
19F NMR (376 MHz, CDCl3) δ –65.4 (3F, s). 
 
(3Z)-5,5,5-Trifluoro-4-(thiophen-2-yl)pent-3-en-2-one (129c) 
The title compound was prepared according to General Procedure B from 
(acetylmethylene)triphenylphosphorane (245 mg, 0.8 mmol) and 2-
(trifluoroacetyl)thiophene (90 µL, 0.7 mmol) for 3 hours and purified by column 
chromatography eluting with 5% EtOAc/hexane to give the major Z-isomer (the unpurified 
mixture contained a 14:1 Z:E ratio of isomers) as a yellow oil (140 mg, 91%). Rf = 0.43 (20% 
EtOAc/hexane); IR (CDCl3) 3109, 1706 (C=O), 1632, 1432, 1357, 1329, 1138, 1046, 851, 
704 cm-1; 1H NMR (360 MHz, CDCl3) δ 7.52 (1H, dd, J = 5.1, 1.1 Hz, ArH), 7.21 (1H, d, J = 
3.6 Hz, ArH), 7.10 (1H, dd, J = 5.1, 3.6 Hz, ArH), 6.71 (1H, q, J = 1.1 Hz, C=CH), 2.09 (3H, 
s, CH3); 
13C NMR (90.6 MHz, CDCl3) δ 199.7 (C), 132.7 (CH, q, J = 4.6 Hz), 131.2 (C, q, J 
= 32.3 Hz), 131.2 (CH), 129.9 (C), 129.5 (CH), 127.6 (CH), 122.3 (C, q, J = 275.1 Hz), 30.0 
(CH3); 
19F NMR (376 MHz, CDCl3) δ –67.3 (3F, s); HRMS (EI) Exact mass calcd for 
C9H6F3OS [M−H]
+: 219.0086, found: 219.0086. 
Determination of the alkene stereochemistry was acheived using a 1H−19F HOESY 


















The title compound was prepared according to General Procedure B 
from 132b (4.51 g, 11 mmol) and trifluoroacetone (0.90 mL, 10 mmol) for 3 hours and 
purified by column chromatography eluting with 10% EtOAc/hexane to give the major E-
isomer (the unpurified mixture contained a 12:1 E:Z ratio of isomers) as a yellow oil (1.16 g, 
48%). Rf = 0.33 (20% EtOAc/hexane); IR (CDCl3) 2939, 2844, 1674 (C=O), 1641, 1513, 
1294, 1175, 1126, 1096, 570 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.91-7.95 (2H, m, ArH), 
7.19 (1H, m, C=CH), 6.96-7.00 (2H, m, ArH), 3.90 (3H, s, OCH3), 2.13 (3H, d, J = 1.3 Hz, 
C=CCH3); 
13C NMR (125.8 MHz, CDCl3) δ 189.7 (C), 164.1 (C), 137.9 (C, q, J = 30.3 Hz), 
131.0 (2 x CH), 130.2 (C), 126.2 (CH, q, J = 5.4 Hz), 123.5 (C, q, J = 274.0 Hz), 114.0 (2 x 
CH), 55.5 (CH3), 12.7 (CH3); 
19F NMR (376 MHz, CDCl3) δ –70.9 (3F, s); HRMS (ES) 
Exact mass calcd for C12H12F3O2 [M+H]
+: 245.0784, found: 245.0787.  
Determination of the alkene stereochemistry was acheived using a 1H−19F HOESY 











The title compound was prepared according to General Procedure B 
from 132c (5.48 g, 13.2 mmol) and trifluoroacetophenone (1.70 mL, 12 mmol) for 6 hours 
and purified by column chromatography eluting with 2% EtOAc/hexane to give the major E-
isomer (the unpurified mixture contained a >19:1 E:Z ratio of isomers) as a yellow oil (3.06 
g, 82%). Spectral data was found to be consistent with that previously reported.110 Rf = 0.57 








775 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.76-7.73 (2H, m, ArH), 7.37-7.35 (2H, m, ArH), 
7.33-7.24 (5H, m, ArH), 7.22 (1H, q, J = 1.4 Hz, C=CH); 13C NMR (125.8 MHz, CDCl3) δ 
191.0 (C), 140.4 (C), 139.3 (C, q, J = 30.9 Hz), 134.3 (C), 130.6 (C), 130.2 (CH, q, J = 5.3 
Hz), 130.2 (2 x CH), 129.6 (CH), 129.03 (2 x CH), 128.96 (2 x CH), 128.4 (2 x CH), 122.7 




The title compound was prepared according to General Procedure B from 
(acetylmethylene)triphenylphosphorane (2.80 g, 8.8 mmol) and heptafluorobutyrophenone 
(1.50 mL, 8 mmol) for 4 hours and purified by column chromatography eluting with 10% 
EtOAc/hexane to give the major E-isomer (the unpurified mixture contained a >19:1 E:Z 
ratio of isomers) as a yellow oil (2.16 g, 86%). Spectral data was found to be consistent with 
that previously reported.57 Rf = 0.54 (20% EtOAc/hexane); IR (neat) 1692 (C=O), 1342, 
1227, 1180, 1159, 1115, 968, 743, 723, 700 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.48-7.40 
(3H, m, ArH), 7.29 (2H, d, J = 7.4 Hz, ArH), 6.72 (1H, s, C=CH), 1.86 (3H, m, CH3); 
13C 
NMR (125.8 MHz, CDCl3) δ 199.2 (C), 138.3 (C, t, J = 21.8 Hz), 136.2 (CH, t, J = 7.7 Hz), 
131.1 (C), 129.8 (CH), 129.5 (2 x CH), 128.6 (2 x CH), 117.7 (C, qt, J = 288.5, 34.1 Hz), 
114.1 (C, tt, J = 257.9, 31.4 Hz), 109.0 (C, tqt, J = 266.5, 38.2, 38.1 Hz), 30.3 (CH3); 
19F 
NMR (376 MHz, CDCl3) δ –80.4 (3F, t, J = 10.4 Hz), −112.1 (2F, q, J = 10.4 Hz), −124.3 
(2F, app s). 
 
General Procedure C: Enantioselective Reduction of α,β-Unsaturated Ketones 
 
A solution of the appropriate ketone (0.5 mmol), Cu(OAc)2·H2O (5.0 mg, 0.025 mmol) and 
(R)-BINAP (15.3 mg, 0.025 mmol) in THF (3 mL) was stirred at 0°C for 15 minutes. PhSiH3 
(93 µL, 0.75 mmol) was then added dropwise. The mixture was then stirred at 0°C for 1 hour 
and then at room temperature until complete consumption of the carbonyl compound as 
observed by TLC analysis. HCl (1mL, 1M) was then added. After 1 hour, the reaction 
mixture was partitioned between saturated NH4Cl solution and CH2Cl2.  The aqueous layer 








(MgSO4) and concentrated in vacuo. Purification of the residue by column chromatography 




The title compound was prepared according to General Procedure C from 
132a (107 mg, 0.5 mmol) for 2 hours and purified by column chromatography eluting with 
20% EtOAc/hexane to give 133a as a yellow oil (73 mg, 68%). Spectral data was found to be 
consistent with that previously reported.57 [α] 24D  +25.0 (c 0.64, CHCl3); Rf = 0.36 (20% 
EtOAc/hexane); IR (neat) 3333 (OH), 1327, 1273, 1171, 1117, 1059, 899, 858, 775, 702 cm-
1; 1H NMR (500 MHz, CDCl3) δ 7.42-7.41 (3H, m, ArH), 7.27-7.25 (2H, m, ArH), 6.39 (1H, 
dq, J = 8.9, 1.4 Hz, C=CH), 4.30-4.25 (1H, m, CHOH), 1.28 (3H, d, J = 6.4 Hz, CHCH3); 
13C NMR (125.8 MHz, CDCl3) δ 138.6 (CH, q, J = 5.2 Hz), 131.5 (C), 131.2 (C, q, J = 30.2 
Hz), 129.4 (2 x CH), 128.9 (CH), 128.5 (2 x CH), 123.1 (C, q, J = 273.4 Hz), 64.4 (CH), 23.0 
(CH3); 
19F NMR (376 MHz, CDCl3) δ –66.6 (3F, s); Enantiomeric excess was determined by 
HPLC with a Chiralpak AD-H column (98:2 hexane:isopropanol, 0.8 mL/min, 230 nm); tr 





The title compound was prepared according to General Procedure C from 129b (110 mg, 0.5 
mmol) for 1.5 hours and purified by column chromatography eluting with 10% 
EtOAc/hexane to give 133b as a yellow oil (75 mg, 68%). Spectral data was found to be 
consistent with that previously reported.111 Rf = 0.45 (20% EtOAc/hexane); IR (neat) 3335 
(OH), 1325, 1281, 1173, 1113, 1007, 997, 841, 762, 741 cm-1; 1H NMR (500 MHz, CDCl3) δ 
7.42-7.35 (5H, m, ArH), 6.33-6.30 (1H, dm, J = 7.9 Hz, C=CH), 5.50 (1H, d, J = 7.9 Hz, 
CHOH), 2.12 (1H, br, OH), 1.92 (3H, d, J = 1.3 Hz, CH3); 
13C NMR (125.8 MHz, CDCl3) δ 
141.7 (C), 134.3 (CH, q, J = 5.7 Hz), 128.9 (2 x CH), 128.3 (CH), 126.6 (C, q, J = 29.8 Hz), 
126.0 (2 x CH), 123.8 (C, q, J = 272.9 Hz), 70.0 (CH), 11.1 (CH3, q, J = 1.3 Hz); 
19F NMR 
(376 MHz, CDCl3) δ –70.1 (3F, s); Enantiomeric excess was determined by HPLC with a 
Chiralpak AD-H column (99:1 hexane:isopropanol, 0.8 mL/min, 230 nm); tr (minor) = 23.9 











(R)-(3Z)-5,5,5-Trifluoro-4-(thiophen-2-yl)pent-3-en-2-ol (133c) and 5,5-
difluoro-4-(thiophen-2-yl)pent-4-en-2-ol (134) 
The title compounds were prepared according to General Procedure C from 
129c (110 mg, 0.5 mmol) for 16 hours and purified by column 
chromatography eluting with 5% EtOAc/hexane to give a yellow oil 
containing an inseparable mixture (3:1) of 133c and 134 (61 mg, 55%).  
133c: Rf = 0.24 (20% EtOAc/hexane); 
1H NMR (500 MHz, CDCl3) δ 7.43 (1H, dd, J = 4.4, 
1.9 Hz, ArH), 7.10-7.08 (2H, m, ArH), 6.46 (1H, dq, J = 8.9, 1.4 Hz, C=CH), 4.59 (1H, dq, J 
= 8.9, 6.5 Hz, CHOH), 1.63 (1H, br, OH), 1.36 (3H, d, J = 6.5 Hz, CH3); 
13C NMR 
(125.8 MHz, CDCl3) δ 140.7 (CH, q, J = 4.9 Hz), 130.6 (C), 129.4 (CH), 127.6 (CH), 127.3 
(CH), 124.4 (C, q, J = 31.4 Hz), 122.6 (C, q, J = 273.7 Hz), 64.5 (CH), 22.9 (CH3); 
19F NMR 
(376 MHz, CDCl3) δ –66.9 (3F, s); GC-MS (EI) m/z 222 (M
+, 4%), 202 (100%); 
Enantiomeric excess was determined by HPLC with a Chiralpak AD-H column (95:5 
hexane:isopropanol, 0.8 mL/min, 210 nm); tr (major) = 10.2 min; tr (minor) = 12.0 min, 59% 
ee. 
134: Rf = 0.24 (20% EtOAc/hexane); 
1H NMR (500 MHz, CDCl3) δ 7.29 (1H, dd, J = 5.2, 
1.1 Hz, ArH), 7.10-7.08 (1H, m, ArH), 7.03 (1H, ddd, J = 4.9, 3.7, 1.0 Hz, ArH), 4.03 (1H, 
ddq, J = 7.6, 6.2, 5.4 Hz, CHOH), 2.62 (1H, dddd, J = 14.5, 7.6, 2.8, 1.4 Hz, CH2COH), 2.53 
(1H, dddd, J = 14.5, 5.4, 2.8, 2.7 Hz, CH2OH), 1.65 (1H, br, OH), 1.27 (3H, d, J = 6.2 Hz, 
CH3); 
13C NMR (125.8 MHz, CDCl3) δ 154.5 (C, dd, J = 295.9, 288.8 Hz), 135.6 (C, dd, J = 
6.8, 3.9 Hz), 127.1 (CH), 125.5 (CH, dd, J = 5.1, 5.1 Hz), 125.0 (CH, dd, J = 6.0, 2.8 Hz), 
85.8 (C, dd, J = 26.1, 13.6 Hz), 66.5 (CH, dd, J = 2.6, 2.6 Hz), 37.5 (CH2, d, J = 1.6 Hz), 23.0 
(CH3); 
19F NMR (376 MHz, CDCl3) δ –83.5 (1F, d, J = 31.9 Hz), –89.7 (1F, d, J = 31.9 Hz); 
GC-MS (EI) m/z 204 (M+, 63%), 159 (37%), 84 (100%). 
 
(R)-(2E)-4,4,4-Trifluoro-1-(4-methoxyphenyl)-3-methylbut-2-en-1-
ol (133d)  
The title compound was prepared according to General Procedure C 
from 129d (123 mg, 0.5 mmol) for 1.5 hours and purified by column chromatography eluting 
with 20% EtOAc/hexane to give 133d as a yellow oil (22 mg, 18%). Rf = 0.17 (20% 
EtOAc/hexane); IR (neat) 3431 (OH), 1512, 1323, 1304, 1250, 1173, 1107, 1076, 1032, 831 
cm-1; 1H NMR (500 MHz, CDCl3) δ 7.32-7.29 (2H, m, ArH), 6.93-6.90 (2H, m, ArH), 6.32 













1.99 (1H, d, J = 3.3 Hz, OH), 1.88 (3H, d, J = 1.2 Hz, C=CCH3); 
13C NMR (125.8 MHz, 
CDCl3) δ 159.6 (C), 134.6 (CH, q, J = 5.7 Hz), 133.9 (C), 127.4 (2 x CH), 126.1 (C, q, J = 
29.8 Hz), 123.9 (C, q, J = 272.9 Hz), 114.3 (2 x CH), 69.7 (CH), 55.3 (CH3), 11.1 (CH3, q, J 
= 1.2 Hz); 19F NMR (376 MHz, CDCl3) δ –70.1 (3F, s); HRMS (EI) Exact mass calcd for 
C12H13F3O2 [M
+]: 246.08622, found: 246.08625. Enantiomeric excess was determined by 
HPLC with a Chiralpak AD-H column (95:5 hexane:isopropanol, 0.8 mL/min, 210 nm); tr 




The title compound was prepared according to General Procedure C 
from 129e (160 mg, 0.5 mmol) for 1.5 hours and purified by column 
chromatography eluting with 10% EtOAc/hexane to give 133e as a beige oil which solidified 
upon standing to an off-white amorphous solid (146 g, 91%). Rf = 0.37 (20% EtOAc/hexane); 
IR (neat) 3337 (OH), 1489, 1306, 1275, 1171, 1121, 1092, 1013, 831, 700 cm-1; 1H NMR 
(500 MHz, CDCl3) δ 7.45-7.43 (3H, m, ArH), 7.34-7.32 (2H, m, ArH), 7.27-7.25 (2H, m, 
ArH), 7.20-7.18 (2H, m, ArH), 6.55 (1H, dq, J = 9.1, 1.4 Hz, C=CH), 5.12 (1H, dd, J = 9.1, 
2.8 Hz, CHOH), 1.99 (1H, d, J = 2.8 Hz, OH); 13C NMR (125.8 MHz, CDCl3) δ 139.9 (C), 
136.1 (CH, q, J = 5.3 Hz), 134.1 (C), 132.5 (C, q, J = 30.5 Hz), 131.1 (C), 129.5 (2 x CH), 
129.2 (CH), 129.0 (2 x CH), 128.7 (2 x CH), 127.5 (2 x CH), 122.9 (C, q, J = 273.6 Hz), 69.8 
(CH); 19F NMR (376 MHz, CDCl3) δ –66.4 (3F, s); HRMS (CI) Exact mass calcd for 
C16H11F3OCl [M–H]
+: 311.0445, found: 311.0444. Enantiomeric excess was determined by 
HPLC with a Chiralpak AD-H column (99:1 hexane:isopropanol, 0.8 mL/min, 230 nm); tr 




The title compound was prepared according to General Procedure C from 
129f (158 mg, 0.5 mmol) for 1.5 hours and purified by column 
chromatography eluting with 10% EtOAc/hexane to give 133f as a white solid (125 g, 79%). 
Spectral data was found to be consistent with that previously reported.57 [α] 24D  +2.3 (c 0.84, 
CHCl3); m.p. 56-57 °C; Rf = 0.29 (20% EtOAc/hexane); IR (neat) 3298 (OH), 1346, 1221, 
1202, 1180, 1161, 1111, 1099, 976, 718 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.42-7.39 (3H, 










CHOH), 1.63 (1H, br, OH), 1.27 (3H, d, J = 6.4 Hz, CH3); 
13C NMR (125.8 MHz, CDCl3) δ 
142.5 (CH, t, J = 8.0 Hz), 131.7 (C), 130.5 (C, t, J = 21.5 Hz), 129.9 (2 x CH), 128.8 (CH), 
128.4 (2 x CH), 117.9 (C, qt, J = 288.3, 34.4 Hz), 114.1 (C, tt, J = 256.3, 31.0 Hz), 109.2 (C, 
tq, J = 291.1, 37.7 Hz), 64.6 (CH), 22.8 (CH3); 
19F NMR (376 MHz, CDCl3) δ –80.4 (3F, t, J 
= 10.2 Hz), –111.0 (2F, dq, J = 25.9, 10.2 Hz), –124.5 (2F, br); Enantiomeric excess was 
determined by HPLC with a Chiralpak AS-H column (99:1 hexane:isopropanol, 0.8 mL/min, 
230 nm); tr (major) = 12.0 min; tr (minor) = 15.7 min, 41% ee. 
 
Stereochemical Determinations 
The absolute stereochemistry of 133a was assigned as (R) by comparison of the direction of 
optical rotation with that reported in the literature.57  
 
(R)-133a: [α] 24D  +25.0 (c 0.64, CHCl3) Herein 
(R)-133a: [α] 20D  +6.4 (c 1.3, CHCl3) Literature 
 
The absolute stereochemistry of 133e was assigned as (R) by comparison of the HPLC trace 
to that of 255d (Chapter 5). In both cases the major product eluted first, suggesting that 133e 
was the (R) isomer. 
 
The absolute stereochemistries of the remaining products 133b,c,d and f were assigned by 
analogy. 
 
Preparation of α,β-Unsaturated Ester Substrates 
 
(E)-4,4,4-Trifluoro-3-methyl-but-2-enoic acid benzyl ester (145a) 
The title compound was prepared according to General Procedure B from 
132d (4.51 g, 11 mmol) and trifluoroacetone (0.90 mL, 10 mmol) for 2.5 hours and purified 
by column chromatography eluting with 5% EtOAc/hexane to give the major E-isomer (the 
unpurified mixture contained a 19:1 E:Z ratio of isomers) as a colourless oil (2.10 g, 86%). Rf 
= 0.68 (20% EtOAc/hexane); IR (CDCl3) 3056, 2958, 1731 (C=O), 1359, 1297, 1258, 1194, 
1131, 1099, 1024 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.43-7.35 (5H, m, ArH), 6.39 (1H, m, 
=CH), 5.23 (2H, s, CH2Ph), 2.28 (3H, d, J = 1.6 Hz, CH3); 
13C NMR (125.8 MHz, CDCl3) δ 














123.1 (C, q, J = 274.4 Hz), 121.2 (CH, q, J = 5.8 Hz), 66.7 (CH2), 12.4 (CH3); 
19F NMR (376 
MHz, CDCl3) δ –71.3 (3F, s); HRMS (EI) Exact mass calcd for C12H11F3O2 [M]
+: 244.0706, 
found: 244.0704. 
Determination of the alkene stereochemistry was acheived using a 1H−19F HOESY 







(E)-4,4,4-Trifluoro-3-phenyl-but-2-enoic acid benzyl ester (145b) 
The title compound was prepared according to General Procedure B from 
132d (4.51 g, 11 mmol) and trifluoroacetophenone (1.4 mL, 10 mmol) for 2 hours and 
purified by column chromatography eluting with 5% EtOAc/5% toluene/90% hexane to give 
the major E-isomer (the unpurified mixture contained a 11:1 E:Z ratio of isomers) as a pale 
yellow oil (1.83 g, 60%). Rf = 0.59 (20% EtOAc/hexane); IR (CDCl3) 3065, 3035, 1735 
(C=O), 1284, 1259, 1179, 1133, 1005, 749, 698 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.42 
(1H, tt, J = 7.5, 1.0 Hz, ArH), 7.37 (2H, tt, J = 7.5, 2.0 Hz, ArH), 7.31-7.26 (5H, m, ArH), 
7.11-7.09 (2H, m, ArH), 6.65 (1H, q, J = 1.0 Hz, =CH), 5.03 (2H, s, CH2Ph); 
13C NMR 
(125.8 MHz, CDCl3) δ 164.0 (C), 142.7 (C, q, J = 30.9 Hz), 135.3 (C), 130.8 (C), 129.4 
(CH), 128.6 (2 x CH), 128.5 (2 x CH), 128.4 (CH), 128.31 (2 x CH), 128.26 (2 x CH), 124.2 
(CH, q, J = 5.5 Hz), 122.4 (C, q, J = 275.0 Hz), 66.9 (CH2); 
19F NMR (376 MHz, CDCl3) δ –
67.8 (3F, s). HRMS (ES) Exact mass calcd for C17H17NF3O2 [M + NH4]
+: 324.1206, found: 
324.1207. 
Determination of the alkene stereochemistry was acheived using a 1H−19F HOESY 







(E)-3-Trifluoromethyl-pent-2-enoic acid benzyl ester (145c) 
The title compound was prepared according to General Procedure B from 
132d (2.23 g, 5.5 mmol) and 1,1,1-trifluorobutanone (680 µL, 5 mmol) for 5.5 hours and 








isomer (the unpurified mixture contained a 9:1 E:Z ratio of isomers) as a colourless oil (0.78 
g, 60%). Rf = 0.75 (20% EtOAc/hexane); IR (film) 1731 (C=O), 1456, 1309, 1257, 1191, 
1130, 1115, 1040, 746, 697 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.41-7.35 (5H, m, ArH), 
6.37 (1H, s, =CH), 5.23 (2H, s, CH2Ph), 2.72 (2H, q, J = 7.4 Hz, CH2CH3), 1.19 (3H, t, J = 
7.4 Hz, CH2CH3); 
13C NMR (125.8 MHz, CDCl3) δ 164.3 (C), 148.3 (C, q, J = 28.7 Hz), 
135.3 (C), 128.7 (2 x CH), 128.5 (CH), 128.4 (2 x CH), 123.5 (C, q, J = 275.3 Hz), 121.3 
(CH, q, J = 6.1 Hz), 66.7 (CH2), 20.3 (CH2), 13.3 (CH3); 
19F NMR (376 MHz, CDCl3) δ –
69.3 (3F, s). HRMS (EI) Exact mass calcd for C13H13F3O2 [M]
+: 258.0862, found: 258.0864. 
Determination of the alkene stereochemistry was acheived using a 1H−19F HOESY 







(E)-3-Trifluoromethyl-hex-2-enoic acid benzyl ester (145d) 
The title compound was prepared according to General Procedure B from 
132d (2.23 g, 5.5 mmol) and 1,1,1-trifluoropentanone (700 µL, 5 mmol) for 5.5 hours and 
purified by column chromatography eluting with 2% EtOAc/hexane to give the major E-
isomer (the unpurified mixture contained a 13:1 E:Z ratio of isomers) as a colourless oil (0.84 
g, 62%). Rf = 0.58 (20% EtOAc/hexane); IR (film) 2967, 1732 (C=O), 1456, 1315, 1295, 
1261, 1236, 1190, 1121, 697 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.40-7.36 (5H, m, J = 2.4 
Hz, ArH), 6.37 (1H, app d, J = 0.9 Hz, =CH), 5.22 (2H, s, CH2Ph), 2.66-2.63 (2H, m, 
CH2CH2CH3), 1.58 (2H, tq, J = 7.5, 7.4 Hz, CH2CH2CH3), 0.96 (3H, t, J = 7.4 Hz, 
CH2CH2CH3); 
13C NMR (125.8 MHz, CDCl3) δ 164.4 (C), 146.8 (C, q, J = 28.9 Hz), 135.2 
(C), 128.7 (2 x CH), 128.5 (CH), 128.4 (2 x CH), 123.4 (C, q, J = 275.0 Hz), 121.7 (CH, q, J 
= 6.2 Hz), 66.7 (CH2), 28.7 (CH2), 22.3 (CH2), 14.1 (CH3); 
19F NMR (376 MHz, CDCl3) δ –
69.1 (3F, s). HRMS (CI) Exact mass calcd for C14H19F3O2N [M + NH4]
+: 290.1362, found 
290.1361. 
Determination of the alkene stereochemistry was acheived using a 1H−19F HOESY 










(Z)-4,4,4-Trifluoro-3-thiophen-2-yl-but-2-enoic acid benzyl ester (145e) 
The title compound was prepared according to General Procedure B from 
132d (1.24 g, 3.9 mmol) and 2-(trifluoroacetyl)thiophene (450 µL, 3.5 mmol) 
for 16 hours and purified by column chromatography eluting with 5% EtOAc/5% toluene/90 
% hexane to give the major Z-isomer (the unpurified mixture contained a 10:1 Z:E ratio of 
isomers) as a yellow oil (0.78 g, 72%). Rf = 0.42 (10% EtOAc/hexane); IR (film) 3067, 3034, 
1735 (C=O), 1456, 1366, 1334, 1282, 1184, 1137, 698 cm-1; 1H NMR (400 MHz, CDCl3) δ 
7.45 (1H, dt, J = 5.1, 1.2 Hz, ArH), 7.32-7.36 (3H, m, ArH), 7.23-7.22 (3H, m, ArH), 7.04 
(1H, ddd, J = 5.1, 3.7, 1.3 Hz, ArH), 6.64 (1H, app s, =CH), 5.15 (2H, s, CH2Ph); 
13C NMR 
(125.8 MHz, CDCl3) δ 164.7 (C), 134.8 (C), 134.7 (C, q, J = 31.7 Hz), 130.5 (CH), 129.8 
(C), 128.8 (CH), 128.55 (2 x CH), 128.49 (CH), 128.5 (2 x CH), 127.1 (CH), 125.1 (C, q, J = 
277.0 Hz), 124.1 (CH, q, J = 5.4 Hz), 67.2 (CH2); 
19F NMR (376 MHz, CDCl3) δ –67.6 (3F, 
s). HMRS (ES) Exact mass calcd for C15H15NF3O2S [M + NH4]
+: 330.0770, found: 330.0772.  
Determination of the alkene stereochemistry was acheived using a 1H−19F HOESY 








(E)-4,4,4-Trifluoro-3-(4-fluorophenyl)-but-2-enoic acid benzyl ester 
(145f) 
The title compound was prepared according to General Procedure B from 
132d (2.26 g, 5.5 mmol) and 4-fluoro-α,α,α-acetophenone (700 µL, 5 mmol) 
for 3 hours and purified by column chromatography eluting with 0→5% EtOAc/hexane to 
give the major E-isomer (the unpurified mixture contained a 12:1 E:Z ratio of isomers) as a 
colourless oil (1.00 g, 62%). Rf = 0.55 (20% EtOAc/hexane); IR (neat) 1736 (C=O), 1512, 
1285, 1256, 1236, 1180, 1157, 1132, 841, 696 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.35-7.31 
(3H, m, ArH), 7.24 (2H, dd, J = 7.5, 5.6 Hz, ArH), 7.17-7.14 (2H, m, ArH), 7.03 (2H, t, J = 
8.5 Hz, ArH), 6.67 (1H, s, =CH), 5.06 (2H, s, CH2Ar); 
13C NMR (125.8 MHz, CDCl3) δ 
164.3 (C), 163.3 (C, d, J = 249.6 Hz), 141.7 (C, q, J = 30.6 Hz), 134.7 (C), 130.7 (2 x CH, d, 








Hz), 122.3 (C, q, J = 275.3 Hz), 115.5 (2 x CH, d, J = 21.9 Hz), 67.1 (CH2); 
19F NMR (376 
MHz, CDCl3) δ –67.8 (3F, s), –111.5 (1F, s); HRMS (EI) Exact mass calcd for C17H12F4O2 
[M]+: 324.0768, found: 324.0768. 
Determination of the alkene stereochemistry was acheived using a 1H−19F HOESY 









(E)-4,4,5,5,6,6,6-Heptafluoro-3-phenyl-hex-2-enoic acid benzyl ester 
(145g) 
The title compound was prepared according to General Procedure B from 
132d (2.23 g, 5.5 mmol) and heptafluoropropyl phenyl ketone (930 µL, 5 mmol) for 4 hours 
and purified by column chromatography eluting with 1% EtOAc/hexane to give the major E-
isomer (the unpurified mixture contained an 11:1 E:Z ratio of isomers) as a colourless oil 
(1.35 g, 67%). Rf = 0.64 (20% EtOAc/hexane); IR (film) 1739 (C=O), 1497, 1457, 1342, 
1231, 1117, 1006, 908, 746, 697 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.42 (1H, tt, J = 7.0, 
1.5 Hz, ArH), 7.39-7.35 (2H, m, ArH), 7.34-7.31 (3H, m, ArH), 7.27-7.26 (2H, m, ArH), 
7.13-7.11 (2H, m, ArH), 6.69-6.67 (1H, m ,=CH), 5.03 (2H, s, CH2Ph); 
13C NMR 
(125.8 MHz, CDCl3) δ 163.8 (C), 142.2 (C, t, J = 21.7 Hz), 134.7 (C), 131.1 (C), 129.3 (CH), 
129.0 (2 x CH), 128.5 (2 x CH), 128.40 (CH), 128.38 (2 x CH), 128.1 (2 x CH), 127.7 (CH, t, 
J = 8.8 Hz), 117.7 (C, qt, J = 288.4, 36.3 Hz), 114.0 (C, tt, J = 258.3, 34.9 Hz), 108.9 (C, tqt, 
J = 266.6, 36.3, 34.9 Hz), 67.0 (CH2); 
19F NMR (376 MHz, CDCl3) δ –80.4 (3F, t, J = 10.2 
Hz), –112.0 (2F, q, J = 10.2 Hz), –124.2 (2F, br s). HMRS (ES) Exact mass calcd for 
C19H17NF7O2 [M + NH4]
+: 424.1142, found: 424.1143. 
Determination of the alkene stereochemistry was acheived using a 1H−19F HOESY 














(E)-4,4,4-Trifluoro-3-(4-fluorophenyl)-but-2-enoic acid methyl ester 
(145h)
112  
The title compound was prepared according to General Procedure B from 
methyl (triphenylphosphoranylidene)acetate (1.84 g, 5.5 mmol) and 4-fluoro-
α,α,α-acetophenone (700 µL, 5 mmol) for 3 hours and purified by column chromatography 
eluting with 5% EtOAc/hexane to give the major E-isomer (the unpurified mixture contained 
an 11:1 E:Z ratio of isomers) as a colourless oil (0.86 g, 69%). Spectral data was found to be 
consistent with that previously reported.112 Rf = 0.56 (20% EtOAc/hexane); IR (film) 1741 
(C=O), 1607, 1513, 1288, 1261, 1213, 1183, 1160, 1134, 841 cm-1; 1H NMR (500 MHz, 
CDCl3) δ 7.38-7.35 (2H, m, ArH), 7.22-7.17 (2H, m, ArH), 6.72 (1H, q, J = 1.0 Hz, =CH), 
3.72 (3H, s, CO2CH3); 
13C NMR (125.8 MHz, CDCl3) δ 164.3 (C), 163.3 (C, d, J = 249.4 
Hz), 142.0 (C, q, J = 31.1 Hz), 130.6 (2 x CH, d, J = 8.5 Hz), 126.6 (C, d, J = 3.6 Hz), 124.3 
(CH, q, J = 5.4 Hz), 122.3 (C, q, J = 274.8 Hz), 115.5 (2 x CH, d, J = 21.9 Hz), 52.1 (CH3); 
19F NMR (376 MHz, CDCl3) δ –67.8 (3F, s), –111.5 (1F, s). HRMS (CI) Exact mass calcd 
for C11H9F4O2 [M + H]
+: 249.0533, found 249.0532. 
Determination of the alkene stereochemistry was acheived using a 1H−19F HOESY 








(E)-3-(4-Chlorophenyl)-4,4,4-trifluoro-but-2-enoic acid methyl ester 
(145i) 
The title compound was prepared according to General Procedure B from 
methyl (triphenylphosphoranylidene)acetate (1.10 g, 3.3 mmol) and 4’-
chloro-2,2,2-trifluoroacetophenone (0.63 g, 3 mmol) for 3 hours and purified by column 
chromatography eluting with 5% EtOAc/5% toluene/90% hexane to give the major E-isomer 
(the unpurified mixture contained a 12:1 E:Z ratio of isomers) as a pale yellow oil (0.42 g, 
53%). Rf = 0.65 (20% EtOAc/hexane); IR (film) 2955, 2929, 1778, 1739 (C=O), 1494, 1286, 








7.39 (1H, t, J = 2.4 Hz, ArH), 7.25 (1H, app s, ArH), 7.23 (1H, app s, ArH), 6.63 (1H, q, J = 
1.3 Hz, =CH), 3.65 (3H, s, CO2CH3); 
13C NMR (125.8 MHz, CDCl3) δ 164.2 (C), 142.0 (C, 
q, J = 31.1 Hz), 135.7 (C), 130.0 (2 x CH), 129.1 (C), 128.6 (2 x CH), 124.4 (CH, q, J = 4.3 
Hz), 122.2 (C, q, J = 220.7 Hz), 52.1 (CH3); 
19F NMR (376 MHz, CDCl3) δ –67.7 (3F, s). 
HMRS (CI) Exact mass calcd for C11H11NF3O2Cl [M-H+NH4]
+: 281.0425, found: 281.0425. 
Determination of the alkene stereochemistry was acheived using a 1H−19F HOESY 








(E)-4,4,4-Trifluoro-3-p-tolyl-but-2-enoic acid methyl ester (145j) 
The title compound was prepared according to General Procedure B from 
methyl (triphenylphosphoranylidene)acetate (1.84 g, 5.5 mmol) and 4-
(trifluoroacetyl)toluene (760 µL, 5 mmol) for 4 hours and purified by column 
chromatography eluting with 30% CH2Cl2/hexane to give the major E-isomer (the unpurified 
mixture contained a 7:1 E:Z ratio of isomers) as a colourless oil (1.22 g, 77 %). Rf = 0.59 
(20% EtOAc/hexane); IR (film) 1741 (C=O), 1515, 1285, 1259, 1207, 1182, 1133, 1011, 
980, 662 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.23 (2H, d, J = 8.1 Hz, ArH), 7.19 (2H, d, J = 
8.1 Hz, ArH), 6.60 (1H, q, J = 1.5 Hz, =CH), 3.64 (3H, s, CO2CH3), 2.40 (3H, s, ArCH3); 
13C NMR (125.8 MHz, CDCl3) δ 164.6 (C), 143.1 (C, q, J = 30.8 Hz), 139.5 (C), 129.0 (2 x 
CH), 128.4 (2 x CH), 127.8 (C), 122.5 (C, q, J = 274.8 Hz), 123.5 (CH, q, J = 5.4 Hz), 52.0 
(CH3), 21.4 (CH3); 
19F NMR (376 MHz, CDCl3) δ –67.6 (3F, s); HRMS (EI) Exact mass 
calcd for C12H11F3O2 [M]
+: 244.0706, found: 244.0706. 
Determination of the alkene stereochemistry was acheived using a 1H−19F HOESY 












7-Methoxy-4-(trifluoromethyl)-2H-chromen-2-one  (145k) 
To a microwave vial containing 3-methoxyphenol (0.55 mL, 5 mmol) and 
ethyl-4,4,4-trifluoroacetoacetate (0.73 mL, 5 mmol) was added 
trifluoroacetic acid (4mL). The mixture was heated under microwave irradiation for 30 
minutes at 135 °C. The bright red reaction mixture was then poured onto ice water. The 
bright pink precipitate which formed was filtered off, dissolved in ethyl acetate, dried 
(MgSO4) and concentrated in vacuo. Purification by column chromatography eluting with 2 – 
10% EtOAc/hexane afforded the desired product as white needles (0.46 g, 37%). Rf = 0.44 
(20% EtOAc/hexane); m.p. 101-102 °C; IR (neat) 1726 (C=O), 1277, 1188, 1177, 1169, 
1142, 1119, 874, 851, 820 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.64 (1H, dq, J = 9.0, 1.8 Hz, 
ArH), 6.93 (1H, dd, J = 9.0, 2.5 Hz, ArH), 6.89 (1H, d, J = 2.5 Hz, ArH), 6.63 (1H, s, =CH), 
3.91 (3H, s, OCH3); 
13C NMR (125.8 MHz, CDCl3) δ 163.5 (C), 159.4 (C), 156.4 (C), 141.6 
(C, q, J = 32.8 Hz), 126.3 (CH, q, J = 2.3 Hz), 121.6 (C, q, J = 275.5 Hz), 113.4 (CH), 112.2 
(CH, q, J = 5.8 Hz), 107.0 (C), 101.4 (CH), 55.9 (CH3); 
19F NMR (376 MHz, CDCl3) δ –64.8 
(3F, s); HRMS (CI) Exact mass calcd for C11H8O3F3 [M+H]
+: 245.0420, found: 245.0415. 
 
2-Oxo-4-(trifluoromethyl)-2H-chromen-7-yl-2,2-
dimethylpropanoate  (145l) 
To a solution of 7-hydroxy-4-(trifluoromethyl)coumarin (0.58 g, 2.5 
mmol) and 4-(dimethylamino)pyridine (30 mg, 0.25 mmol) in 
dichloromethane (20 mL) was added pyridine (0.22 mL, 2.75 mmol) and pivaloyl chloride 
(0.34 mL, 2.75 mmol). The mixture was allowed to stir at room temperature for 24 hours, 
then saturated NaHCO3 solution (20 mL) was added. The organic layer was separated and the 
aqueous layer was extracted with CH2Cl2 (20mL x 2). The combined organic layers were 
dried (MgSO4) and concentrated in vacuo to afford a white solid (0.71 g, 90%). Rf = 0.53 
(20% EtOAc/hexane); m.p. 84-86 °C; IR (neat) 1749 (C=O), 1261, 1184, 1167, 1146, 1128, 
1092, 908, 874, 650 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.74 (1H, d, J = 8.3 Hz, ArH), 7.19 
(1H, d, J = 2.0 Hz, ArH), 7.11 (1H, dd, J = 8.3, 2.0 Hz, ArH), 6.78 (1H, s, =CH), 1.39 (9H, s, 
C(CH3)3); 
13C NMR (125.8 MHz, CDCl3) δ 176.1 (C), 158.5 (C), 155.1 (C), 154.6 (C), 141.1 
(C, q, J = 33.1 Hz), 126.2 (CH), 121.4 (C, q, J = 277.5 Hz), 119.0 (CH), 115.2 (CH, q, J = 5.6 
Hz), 111.1 (C), 111.0 (CH), 39.3 (C), 27.0 (3 x CH3); 











(3F, s). HRMS (ES) Exact mass calcd for C15H17O4F3N [M+NH4]
+: 332.1104, found: 
332.1104. 
 
Reductions of α,β-Unsaturated Esters 
 












( )-BINAP (5 mol%)
PhSiH3, toluene
 
A solution of the appropriate ester (0.5 mmol), Cu(OAc)2·H2O (5.0 mg, 0.025 mmol), (±)-
BINAP (15.3 mg, 0.025 mmol) in toluene (2 mL) was stirred at room temperature for 15 
minutes before being cooled to 0 °C. PhSiH3 (93 µL, 0.75 mmol) was then added dropwise. 
The mixture was then stirred at 0°C for 1 hour and then at room temperature until complete 
consumption of the carbonyl compound as observed by TLC analysis, or until no further 
reaction progress could be seen. HCl (1mL, 1M) was then added. After 1 hour, the reaction 
mixture was partitioned between saturated NH4Cl solution and CH2Cl2.  The aqueous layer 
was separated and extracted with CH2Cl2 (x 2) and the combined organic fractions were dried 
(MgSO4) and concentrated in vacuo. Purification of the residue by column chromatography 
afforded the desired saturated ester. 
 
General Procedure E: Enantioselective Reduction of α,β-Unsaturated Esters. 
 
As for General Procedure D, but with Cu(OAc)2·H2O (3.0 mg, 0.015 mmol) and (R)-BINAP 
(9.3 mg, 0.015 mmol) employed as ligand. 
 
Benzyl 4,4,4-trifluoro-3-methylbutanoate  (149a)  
The title compound was prepared according to General Procedure D from 
145a (122 mg, 0.50 mmol) and purified by column chromatography (2% 
EtOAc/hexane) to give a colourless oil (78 mg, 63%). Rf = 0.26 (30% CH2Cl2/hexane); IR 
(film) 1740 (C=O), 1304, 1287, 1269, 1238, 1177, 1128, 1020, 739, 698  cm-1; 1H NMR (400 
MHz, CDCl3) δ 7.34-7.42 (5H, m, ArH), 5.17 (2H, s, CH2Ph), 2.78-2.84 (1H, m, CHCF3), 
2.75 (1H, dd, J = 16.4, 3.7 Hz, CH2CO), 2.36 (1H, dd, J = 16.4, 9.4 Hz, CH2CO), 1.18 (3H, 
d, J = 7.0 Hz, CHCH3); 
13C NMR (125.8 MHz, CDCl3) δ 170.6 (C), 135.5 (C), 128.7 (2 x 






29.1 Hz), 34.8 (CH2, q, J = 2.6 Hz), 13.0 (CH3, q, J = 2.8 Hz); 
19F NMR (235 MHz, CDCl3) δ 
–74.0 (3F, s); HRMS (EI) Exact mass calcd for C12H13F3O2 [M
+]: 246.0862, found: 246.0862. 
 
(R)-Benzyl 4,4,4-trifluoro-3-phenylbutanoate (149b)  
The title compound was prepared according to General Procedure E from 
145b (153 mg, 0.50 mmol) and purified by column chromatography (2% EtOAc/hexane) to 
give a colourless oil, which solidified upon standing to give a white solid (137 mg, 89%). 
[α] 24D  –16.6 (c 0.96, CHCl3); Rf = 0.44 (20% EtOAc/hexane); m.p. 30-32 °C; IR (CDCl3) 
3583, 1727 (C=O), 1498, 1455, 1305, 1250, 1159, 1106, 752, 697cm-1; 1H NMR (500 MHz, 
CDCl3) δ 7.31-7.36 (8H, m, ArH), 7.17-7.19 (2H, m, ArH), 5.06 (1H, d, J = 12.3 Hz, 
CH2Ph), 5.02 (1H, d, J = 12.3 Hz, CH2Ph), 3.94 (1H, dqd, J = 9.6, 9.3, 5.0 Hz, CF3CH), 3.09 
(1H, dd, J = 16.2, 5.0 Hz, CH2CO2Bn), 2.98 (1H, dd, J = 16.2, 9.6 Hz, CH2CO2Bn); 
13C 
NMR (125.8 MHz, CDCl3) δ 169.8 (C), 135.3 (C), 133.5 (C), 128.9 (2 x CH), 128.7 (2 x 
CH), 128.6 (CH), 128.5 (2 x CH), 128.3 (CH), 128.2 (2 x CH), 126.3 (C, q, J = 279.7 Hz), 
66.8 (CH2), 46.1 (CH, q, J = 27.8 Hz), 34.5 (CH2, q, J = 2.3 Hz); 
19F NMR (376 MHz, 
CDCl3) δ –70.4 (3F, s). HRMS (ES) Exact mass calcd for C17H19NO2F3 [M+NH4]
+: 
326.1362, found: 326.1363. Enantiomeric excess was determined by GC with a Cyclodex-B 
column (inlet T = 220°C, oven T = 220°C, 0.4 mL/min); tr (major) = 9.8 min; tr (minor) = 
11.5 min, 99% ee. 
 
Benzyl 4,4,4-trifluoro-3-ethylbutanoate  (149c) 
The title compound was prepared according to General Procedure D from 
145c (129 mg, 0.50 mmol) and purified by column chromatography (2% 
EtOAc/hexane) to give a colourless oil (84 mg, 65%). Rf = 0.69 (20% EtOAc/hexane); IR 
(film) 2924, 1742 (C=O), 1690, 1271, 1256, 1231, 1175, 1128, 739, 698 cm-1; 1H NMR (500 
MHz, CDCl3) δ 7.35-7.39 (5H, m, ArH), 5.16 (2H, s, CH2Ph), 2.64-2.73 (2H, m, CHCF3 and 
CH2C=O), 2.41-2.48 (1H, m, CH2C=O), 1.74 (1H, dqd, J = 14.9, 7.4, 6.4 Hz, CH2CH3), 1.51 
(1H, dqd, J = 14.9, 7.4, 6.4 Hz, CH2CH3), 0.99 (3H, td, J = 7.4, 0.9 Hz, CH2CH3); 
13C NMR 
(125.8 MHz, CDCl3) δ 170.9 (C), 135.5 (C), 128.9 (2 x CH), 128.4 (CH), 128.3 (2 x CH), 
127.8 (C, q, J = 279.8 Hz), 66.8 (CH2), 41.0 (CH, q, J = 26.0 Hz), 32.9 (CH2, q, J = 2.7 Hz), 
21.3 (CH2, q, J = 2.3 Hz), 11.0 (CH3); 
19F NMR (376 MHz, CDCl3) δ –71.3 (3F, s); HRMS 
(EI) Exact mass calcd for C13H15F3O2 [M











Benzyl 3-(trifluoromethyl)hexanoate  (149d) 
The title compound was prepared according to General Procedure D from 
145d (136 mg, 0.50 mmol) and purified by column chromatography (1% 
EtOAc/hexane) to give a colourless oil (85 mg, 62%). Rf = 0.66 (20% EtOAc/hexane); IR 
(film) 2965, 1742 (C=O), 1258, 1231, 1175, 1113, 1051, 1013, 795, 698 cm-1; 1H NMR (500 
MHz, CDCl3) δ 7.34-7.41 (5H, m, ArH), 5.17 (2H, s, CH2Ph), 2.78-2.70 (1H, m, CHCF3), 
2.67 (1H, dd, J = 16.3, 5.7 Hz, CH2CO), 2.43 (1H, dd, J = 16.3, 7.4 Hz, CH2CO), 1.61-1.69 
(1H, m, CH2CH2), 1.37-1.43 (3H, m, CH2CH2), 0.92 (3H, t, J = 7.1 Hz, CH2CH3); 
13C NMR 
(125.8 MHz, CDCl3) δ 171.0 (C), 135.5 (C), 128.6 (2 x CH), 128.4 (CH), 128.3 (2 x CH), 
127.8 (C, q, J = 279.7 Hz), 66.8 (CH2), 39.5 (CH, q, J = 26.3 Hz), 33.4 (CH2, q, J = 2.8 Hz), 
30.4 (CH2, q, J = 2.0 Hz), 19.8 (CH2), 13.9 (CH3); 
19F NMR (376 MHz, CDCl3) δ –71.5 (3F, 
s); HRMS (ES) Exact mass calcd for C14H21F3O2N [M+NH4]
+: 292.1524, found: 292.1511. 
 
Benzyl 4,4,4-trifluoro-3-(thiophen-2-yl) butanoate (149e) and benzyl 4,4-
difluoro-3-(thiophen-2-yl) but-3-enoate (150).  
The title compounds were prepared according to General Procedure D from 
145e (156 mg, 0.50 mmol) and purified by column chromatography (1% 
EtOAc/hexane) to give a light brown oil containing an inseparable mixture of 
products 149e and 150 (3.3:1, 53 mg, 34%).  
149e: Rf = 0.26 (10% EtOAc/hexane); 
1H NMR (500 MHz, CDCl3) δ 7.24-
7.38 (6H, m, ArH), 6.98-7.06 (2H, m, ArH),  5.11 (1H, d, J = 12.0 Hz, CH2Ph), 5.07 (1H, d, 
J = 12.0 Hz, CH2Ph), 4.27 (1H, qdd, J = 18.5, 10.0, 4.7 Hz, CHCF3), 3.10 (1H, dd, J = 16.2, 
4.7 Hz, CH2CO), 2.95 (1H, dd, J = 16.2, 10.0 Hz, CH2CO); 
13C NMR (125.8 MHz, CDCl3) δ 
169.5 (C), 135.2 (C), 128.6 (2 x CH), 128.4 (CH), 128.2 (2 x CH), 127.7 (CH), 127.1 (C), 
126.9 (CH), 125.9 (CH), 125.5 (C, q, J = 280.2 Hz), 67.0 (CH2), 41.7 (CH, q, J = 29.5 Hz), 
35.7 (CH2, q, J = 2.1 Hz); 
19F NMR (376 MHz, CDCl3) δ –71.4 (3F, s); GC-MS (EI) m/z 314 
(M+, 7%), 294 (2%), 223 (10%), 165 (13%), 91 (100%). 
150: Rf = 0.26 (10% EtOAc/hexane); 
1H NMR (500 MHz, CDCl3) δ 7.24-7.38 (6H, m, ArH), 
6.98-7.06 (2H, m, ArH), 5.17 (2H, s, CH2Ph), 3.50 (2H, t, J = 2.0 Hz, CH2CO); 
13C NMR 
(125.8 MHz, CDCl3) δ 169.6 (C, dd, J = 4.1, 2.9 Hz), 154.7 (C, dd, J = 295.9, 290.1 Hz), 
134.8 (C, dd, J = 7.2, 3.0 Hz), 128.5 (2 x CH), 128.3 (CH), 128.1 (2 x CH), 127.4 (CH), 














25.9, 18.3 Hz), 70.0 (CH2), 33.6 (CH2, d, J = 3.0 Hz); 
19F NMR (376 MHz, CDCl3) δ –83.0 
(1F, d, J = 27.9 Hz), –89.1 (1F, d, J = 27.9 Hz); GC-MS (EI) m/z 314 (M+, 1%), 91 (100%). 
 
Benzyl 4,4,4-trifluoro-3-(4-fluorophenyl)butanoate  (149f).  
The title compound was prepared according to General Procedure D from 
145f (162 mg, 0.50 mmol) and purified by column chromatography (1% 
EtOAc/hexane) to give a colourless oil (124 mg, 76%). Rf = 0.44 (10% 
EtOAc/hexane); IR (film) 1738 (C=O), 1514, 1366, 1288, 1256, 1234, 1175, 1051, 841, 698 
cm-1; 1H NMR (500 MHz, CDCl3) δ 7.26-7.41 (5H, m, ArH), 7.18-7.19 (2H, m, ArH), 7.05 
(2H, dt, J = 8.7, 2.2 Hz, ArH), 5.04-5.10 (2H, m, CH2Ph), 3.95 (1H, qdd, J = 18.8, 9.8, 4.3 
Hz, CHCF3), 3.10 (1H, ddq, J = 16.1, 4.3, 3.9 Hz, CH2CO), 2.95 (1H, ddq, J = 16.1, 9.8, 3.6 
Hz, CH2CO); 
13C NMR (125.8 MHz, CDCl3) δ 169.6 (C), 162.7 (C, d, J = 247.7 Hz), 135.2 
(C), 130.6 (2 x CH, d, J = 8.3 Hz), 129.2 (C, d, J = 1.4 Hz), 128.5 (2 x CH), 128.4 (CH), 
128.2 (2 x CH), 126.1 (C, q, J = 279.5 Hz), 115.7 (2 x CH, d, J = 21.7 Hz), 66.9 (CH2), 45.5 
(CH, q, J = 28.1 Hz), 34.5 (CH2, q, J = 2.1 Hz); 
19F NMR (376 MHz, CDCl3) δ -70.7 (3F, s), 
–113.4 (1F, s); HRMS (ES) Exact mass calcd for C17H18F4O2N [M+NH4]
+: 344.1268, found: 
344.1267. 
 
4,4,5,5,6,6,6-Heptafluoro-3-phenylhexanoic acid benzyl ester (149g) 
The title compound was prepared according to General Procedure D from 
145g (203 mg, 0.50 mmol) and purified by column chromatography (1% 
EtOAc/hexane) to give an inseparable mixture of starting material and product (6:1) as a 
colourless oil (97 mg, 48%). Rf = 0.44 (20% EtOAc/hexane); 
1H NMR (500 MHz, CDCl3) δ 
7.35-7.32 (8H, m, ArH), 7.18-7.17 (2H, m, ArH), 5.02 (2H, s, CH2Ph), 4.07 (1H, m, 
CHCH2), 3.18 (1H, dd, J = 16.1, 4.4 Hz, CHCH2), 2.99 (1H, dd, J = 16.1, 10.3 Hz, CHCH2); 
13C NMR (125.8 MHz, CDCl3) δ 169.8 (C), 135.3 (C), 133.3 (C, t, J = 5.5 Hz), 129.4 (2 x 
CH), 128.6 (2 x CH), 128.53 (CH), 128.51 (2 x CH), 128.3 (CH), 128.1 (2 x CH), 118.4 (C, 
qt, J = 255.7, 34.7 Hz), 116.6 (C, tt, J = 235.4, 29.5 Hz), 109.4 (C, tq, J = 265.9, 38.2 Hz), 
66.8 (CH2), 44.1 (CH, t, J = 21.0 Hz), 34.3 (CH2, t, J = 3.8 Hz); 
19F NMR (376 MHz, CDCl3) 
δ –80.6 (3F, dd, J = 12.3, 9.9 Hz), –112.7 (1F, ddqd, J = 277.6, 14.7, 12.3, 4.1 Hz), –116.7 
(1F, ddqd, J = 277.6, 14.7, 9.9, 9.3 Hz), –122.8 (1F, ddd, J = 290.2, 14.7, 9.3 Hz), –125.0 












Methyl 4,4,4-trifluoro-3-(4-fluorophenyl)butanoate  (149h).  
The title compound was prepared according to General Procedure D from 
145h (124 mg, 0.50 mmol) and purified by column chromatography (2% 
EtOAc/hexane) to give a colourless oil (87 mg, 70%). Rf = 0.34 (20% 
EtOAc/hexane); IR (film) 1743 (C=O), 1514, 1439, 1308, 1258, 1227, 1155, 1109, 966, 829 
cm-1; 1H NMR (500 MHz, CDCl3) δ 7.32 (2H, dd, J = 8.5, 5.3 Hz, ArH), 7.09-7.04 (2H, m, 
ArH), 3.90 (1H, dqd, J = 10.0, 9.3, 4.8 Hz, CHCF3), 3.62 (3H, s, OCH3), 3.04 (1H, dd, J = 
16.4, 4.8 Hz, CH2CO2Me), 2.88 (1H, dd, J = 16.4, 10.0 Hz, CH2CO2Me); 
13C NMR 
(125.8 MHz, CDCl3) δ 170.3 (C), 162.7 (C, d, J = 247.7 Hz), 130.6 (2 x CH, d, J = 8.3 Hz), 
129.5 (C, dq, J = 6.0, 2.5 Hz), 126.2 (C, q, J = 279.7 Hz), 115.8 (2 x CH, d, J = 21.6 Hz), 
52.1 (CH3), 45.4 (CH, q, J = 28.0 Hz), 34.3 (CH2, q, J = 2.2 Hz); 
19F NMR (376 MHz, 
CDCl3) δ -70.7 (3F, s), –113.4 (1F, s); HRMS (EI) Exact mass calcd for C11H10F4O2 [M
+]: 
250.06114, found: 250.06184. 
 
Methyl 4,4,4-trifluoro-3-(4-methylphenyl)butanoate  (149j).  
The title compound was prepared according to General Procedure D from 
145j (122 mg, 0.50 mmol) and purified by column chromatography (2% 
EtOAc/hexane) to give a colourless oil (94 mg, 76%). Rf = 0.53 (20% 
EtOAc/hexane); IR (film) 1744 (C=O), 1439, 1302, 1258, 1217, 1153, 1105, 964, 912, 806 
cm-1; 1H NMR (500 MHz, CDCl3) δ 7.23 (2H, d, J = 8.0 Hz, ArH), 7.18 (2H, d, J = 8.0 Hz, 
ArH), 3.90 (1H, dqd, J = 9.8, 9.4, 5.1 Hz, CHCF3), 3.62 (3H, s, OCH3), 3.03 (1H, dd, J = 
16.3, 5.1 Hz, CH2CO2Me), 2.90 (1H, dd, J = 16.3, 9.8 Hz, CH2CO2Me), 2.35 (3H, s, 
ArCH3); 
13C NMR (125.8 MHz, CDCl3) δ 170.6 (C), 138.3 (C), 130.6 (C, q, J = 1.8 Hz), 
129.4 (2 x CH), 128.7 (2 x CH), 126.4 (C, q, J = 279.6 Hz), 52.0 (CH3), 45.7 (CH, q, J = 27.7 
Hz), 34.2 (CH2, q, J = 2.3 Hz), 21.1 (CH3); 
19F NMR (376 MHz, CDCl3) δ -70.6 (3F, s); 
HRMS (EI) Exact mass calcd for C12H13F3O2 [M




The title compound was prepared according to General Procedure D from 
145k (122 mg, 0.50 mmol) and purified by column chromatography (10% 











80 °C; IR (solid) 1746 (C=O), 1516, 1439, 1306, 1260, 1227, 1157, 1111, 966, 912 cm-1; 1H 
NMR (500 MHz, CDCl3) δ 7.22 (1H, d, J = 8.5 Hz, ArH), 6.75 (1H, dd, J = 8.5, 2.6 Hz, 
ArH), 6.66 (1H, d, J = 2.6 Hz, ArH), 3.82 (3H, s, OCH3), 3.68-3.61 (1H, m, CHCF3), 3.14 
(1H, dd, J = 17.0, 1.9 Hz, CH2C=O), 2.95 (1H, dd, J = 17.0, 7.4 Hz, CH2C=O); 
13C NMR 
(125.8 MHz, CDCl3) δ 164.9 (C), 161.5 (C), 153.2 (C), 130.6 (CH), 125.6 (C, q, J = 280.5 
Hz), 111.2 (CH), 106.6 (C, q, J = 1.8 Hz), 102.8 (CH), 55.6 (CH3), 39.6 (CH, q, J = 29.7 Hz), 
28.7 (CH2, q, J = 2.5 Hz); 
19F NMR (376 MHz, CDCl3) δ –73.1 (3F, s); HRMS (EI) Exact 
mass calcd for C11H9O3F3 [M
+]: 246.0498, found: 246.0499. 
 
2-oxo-4-(trifluoromethyl)-3,4-dihydro-2H-1-benzopyran-7-yl 2,2-
dimethylpropanoate  (149l) 
The title compound was prepared according to General Procedure D from 
145l (157 mg, 0.50 mmol) and purified by column chromatography (10% EtOAc/hexane) to 
give a white solid (80 mg, 51%). Rf = 0.29 (20% EtOAc/hexane); m.p. 94-98 °C; IR (solid) 
1746 (C=O), 1516, 1439, 1306, 1261, 1225, 1159, 1113, 966, 557 cm-1; 1H NMR (500 MHz, 
CDCl3) δ 7.33 (1H, d, J = 8.4 Hz, ArH), 6.93 (1H, dd, J = 8.4, 2.3 Hz, ArH), 6.88 (1H, d, J = 
2.3 Hz, ArH), 3.75-3.67 (1H, m, CHCF3), 3.15 (1H, dd, J = 17.0, 1.9 Hz, CH2C=O), 2.97 
(1H, dd, J = 17.0, 7.4 Hz, CH2C=O), 1.36 (9H, s, C(CH3)3); 
13C NMR (125.8 MHz, CDCl3) δ 
176.5 (C), 164.2 (C), 152.70 (C), 152.70 (C), 130.6 (CH), 125.4 (C, q, J = 280.5 Hz), 118.2 
(CH), 112.2 (C, q, J = 1.6 Hz), 111.3 (CH), 39.8 (C, q, J = 29.8 Hz), 39.1 (C), 28.4 (CH2, q, J 
= 2.5 Hz), 27.0 (3 x CH3); 
19F NMR (376 MHz, CDCl3) δ –72.7 (3F, s); HRMS (EI) Exact 
mass calcd for C15H15O4F3 [M





5.    Enantioselective Metal-Catalysed Arylations of β-
Fluoroalkyl-α,β-Unsaturated Carbonyl Compounds 
 
Asymmetric carbon−carbon bond-forming reactions are of great utility in organic synthesis. 
One of the most popular methods is the metal-catalysed conjugate addition. As part of our 
exploration of the reactivity of β-fluoroalkyl-α,β-unsaturated carbonyl compounds, we 
wished to develop the introduction of further functionality into these substrates 
enantioselectively though the formation of  a carbon−carbon bond. 
 
Organoboron species (and boronic acids in particular) are excellent nucleophiles for such 
reactions.113 This effectiveness is due to their good stability towards air and moisture relative 
to other organometallic reagents, their lack of reactivity in the absence of catalyst (which 
prevents a decrease in enantiomeric excess due to uncatalysed background reactions), their 
wide availability and generally low toxicity. One class of reaction which has been explored 
over the past fifteen years is the rhodium-catalysed arylation of enones. 
 
5.1       Introduction 
5.1.1    Rhodium-Catalysed 1,4-Arylations of α,β-Unsaturated Carbonyl 
Compounds 
 
The first report of the 1,4-addition of aryl and alkenyl boronic acids to α,β-unsaturated 
ketones under rhodium catalysis came from the group of Miyaura in 1997 (Scheme 5.1).114  
Screening conducted on methyl vinyl ketone revealed that a number of phosphine ligands 
worked well in the reaction, but dppb was eventually selected for further experimentation. 
There were also a number of rhodium catalysts and solvents that could be employed, but the 
addition of water to the mixture was found to be essential for high yields. A range of 
substrates and boronic acids were shown to undergo reaction under the optimised conditions 
to give good yields of the isolated ketone products.   
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Scheme 5.1 aDMF bcyclohexane cMeOH 
 
The first enantioselective example of the rhodium-catalysed 1,4-arylation of enones was 
published by Hayashi and Miyaura in 1998.115 BINAP was the chiral ligand of choice for this 
reaction and there were also changes to the rhodium catalyst (Rh(acac)(C2H4)2) and solvent 
(dioxane/water 10:1) used. Ees for a range of substrates and boronic acids were all above 
90% and the observed yields were also generally very good (Scheme 5.2). 
 
 
Scheme 5.2 aAbsolute geometry not determined 
 
An initial proposed mechanism was given in this communication and further details were 
disclosed in a full paper from 2002.116 A basic outline is given in Scheme 5.3. The cycle 
begins with the transmetallation of the aryl group from the boron centre to rhodium to give a 
rhodium-aryl species (159). Co-ordination of the rhodium species to the alkene of the 
substrate is followed by insertion of the enone into the rhodium-aryl bond to give a rhodium 
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enolate (161). The hydrolysis of this enolate is then required to release a molecule of product 
(157) and regenerate the active catalyst. All of the intermediates were observed in NMR 
experiments. The detailed mechanistic study also led to the discovery of a more active 
catalyst complex. It was discovered that a temperature of above 60 °C was required for 
transmetallation to Rh(acac)(BINAP), whereas transmetallation to [Rh(OH)2(BINAP)] occurs 
rapidly at 25 °C. The [Rh(OH)2(BINAP)] complex can be generated in situ from 





The first report of the extension of rhodium-catalysed arylation methodology to α,β-
unsaturated esters was described by Hayashi in 1999.117 The application of both boronic acids 
and in-situ-generated lithium borates (which were originally reported by the same authors 
earlier in the same year118) was described, with the latter giving more general results 






Unsaturated lactones were also found to be arylated smoothly using rhodium catalysis. In this 
case, arylboronic acids were found to be the best aryl source. Again, yields and ees were 
generally excellent, although the isolated yield for a five-membered ring substrate was poor 
(Scheme 5.5).  In a slightly later publication by Miyaura, almost identical conditions were 





The next substrates for which rhodium-catalysed conjugate arylations were found to be 
successful were alkenylphosphonates.120 Reaction yields were found to be disappointingly 
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low when boronic acids were employed. However, the application of triarylcyclotriboroxines 
gave the desired products in generally excellent yields and ees (Scheme 5.6). Employing a 
substrate with the opposite double bond geometry gave the opposite enantiomer as product 
(167a and 167f). The slow isomerisation of the Z starting material into the E was observed 
under the reaction conditions, giving decreased ees with prolonged reaction times.    
 
 
Scheme 5.6 aSubstrate was (Z)-isomer 
 
The asymmetric arylation of nitroalkenes has also been reported.121 The conditions employed 
were the same as those described previously for unsaturated ketones, esters and 
phosphonates. Yields and enantiomeric excesses were excellent for the arylation of 6-
membered ring substrates, but ees were decreased for the alkenylation of these substrates and 
the arylation of 5-membered rings (Scheme 5.7). An acyclic substrate also underwent 
reaction (169e), although the yield was significantly lower even when 10 equivalents of 






The rhodium-catalysed arylation of cyclic α,β-unsaturated amides was reported in 2001.122 
The examples given were limited to the reaction of one substrate with three arylboroxines: 
phenyl and the electron-deficient p-F-phenyl and p-Cl-phenyl (Scheme 5.8). For the p-F-
phenyl example, the isolated yield of product was found to be significantly higher for the 





































Scheme 5.8 Absolute geometry not determined 
 
Acyclic unsaturated amides were reported as successful substrates in rhodium-catalysed 
arylations later the same year.123 Initially, the reaction gave poor conversions, which resulted 
in low yields. However, it was found that the addition of base, which allows the formation of 
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RhOH species in situ, led to increased conversions due to the accelerated rate of 
transmetallation of the aryl group to the rhodium centre (vide supra). The reaction worked 
well for a range of substituents on the nitrogen atom (although no reaction is observed when 
dialkyl amides were tested) and boronic acids (Scheme 5.9). The β-substituent had a greater 






So far, the only chiral ligand that we have seen employed in these rhodium-catalysed 
arylations is BINAP. However, in 2003, Hayashi reported the first use of chiral dienes as 
ligands.124 The use of the resulting new catalyst complex allowed arylations to occur at lower 
temperatures than in previous reports, with cyclohexenone undergoing reaction with phenyl 
boronic acid at 20 °C. A range of cyclic and acyclic enones were reacted with aryl and 
alkenyl boronic acids to give the expected products in excellent yields and enantiomeric 







In this publication, the use of the less reactive stannanes as an aryl source was shown to be 
successful with diene ligands (Equation 5.1). Previously, attempts employing (S)-BINAP 
had given yields of lower than 10%.  
 
Ligand 173 (6.6 mol%)
[RhCl(C2H4)2]2 (3 mol%)
















Another reported application of diene ligands is in the arylation of fumaric and maleic 
compounds; a substrate class which had previously not been successful in the rhodium-
catalysed process.125 Chiral norbornadiene ligand 176 was found to be the most efficient and 
a range of 2-substituted-1,4-dicarbonyl compounds were synthesised in excellent yields and 




Scheme 5.11 aAbsolute geometry not determined 
 
Diene ligands have also been used by the group of Zu and Lin in their expansion of the 
substrate scope for nitroalkene arylations to include those without an α-substituent (Scheme 
5.12).126 Enantiomeric excesses were excellent (95-97% ee) when bulky arylboronic acids (1-
naphthyl and 2-tolyl) were employed and were generally good for all substrates with an aryl 
substituent (82-97% ee). However, a drop in enantiomeric excess values was observed for 






The first example of the rhodium-catalysed conjugate arylation to form quaternary 
stereocentres was reported by Hayashi in 2006.127 3-Substituted maleimides underwent 
reaction with (R)-H8-BINAP as ligand to give 3,3-disubstituted succinimides with excellent 































































Rhodium-catalysed arylations generating quaternary stereocentres were extended to cyclic 
and acyclic enone substrates by the same group in 2009.128 In this publication, sodium 
tetraarylborate salts were used in place of boronic acids as the aryl source. It is believed that 
the advantage of these air stable borate salts is a result of the release of triarylborane, which 
acts as a Lewis acid to assist the insertion of substrate into the rhodium-aryl bond. Yields and 






In 2007, Iyer and co-workers described the results of a study using microwave irradiation in 
the racemic rhodium-catalysed arylation of maleimides using boronic acids.129 Not only were 
reaction times found to be shorter, but the scope was found to be broader under their 
conditions. Protection of the maleimide nitrogen was no longer required and electron 
deficient boronic acids, which failed to react under conventional heating, gave good yields 
(Scheme 5.15). However, ortho-substituted boronic acids were found not to react under 
either set of conditions. 
 
 
Scheme 5.15 Yields in parenthesis indicate those obtained under conventional heating at 50 °C for 6 hours. 
Absolute geometries were not determined. 
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The first contribution from the Lam group to rhodium-catalysed arylation chemistry was 
published in 2010 and demonstrates the reaction of alkenylheteroarenes.130 A range of 
heterocyclic substrates were shown to react with a number of different boronic acids in 
excellent yields and enantiomeric excesses (Scheme 5.16) employing a novel chiral diene 
ligand 189. Alkenyl boronic acids were shown to be more troublesome giving only small 
quantities of the desired product under various conditions. Protodeboration was the major 
outcome. MIDA-boronate 192 which releases the appropriate boronic acid gradually under 
basic conditions was found to give superior results, although the enantiomeric excess was still 








A further report has also described the reaction of alkenyl nitroarenes in a similar manner.131 
The diene ligand employed was changed to dibenzyl amide 189b and additional water was 
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added, but otherwise the optimised conditions matched those required for the reaction of 
alkenylheteroarenes. Again, yields and ees were found to be very high for a number of 





Other reports from the past three years have often focused on the synthesis of new ligand 
classes, which have been shown to be successful in the arylation of cyclic enones. Examples 
include tetrafluorobenzobarrelenes (195)132, several different sulfoxide-alkene hybrids (196-






However, it is not just enantioselective conjugate additions of arylboronic acids that can be 
catalysed by rhodium. 1,2-Arylations have also been reported.  
 
5.1.2    Rhodium-Catalysed 1,2-Arylations of Carbonyl Compounds  
 
The seminal report of rhodium-catalysed 1,2-arylation using boronic acids came from 
Miyaura in 1998.135 The optimised conditions involve dppf as ligand and a mixture of DME 
and water as solvent. The reaction of a range of aldehydes and boronic acids was found to 
proceed smoothly under these conditions (Scheme 5.19). Problematic reactants included the 
electron-poor 4-nitrobenzaldehyde and the use of 4-acetylphenyl boronic acid, which both 





This publication also describes the earliest attempt at an enantioselective version. Employing 
(S)-MeO-MOP (202) as ligand, 1-naphthaldehyde was arylated with phenyl boronic acid to 





Following this publication, there have been many attempts to optimise the ees for the 
arylation of aldehydes, most of which have met with limited success. The first of these came 
from the group of Bolm in 2005 and described the use of imidazolium salts as ligands.136  
Seven different salts were screened but the best ee obtained for the reaction of 4-
chlorobenzaldehyde with phenyl boronic acid was only 29%. 
 
There were several further reports in 2006. In one, a number of chiral bisphosphine ligands 
were screened and iPr-DuPhos was discovered to give the best enantioselectivity.137 For the 
eight examples described, the ees ranged from 36 to 66%. Higher enantioselectivity values 







Excellent yields and good ee values were obtained when chiral spiro monophosphite ligand 





A report from Feringa, Minnaard and co-workers on the use of bidentate phosphoramidite 
ligands displayed ees of up to 75% (Scheme 5.22).140 The authors also expanded on the effect 
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of the ligand in the arylation of aldehydes with an extensive phosphoramidite and phosphite 
library screening study.141 No increases in enantioselectivity were reported, but it was 





As the use of diene ligands has seen such success in enantioselective rhodium-catalysed 
conjugate arylations, it is not surprising that their use in direct arylations has been reported.142 
Screening was carried out on the reaction of phenylboronic acid with p-
trifluoromethylbenzaldehyde using a bicycloheptadiene ligand. Unfortunately, the highest ee 
obtained whilst retaining a high yield was 42%. More success has been achieved with 
tetrafluorobenzobarrelene ligands, for which yields were excellent and the enantiomeric 
excesses were much higher (Scheme 5.23).143 The authors attribute the success of this ligand 
class to their good coordination ability toward transition metals, their small bite angle and 
their electron-deficient character. Additionally, the synthesis of these ligands is 






Another publication in which good enantiomeric excesses are obtained describes the use of 
axially chiral fluoroalcohol-substituted phosphine ligands 206.144 The paper contains 13 





There are fewer examples of the enantioselective rhodium-catalysed arylation of ketones and, 
until very recently, only particularly electrophilic ketones had been successfully reacted. One 
example of a successful substrate class is isatins. Two reports of their arylation appeared in a 
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short space of time. The first describes a racemic reaction with one asymmetric example 











Trifluoromethyl ketones have also been found to be reactive enough to undergo rhodium-
catalysed arylations.147 Again, a phosphoramidite was the ligand of choice. Ten examples are 





α-Ketoesters have also been found to undergo rhodium-catalysed arylation with boronic acids 
in mostly excellent yields and high ees (Scheme 5.27).148 Spiromonophosphite ligands were 
employed and the products were shown to undergo smooth reduction and hydrolysis to give 
vicinal diols and α-hydroxy acids respectively. In 2012, another report of the asymmetric 
arylation of α-ketoesters and diketones was published.149 A sulfur-olefin hybrid ligand (217) 
was used in the arylation of α-keto-naphthyl esters to give 21 examples all with ees above 
90% (Scheme 5.28). The enantiomeric excesses for diketones were also above 90% for aryl 
ketones, but there was some decrease when one or both of the ketones were aliphatic (e.g. 









Very recently, the reaction of unactivated ketones has been described.150 Anhydrous 
conditions were used with a diene ligand to give chiral tertiary alcohol products in up to 68% 






Whilst considerable success has been achieved in the arylation of carbonyl compounds under 
rhodium catalysis, there is still room for improvement in two main areas. Firstly, 
enantiomeric excesses are still variable, with aldehydes and unactivated ketones in particular 
often giving poor ee values. Secondly, the cost of rhodium limits the application of such 
chemistry in a commercial environment, especially on large scale. Therefore, there is a need 
to look at the asymmetric arylation of aldehydes using boronic acids catalysed by metals 
other than rhodium. 
 
5.1.3    Asymmetric 1,2-Arylations of Aldehydes with Boronic Acids 
Catalysed by Metals Other than Rhodium 
 
As well as rhodium, enantioselective arylation with boron nucleophiles have been reported 
using palladium, nickel, cobalt, copper and ruthenium catalysts. 
 
Palladium-catalysed additions of boronic acids to aldehydes were described by Ito in 2005.151 
However, an enantioselective version proved to be somewhat difficult to achieve. Chiral N-
heterocyclic carbene (NHC) palladium complexes were tested by Shi in the arylation of 
benzaldehydes152 and although yields were high, the enantiomeric excesses were 
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disappointing. The highest ee in the publication is 65%, but most examples are much lower 
(Scheme 5.30). The enantioselective palladium-catalysed arylation of aldehydes with boronic 
acids remains an unsolved problem. 
 
 
Scheme 5.30 aAbsolute stereochemistry was not determined 
 
 
The first example of an enantioselective nickel-catalysed arylation of aldehydes was reported 
by Aoyama in a communication in 2007153 followed by a full paper in the following year.154 
The substrate scope was found to be broad when a range of arylboroxines were reacted with 
aromatic aldehydes, giving good yields. Enantioselectivities were in the range of 65-78% 
when (R,R)-Et-Duphos was employed as ligand for 2-substituted aromatic aldehydes. 
Unfortunately, when no ortho-substituent was present on the aromatic ring (e.g. 201x), 




Scheme 5.31 aAbsolute stereochemistry was not determined 
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Some improvement was observed when the aryl source was changed to potassium 
aryltrifluoroborates, although p-Me- and p-MeO-benzaldehydes still gave much poorer ees 
than other substrates (Scheme 5.32).  
 
 
Scheme 5.32 aAbsolute stereochemistry was not determined 
 
The substrate scope was extended by the same authors in the following year to include α,β-
unsaturated aldehydes,155 which selectively underwent the 1,2-addition under optimised 
conditions (Scheme 5.33). A range of unsaturated aldehydes were arylated in good yields, 
with the exception of the reaction of β-aliphatic substrates which gave much lower values. 
Enantiomeric excesses are only reported for two of the products and these are both 
disappointing at 39% for 223a and 36% for 223b.  
 
 
Scheme 5.33  aAbsolute stereochemistry was not determined 
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A further publication in the same year details the group’s attempts to increase the 
enantiomeric excesses for problematic benzaldehyde substrates, such as p-
methylbenzaldehyde.156 Their aim was achieved by the introduction of an easily removed 
dimethylphenylsilyl substituent into the ortho-position of the aldehyde and the use of 
aryltriolborates (225) as the arylating agent. All of the yields and enantiomeric excesses 
obtained were excellent (Scheme 5.34). Interestingly, reaction of the p-methyl-substituted 





Cobalt-catalysed arylations employing (R,R)-BDPP as ligand gave a range of diarylmethanol 






Copper was first revealed as a cheap alternative to rhodium in the enantioselective arylation 
of aldehydes using boron species by Shibasaki in 2006.158 CuF2·H2O was used in conjunction 
with DTBM-SEGPHOS ligand to arylate benzaldehydes with the ethylene glycol ester of 
phenylboronic acid as the aryl source. An additive is required to obtain good yields and 15 
mol% of PhBF3K was found to give the best results. The additive acts to speed up catalyst 
turnover. Only four examples of arylation were given, but yields and ees were consistently 





Finally, there have been three reports of a very successful arylation of aldehydes under 
ruthenium catalysis by the group of Miyaura. In the first, a bidentate BINOL-derived 
phosphoramidite 228 was used as ligand to arylate a wide range of aromatic and 
heteroaromatic aldehydes.159 The use of other ligands in this reaction gave significantly lower 




Scheme 5.37 aAbsolute stereochemistry not determined 
 
The O-linked-BINOL ligand 228 was also employed in the arylation of aliphatic aldehydes 
and ketoesters.160 Enantiomeric excesses were excellent for all of the 39 examples although 






The scope was extended to cover glyoxylate substrates.161 Enantioselectivities were good to 
excellent for a number of substituted boronic acids, but an ee of only 16% was observed for 
reaction with 3-chlorophenyl boronic acid. This poor enantioselectivity was solved by the 
addition of methyldiphenylphosphine to the reaction mixture as an extra ligand. The 
methyldiphenylphosphine is believed to displace a triphenylphosphine ligand on the 





Scheme 5.39 aValues in parenthesis are those obtained with PMePh2 (2.2 mol%) as an additive. 
In summary, rhodium-catalysed arylations are a powerful method for the enantioselective 
synthesis of both carbonyl compounds with a β-stereocentre and diarylmethanols. There is 
also a need for development of similar methods which employ cheaper metals than rhodium. 
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5.2     Results and Discussion 
 
The asymmetric formation of carbon−carbon bonds is of great importance throughout organic 
chemistry. As we have seen, the metal-catalysed reaction of conjugate acceptors with boronic 
acids is an excellent approach. As such, the utility of such methodology in the reaction of β-
fluoroalkyl-α,β-unsaturated carbonyl compounds deserves thorough investigation.  
 
5.2.1    Enantioselective Metal-Catalysed Arylations of β-Fluoroalkyl-α,β-
Unsaturated Ketones and Esters 
 
With a number of β-fluoroalkyl enones in hand from our previous endeavours (see Chapter 
4.2.1), we embarked upon an investigation into the reaction of such compounds under 
conditions commonly employed for conjugate arylations. Rhodium was selected for early 
experimentation due to the significant prominence of this metal in enantioselective conjugate 
arylation chemistry. Compound 129a was subjected to reaction with p-tolylboronic acid in 
the presence of [Rh(cod)Cl]2 (2.5 mol%) and KOH (2.5 equivalents) in dioxane/H2O (9:1) 
under microwave irradiation at 80 °C (Equation 5.5). As we have seen, there are limited 
examples of the reaction of ketones in rhodium-catalysed arylations, so it was somewhat 
surprising that 30% conversion to the product of 1,2-arylation was observed. The remainder 
was unreacted starting material and none of the extremely hindered product of conjugate 





Subjecting a further substrate, 129b, and phenyl boronic acid to the same conditions for 30 





Although not the intended products, the compounds obtained by this reaction are chiral allylic 
alcohols, which could also be used in further transformations as a useful enantioenriched 
fluoroalkylated building block. Therefore, screening to obtain conditions for an 
enantioselective version of this reaction was undertaken. For enantioselective reactions, 
[Rh(C2H4)2Cl]2 was employed as catalyst due to the greater lability of the ethylene ligands 
relative to COD, which allows for the more rapid formation of the rhodium-chiral ligand 
complex. 
 
Initially, the use of chiral diene ligands was investigated, as these have been shown to give 
high enantiomeric excesses in the reaction of a range of substrates in rhodium-catalysed 
arylations with boronic acids. However, in this case, they were found not to be the best class 
of ligand and conversions obtained were very poor (Table 5.1) with only one ligand (189b) 
giving any desired product at all (8% conversion). The remainder of the reaction mixture was 
mostly starting material, although with some of the dienes, a small amount of double bond 
isomerisation was observed (<5%). As a result of the very low conversions, enantiomeric 
excesses were not measured for these reactions. 
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Table 5.1 Ligands synthesised by Benoit Gourdet, Iain Roy and Aarkarsh Saxena. aResult obtained by 
Graham Pattison 
 
The use of chiral bisphosphine ligands was immediately shown to be more promising, with 
several ligands giving moderate to good conversions. Selected examples of the ligands 
screened are shown in Table 5.2. As a result of this screening, two ligands were identified as 
showing potential for further optimisation and it is these that formed the basis of later 
research. (R,R)-MeDuPhos gave almost complete conversion to the desired product after an 
hour at 80 °C, although the enantiomeric excess required improvement at only 44%. (S)-
MeO-BIPHEP gave the highest enantiomeric excess obtained, at 76%, but for this ligand the 
conversion was a disappointing 29% under these conditions. In most cases, increasing the 
steric bulk of the ligand employed resulted in a significant decrease in conversion to the 















































































































Table 5.2 a12 mol% ligand employed. bMajor enantiomer obtained opposite to that obtained for (R)-BINAP. 
 
Firstly, the effect of temperature on the reaction using (S,S)-MeDuPhos was investigated. 
Unfortunately, decreasing the temperature below 80 °C led only to decreased conversions 
with no significant improvement to the enantiomeric excesses. Decreasing the amount of base 






Solvent screening was carried out next (Table 5.3). For most of the solvents tried, no more 
than a trace of product was formed and the reactions were very messy with a number of side 
products observed, including those of double bond isomerisation and reduction. THF gave a 
decreased conversion compared to dioxane and the ee was slightly lower (38%). There was 
no starting material remaining when methanol was used as solvent, but there was 31% of an 
unidentified side product and the ee was not improved. Trifluorotoluene also resulted in no 
remaining starting material being observed, but there was no desired product either. After the 





Product (%) ee (%) 
dioxane/water (9:1) 97 44 
Water <5 − 
THF/water (9:1) 51 38 
DCE/water (9:1) <5 − 
Methanol 69 42 
acetonitrile/water (9:1) <5 − 
heptane/water (9:1) <5 − 
trifluorotoluene/water 
(9:1) <5 − 
MTBE/water (9:1) <5 − 
Table 5.3 
 
The use of other boron-based aryl sources was also explored with (R,R)-MeDuPhos as ligand, 
including boronic esters, sodium tetraarylborate salts and potassium trifluoroborates. Out of 




As no improvement in enantioselectivity had been observed after extensive screening with 
(R,R)-MeDuPhos as ligand, our hopes then rested on increasing the conversions obtained 
with (S)-MeOBIPHEP as ligand, which gave a 76% ee during ligand screening, but only a 
29% conversion.  
 
Increasing the amount of boronic acid employed to 5 equivalents gave no improvement to the 
conversion when water was used as part of the solvent mixture (9:1 with dioxane). However, 
when only 5 equivalents of water were employed along with 5 equivalents of boronic acid, 
the conversion to desired product increased to 40 % (Table 5.4). Switching the proton source 
to methanol (5 equiv) gave 51% conversion. Bulkier alcohols, such as tbutyl alcohol resulted 












Decreasing the reaction temperature (with the aim of decreasing the rate of protodeboration 
of the boronic acid) to 60 °C gave only 10% conversion, which increased to 42% when the 





As a major limiting factor in the conversions of these reactions is the protodeboration of 
boronic acids, further screening was conducted with the aim of decreasing the amount of 
protodeboration. Bases other than KOH and different quantities of base were explored. No 
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improvement to the conversions was observed and a significant decrease was seen when the 
equivalents of base were dropped below two. Lewis acids, including diethylzinc, aluminium 
triflate, and titanium tetrachloride, were also tested in place of base, but no desired product 
formation was observed.  
 
Addition of furthur equivalents of boronic acid after 30 minutes reaction time and the slow 
addition of the boronic acid by syringe pump over the course of one hour resulted in no 
improvement and in the case of the slow addition, actually led to a decrease in the amount of 
desired product formed.  
 
Other rhodium sources were also tested including rhodium acetate and cationic rhodium 
catalysts, but once again none of these offered any improvement to the conversions. Finally, 
variations in reaction times, heating methods (thermal versus microwave irradiation) and 
concentration were explored.  
 
The best results obtained are shown in Table 5.5 along with the scope. The less sterically 
hindered methyl ketones offer the best conversions and enantiomeric excesses which are 
comparable to much of the existing literature. The lower ees for more hindered ketones 
(235d, 235f and 235g) are presumably a result of decreased steric discrimination of the two 







In addition to the enantioselective reaction, we also sought to optimise a set of racemic 
conditions for the arylation of β-fluoroalkyl-α,β-unsaturated ketones. The initial conversion 
with no ligand present was 33% using [Rh(cod)Cl]2, KOH and 2.4 equivalents of boronic 
acid. Screening of racemic ligands was then conducted and the results are shown in Table 
















Furthur screening of concentrations, temperatures and reaction times failed to increase the 
observed conversions above 46% (achieved with Johnphos when the temperature was 





Fortunately, it was discovered that switching the aryl source from phenylboronic acid to 
sodium tetraphenylborate gave complete consumption of starting materials after one hour 
heating at 80 °C under microwave irradiation. The scope is shown in Table 5.7. The reaction 
gives moderate to good yields for a range of substrates. The yield was substantially lower for 
the introduction of the p-chlorophenyl group (235c) despite the use of higher temperature, 
presumably due to the lower reactivity of electron-deficient borates. The reaction was found 
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to be particularly poor for the substrate containing a deactivating p-MeO-phenyl ketone 
(235h). In this case, some of the product of 1,4-arylation (16%) was also observed as well as 
unreacted starting material (16%). Only 6% conversion was seen for the arylation of 129a 




Table 5.7 aReaction carried out at 120 °C bNMR conversion 
 
Whilst there was no starting material remaining in these reactions, the isolated yields were 
modest due to the amount of side product formation. There were up to 14 side products 






Compound 133 is the product of a 1,2-reduction. It seems likely that this was formed by the 
reaction of the enone starting material with rhodium-hydride. However, it is not known how 
the rhodium-hydride forms under the reaction conditions. Compound 242 is the product of 
overall hydrogen fluoride elimination. It is feasible that this could occur as given in Scheme 
5.41. The proposed mechanism involves a similar sequence of events to that given earlier for 





Compound 243 could be formed by the intramolecular attack of the oxygen anion of 




Only sodium tetraphenylborate is commercially available, so most of the other tetraarylborate 
salts were synthesised using Method A shown in Scheme 5.43. This method of synthesis fails 







The success of tetraarylborate salts in the racemic reaction encouraged us to re-explore the 
use of these as an aryl source in the enantioselective version. Unfortunately, the use of 
[Rh(C2H4)2Cl]2 with a range of ligands and sodium tetraphenylborate gave no product 
formation. Switching back to [Rh(cod)Cl]2 as catalyst and adding chiral ligands led to 
decreased conversions compared to the ligand-free reaction and no enantioselectivity was 
observed.  
 
Finally, we investigated the use of metals other than rhodium in the enantioselective arylation 
of β-fluoroalkyl-α,β-unsaturated ketones. Despite the screening of a broad range of conditions 
employing manganese, iron, cobalt, nickel, copper, ruthenium, palladium, silver, iridium, 
platinum, gold and indium, no desired product was observed for reaction with any metal other 
than rhodium. Iridium gave 10-20 % of 1,2-reduction product and other metals mostly 
returned starting materials only. (The screening of other metals was carried out in 
collaboration with Graham Pattison.) 
 
We have seen that the arylation of β-fluoroalkyl-α,β-unsaturated ketones gives the product of 
a 1,2-addition to the carbonyl group rather than the more usual 1,4-addition. It was expected 
that the reaction of β-trifluoromethyl-α,β-unsaturated esters, on the other hand, would give 
the product of conjugate addition. However, it was also likely that harsh conditions would be 
required to generate the very hindered quaternary stereocentre bearing a fluoroalkyl group. 
Nevertheless, as success in the development of suitable conditions would lead to a method for 
the synthesis of compounds currently difficult to access, endeavours in this area are desirable.  
 
Initial attempts employing boronic acids gave no product under a range of racemic conditions 
tested. Boroxines were also unsuccessful. However, the use of sodium tetraarylborate salts, 
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which have been previously reported in arylations to give quaternary stereocentres,128 gave 
better results. With [Rh(cod)Cl]2, a conversion of 25% was obtained after 45 minutes heating 
at 80 °C under microwave irradiation. We then sought to obtain enantioselective conditions 
through the addition of a chiral ligand to the reaction mixture. Heating under microwave 
irradiation at 120 °C for an hour in the presence of diene ligand 189a gave 88% conversion to 
the desired product with an enantiomeric excess of 96% (Scheme 5.44). Unfortunately, the 
reaction lacks reproducibility and further repeats have given vastly differing conversions 





Other diene ligands were screened with the hope of selecting one that gives better and more 
consistent conversions to desired product. The results are given in Scheme 5.45. The only 
other ligand that gave more than a trace of desired product was the monocyclohexylamine 














Scheme 5.45 Ligands were synthesised by Benoit Gourdet, Iain Roy and Aarkarsh Saxena 
 
So far, no improved conditions for the conjugate arylation of β-trifluoromethyl-α,β-
unsaturated esters have been found. It seems likely that a radically different approach is 
required to achieve successful conditions for such a challenging transformation. 
 
At this point a decision was made to investigate the reactions of more reactive substrates: β-
fluoroalkyl-α,β-unsaturated aldehydes.  
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5.2.2    Enantioselective Metal-Catalysed 1,2-Arylations of β-Fluoroalkyl-
α,β-Unsaturated Aldehydes 
 
The greater reactivity of aldehydes relative to ketones was expected to increase the 
conversion to the product of 1,2-arylation. The allylic alcohols thus obtained could then be 
used as chiral fluorinated building blocks for furthur elaboration into a range of structures. 
 
The first challenge encountered was the synthesis of these new substrates. Initial attempts 
focused on the direct formation of the enal through a Wittig reaction in the exact same 
manner as used for the ketones (Scheme 5.46). Unfortunately, a number of problems arose 
with this method. The first attempt gave good stereoselectivity with a 17:1 ratio of E to Z, but 
also gave a substantial amount (approximately 50% of the reaction mixture) of 249. This was 
formed by the reaction of the initial product with a further molecule of ylide. Additionally, 
the isolated yield was disappointing (48% for both products combined). In an attempt to 
minimise the formation of 249, the reaction was repeated at a lower concentration. This 
change decreased the amount of 249 to 30%, but gave poorer stereoselectivity (<9:1 E:Z). 
Attempts to separate these isomers by column chromatography not only failed, but also 
revealed the low isolated yields achieved earlier to be the result of instability of the aldehyde 



























A new approach to the synthesis was sought. The application of a Meyer-Schuster reaction 
was explored (Scheme 5.47), although no product was observed under a range of conditions 
based on literature precedent, such as the use of indium trichloride162 and the combination of 




A more successful approach was developed by synthesising the α,β-unsaturated ethyl esters, 
reducing these with DIBAL to give allylic alcohols (252) and then oxidising the alcohols with 
manganese dioxide to give the desired aldehydes (Scheme 5.48). Advantages to this approach 
are the separability of the E/Z isomers at the ester stage and lack of purification required for 
the aldehyde product. Simply filtering the reaction mixture through celite gave clean α,β-
unsaturated aldehydes which were used directly in the arylation reactions. Scheme 5.48 
shows the aldehydes that were made using this approach. The α,β-unsaturated aldehydes were 
found to be stable at room temperature for up to four weeks, but would last for up to three 
months when stored at, or below, 0 °C. The exception to this is 248b, which degraded much 
more quickly and was therefore stored as the allylic alcohol and oxidised immediately prior 




Scheme 5.48 Yields given are those over all 3 steps. 
 
Most of the fluoroalkyl ketones were commercially available. However, in the case of 248e 
the precursor ketone had to be synthesised. Simple alkylation of trifluoroacetic acid using 
Grignard reagent gave the desired ketone (Equation 5.10). The conditions used were based 
on a literature procedure which describes the reaction of ethyl trifluoroacetate with Grignard 
reagent.164 Trifluoroacetic acid, which has been used in similar reactions,165 was employed in 






Initially, the racemic arylation of 248a was carried out using phenyl boronic acid and 
rhodium-catalysis ([Rh(cod)Cl]2). Complete conversion to desired product was observed after 
30 minutes at 70 °C. The scope of the racemic reaction was then explored. Some examples 
are shown in Table 5.8. With respect to the boronic acid component, both electron rich 
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(255o) and electron poor (255d) aromatics worked well. The ring could also be substituted in 
the ortho (255p), meta (255b) and para (255d and 255o) positions with minimal effect on the 
isolated product yields. The β-substituent of the unsaturated aldehyde could be varied from 
phenyl (255a, b, d, g, o and p) to fluorophenyl (255i), thiophenyl (255k) and alkyl (255m) 






Work was then carried out towards our major aim of the development of a set of 
enantioselective conditions to give the allylic alcohols in high enantiomeric excesses. Initial 
screening focused on the use of rhodium with chiral non-racemic ligands. [Rh(C2H4)2Cl]2 
was used along with 2 equivalents of KOH in dioxane and water (9:1). Selected results of this 
screening are give in Table 5.9. A number of ligands gave good conversions to the arylation 
product, although many gave a substantial amount of side-product 130g, which presumably 
forms by a β-hydride elimination of the intermediate rhodium alkoxide (258) instead of the 
desired hydrolysis (Scheme 5.49). Unfortunately, the best enantiomeric excess observed 
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during the ligand screen was 42%, which was seen with both (R)-MeO-BIPHEP and an 





Table 5.9 Conversions were obtained by 1H and 19F NMR. Values in parenthesis are the amount of 130g 
















50 Dioxane/H2O (9:1) KOH <5 - 
70 THF/H2O (9:1) KOH <5 - 
70 Toluene/H2O (9:1) KOH 88 16 
70 Methanol KOH 87 42 
70 
t
Butanol KOH 73 (27) 46 
70 DCM/H2O (9:1) KOH 79 (21) 27 
70 DME/H2O (9:1) KOH 56 - 
70 Dioxane/H2O (9:1) K3PO4 <5 - 
70 Dioxane/H2O (9:1) NEt3 15 33 
70 Dioxane/H2O (9:1) K2CO3 >95 27 
Table 5.10 Conversions were obtained by 1H and 19F NMR. Values in parenthesis are the amount of 130g 
formed. 
 
As rhodium was giving disappointing results, other metals (which would be more desirable 
anyway for cost and availability) were tried in the arylation reaction. 
 
Whilst there are no examples in the literature of an enantioselective arylation of aldehydes 
catalysed by iron, there is a racemic report of such a reaction.166 Only aromatic aldehydes 
with electron withdrawing substituents on the ring were found to undergo reaction with 
boronic acids under iron(III) chloride catalysis. All attempts to apply similar conditions 
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(FeCl3, K2CO3, THF, 90 °C) to our system employing chiral ligands gave poor results; with 





Copper catalysis was found to be even less successful; with none of the ligands (Me-DuPhos, 
MeO-BIPHEP, and Monophos) screened with conditions based on those reported by 





In terms of conversion, palladium was a far more suitable catalyst. With a number of ligands 
(including 256, MeO-BIPHEP, and Me-DuPhos), the arylation of β-fluoroalkyl-α,β-
unsaturated aldehydes was found to occur in high conversions at 60 °C with palladium (II) 






Ruthenium was another metal that showed promise from initial screening. A number of 
commercially-available chiral non-racemic ligands were tested in conjuction with [RuCl2(p-
cymene)]2 and in some cases (such as with Me-DuPhos), high conversions were observed and 
the reactions looked very clean by crude NMR. Unfortunately, low enantiomeric excesses 
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were still a problem with 22% being the highest obtained. The breakthrough was observed 
when Miyaura’s Me-Bipam ligand159,160,161 was synthesised and tested. Under the initial 
conditions attempted (Equation 5.14), the desired product was obtained in >95% conversion 





Additional screening was then carried out to determine the optimum conditions employing 
this ligand. As the reaction completed cleanly at 90 °C, lower temperatures were investigated 
first. Surprisingly, when the temperature was decreased to 60 °C, 255a was no longer the 
major product obtained and 48% of the reaction mixture was found to be 129g (11% starting 
material also remained after 16 hours reaction time and the remaining 41% was the desired 





The ketone product is most likely formed by a beta-hydride elimination as in Scheme 5.49. 
There is literature precedent for ruthenium-catalysed arylation of aldehydes with boronic 





A brief survey of alternative solvents was also conducted (although choice here was restricted 
by the requirement for a high boiling point). No desired product was obtained when dioxane 
or DMF were used in a 4:1 ratio with water. Water alone also returned only starting material. 
Dichloroethane was found to give 86% conversion and an ee of 84% after 16 hours, but as 
there was no clear advantage to the use of DCE over toluene, no change was made to the 








Toluene/H2O (4:1) >95 84 
dioxane/H2O (4:1) <5 - 
DMF/H2O (4:1) <5 - 
H2O <5 - 
DCE/H2O (4:1) 86 84 
Table 5.11 
 
The base employed was found to have a highly significant effect on the enantioselectivity of 
the reaction as well as the amount of conversion to product (Table 5.12) and, again, the 









K2CO3 >95 85 
KOH 80 78 
NEt3 40 16 
K3PO4 50 0 
Table 5.12 
 
The ethyl analogue of the Bipam ligand (264, Figure 5.1) was also synthesised but was found 





After the optimisation screening had been completed, the conditions selected were those that 
were initially tested (Equation 5.9). The scope was then examined (Table 5.13). In addition 
to phenylboronic acid (255a, 255g, 255i, 255k and 255m), arylboronic acids containing alkyl 
(255b, 255c, and 255n), halogen (255d, 255j and 255l), or methoxy substituents (255e) were 
successful reaction partners, as was 2-naphthylboronic acid (255f and 255h). With respect to 
the β-substituents of the enal, variation of the phenyl group in 255a to 4-fluorophenyl (255i 
and 255j), and 2-thienyl (255k and 255l) is well tolerated. However, with an alkyl group 
(255m and 255n) yields were lower. This is due to some starting material remaining in the 
reaction mixture as well as some degradation under the reaction conditions. Furthermore, the 
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β-perfluoroalkyl substituent may be varied from trifluoromethyl to n-heptafluoropropyl (255g 
and 255h) without affecting the efficiency of the reaction. The enantiomeric excesses of the 
products were fairly consistent (generally >80% ee), though slightly diminished selectivities 
were observed in some cases (255e, 255h, and 255m) and much lower values in others (255q, 
255r, and 255s, vide infra). In addition to the arylation products, the reactions also often 
produced varying quantities of the carboxylic acids resulting from the oxidation of the enal. 
Whilst the origin of this oxidation is unknown, attempts were made to decrease the amount of 







































255a  Ar = Ph                    
255b  Ar = 3-MeC6H4 
255c  Ar = 3,5-Me2C6H3 
255d  Ar = 4-ClC6H4 
255e  Ar = 3-MeOC6H4 





















255g  Ar = Ph 











255i  Ar = Ph 











255k  Ar = Ph 











255m  Ar = Ph  





Table 5.13 All yields are those of isolated material. All reactions were conducted on a 0.5 mmol scale 
 
Unfortunately, not all of the arylations tested were as successful as those shown in Table 
5.12. For example, whilst the reaction with most electron-deficient boronic acids occurred 
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smoothly, electron-donating substituents were less well tolerated. Reaction of p-
methoxyphenyl boronic acid with 248a occurred smoothly under the optimised racemic 
conditions to give the desired product (255o) in 76% yield (Table 5.8). Under the 
enantioselective ruthenium-catalysed conditions, only a 20% conversion was observed, 





Interesting results were obtained with ortho-substituents present. In the reaction of 248a with 
o-tolyl boronic acid, only 73% of the expected product 255p was observed. The remaining 
27% was found to be 255t, the product of reaction with p-tolyl boronic acid (Equation 5.17). 
Again, this is a result that was not observed under the racemic rhodium-catalysed arylation 
conditions. The mechanism of formation of this product is as yet unclear, although it seems 
likely that a migration occurs at some point. Incorporation of the toluene reaction solvent 
through a C-H activation process has been ruled out through control experiments in which no 
boronic acid was added. O-fluorophenyl boronic acid gave less than 5% conversion to 
product. There are no reports of the application of o-substituted arylboronic acids in the 





Another class of boronic acid that gave unexpected, and as yet unexplained, results were 
those containing trifluoromethyl substituents. The reaction with p-
trifluoromethylphenylboronic acid gave the desired product in somewhat diminished yields 
(38% for both 255q and 255r), and the enantiomeric excesses were found to be substantially 
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lower (0% for 255q and 6% for 255r, Scheme 5.51). The reaction of 3,5-
ditrifluoromethylphenylboronic acid was also found to give the product (255s) in low yield 
(26%, some starting material remained) and again with an ee lower than expected (54%, 





Functional groups on the boronic acid that were found to inhibit the reaction were ketones 
and nitriles. It is possible that this is due to the co-ordination of these groups to ruthenium 
preventing the transmetallation to ruthenium and/or the insertion into the aldehyde C=O 
bond. Alkenyl boronic acids were also tested, although these are known to be more 
challenging due to the rapid protodeboration of these species.130 16% conversion to the 
desired product was observed in the reaction of trans-2-phenylvinyl boronic acid with 248a, 
which did not increase when the MIDA-boronate equivalent (from which the boronic acid is 





Heteroaromatic boronic acids were also found to give very poor conversion to desired 
product. However, MIDA-boronates were found to be much more successful here and 
complete conversion to desired product was observed on a 0.1 mmol scale test reaction with 
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2-furanyl MIDA-boronate (Equation 5.19). Unfortunately, upon scale-up of this reaction, the 
product was found to degrade rapidly upon standing as well as upon silica gel and no 





As described earlier, the isolated yields for the ruthenium-catalysed arylation were found to 
be somewhat lower than expected given the appearance of the crude NMR, in which in 
almost all cases, only the product of arylation was observed. Whilst testing various work-up 
procedures in order to remedy this issue, a component of the reaction mixture which 
remained in the aqueous layer upon extraction with several organic solvents was discovered. 
Analysis of this compound (isolated upon reaction of 248c with phenylboronic acid) revealed 
it to be carboxylic acid, 261 (Figure 5.2). It was believed that this was formed by oxidation 
of the starting material aldehyde under the reaction conditions. Inhibition of this oxidation 





As the use of hydroquinone and TEMPO in ruthenium-catalysed oxidations of alcohols to 
aldehydes prevented any over-oxidation to the carboxylic acid,168 it was reasoned that the 
addition of these compounds to the ruthenium-catalysed arylation reaction mixture could 
prevent oxidation of the aldehyde. Unfortunately, no substantial improvement was observed 
upon addition of various amounts of these compounds, or sodium ascorbate, as an additive. It 
was also considered possible that the use of water in this reaction may be encouraging the 
oxidation. To test this, 5 equivalents of methanol was used as a proton source in place of the 
water, but carboxylic acid formation was still observed. Increasing the number of equivalents 
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of boronic acid employed to 2.5 was also tried with no success. An explanation for and 
solution to the problem of carboxylic acid formation under the optimised conditions is still 
sought. 
 
Once conditions had been obtained for the enantioselective arylation of β-fluoroalkyl-α,β-
unsaturated aldehydes, we looked to demonstrate potential uses of the chiral allylic alcohols 
thus formed in further manipulations to give other useful enantioenriched fluorinated 
compounds.   
 
A survey of the existing literature revealed a small number of reactions that employed β-
fluoroalkyl allylic alcohols similar to 255a-255n. The adaptation of one of these reactions to 
allow the employment of products 255a-255n was then embarked upon. 
 
Konno and co-workers have reported the palladium-catalysed formate reduction of fluorine-
containing allylic mesylates and acetates.57 Conversion of alcohol 255d into the 
corresponding acetate ester 262 was followed by the application of the conditions for 
formate-reduction reported by Konno (Equation 5.20). This afforded 263 containing a 
stereogenic trifluoromethyl group in 66% yield. Unfortunately, the reaction was accompanied 
by a diminuation in enantiopurity upon going from 255d (87% ee) to 263 (64% ee). This is 





The above transformation illustrates just one of the possible transformations that could be 
carried out on the arylation products to give a diverse range of enantioenriched fluorinated 
structures.
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5.3 Conclusions and Future Work 
 
An investigation has been conducted into the arylation of β-fluoroalkyl-α,β-unsaturated 
compounds. Under standard rhodium-catalysed arylation conditions, both enones and enals 
were found to undergo 1,2-arylation to give allylic alcohols as products. Both a racemic and 
an enantioselective arylation of enones have been developed. The conversions and 
enantiomeric excesses are somewhat modest for the enantioselective arylation of enones. 
Better results have been obtained for the enals for which a set of ruthenium-catalysed 
conditions affording chiral allylic alcohols in good yields and ees have been discovered. The 
products of this reaction have also been shown to undergo furthur elaboration to give 
fluoroalkylated stereocentres with good enantiomeric excesses.  
 
Work into the mechanism of the ruthenium-catalysed process could help to extend the scope 
of this reaction to include the addition of ortho-substituted aryl species and alkenyl groups. It 
may also allow conditions leading to higher isolated yields to be developed thorugh the 
removal of the unwanted oxidation. The reaction of esters also requires further work in order 
to obtain suitable conditions for the conjugate arylation of this challenging substrate class. 
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5.4    Experimental 
 
General Information 
All reactions were carried out under a nitrogen atmosphere in oven-dried apparatus. THF, 
toluene, dichloromethane, diethyl ether and methanol were dried and purified by passage 
through activated alumina columns using a solvent purification system. All commercially 
available reagents were used as received. Thin layer chromatography (TLC) was performed 
on Merck DF-Alufoilien 60F254 0.2 mm precoated plates. Product spots were visualized by 
UV light at 254 nm, and subsequently developed using potassium permanganate or vanillin as 
appropriate. Flash column chromatography was carried out using silica gel (Fisher Scientific 
60Å particle size 35-70 micron) employing the method of Still and co-workers.40 Melting 
points were recorded on a Gallenkamp melting point apparatus and are uncorrected. Infra-red 
spectra were recorded on a Shimadzu IRAffinity-1 instrument as a thin film or as a solid. 1H 
NMR spectra were recorded on a Bruker AVA500 (500 MHz) spectrometer or a Bruker 
AVA400 (400 MHz) spectrometer. Chemical shifts (δ) are quoted in parts per million (ppm) 
downfield of tetramethylsilane, using residual protonated solvent as internal standard (CDCl3 
at 7.27 ppm; CD3OD at 4.84 ppm). Abbreviations used in the description of resonances are: s 
(singlet), d (doublet), t (triplet), q, (quartet), sept (septet), app (apparent), br (broad). 
Coupling constants (J) are quoted to the nearest 0.1 Hz. Proton-decoupled 13C NMR spectra 
were recorded on a Bruker AVA500 (125.8 MHz) spectrometer. Chemical shifts (δ) are 
quoted in parts per million (ppm) downfield of tetramethylsilane, using deuterated solvent as 
internal standard (CDCl3 at 77.0 ppm; CD3OD at 49.05 ppm). Assignments were made using 
the DEPT sequence with secondary pulses at 90° and 135°. Proton-decoupled 19F NMR 
spectra were recorded on a Bruker AVA400 (378 MHz) spectrometer. Chemical shifts are 
reported in parts per million (ppm) downfield of CFCl3, using fluorobenzene as internal 
standard (C6H5F at –113.2 ppm). 
31P NMR spectra were recorded on a bruker AVA400 
(161.9 MHz) spectrometer. Chemical shifts are reported in parts per million (ppm) downfield 
of phosphoric acid. High-resolution mass spectra were recorded using electrospray ionisation 
(ES), electron impact ionisation (EI) or atmospheric solids analysis probe (ASAP) techniques 
on a Finnigan MAT 900 XLT spectrometer or a Finnigan MAT 95XP spectrometer or a 
Thermofisher LTQ Orbitrap XL spectrometer at the EPSRC National Mass Spectrometry 
Service Centre, University of Wales, Swansea or using electron impact ionisation on a 
Finnigan MAT 900 spectrometer at the University of Edinburgh. Optical rotations were 
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performed on an Optical Activity POLAAR 20 polarimeter. Chiral HPLC analysis was 
performed on an Agilent 1100 instrument or an Agilent 1260 instrument using 4.6 x 250 mm 
columns. 
 
General Procedure A: Synthesis of Sodium Tetraarylborates A. 
 
To magnesium turnings (3.24 g, 133 mmol) and a flake of iodine in Et2O (100 mL) was 
added the appropriate bromobenzene (111 mmol, 5.55 equiv) in Et2O (100 mL) over 1 hour. 
After 90 minutes of further stirring, NaBF4 (2.20 g, 20 mmol) was added. After 40 hours of 
stirring at room temperature, the reaction mixture was poured into sodium carbonate solution 
(500 mL, 1M) and stirred for a further 15 minutes. The mixture was filtered through a celite 
layer, the organic layer was separated and the aqueous layer was extracted with Et2O (2 x 100 
mL). The combined organic layers were dried (MgSO4) and the solvent removed under 
reduced pressure. The solid obtained was washed with CHCl3 and hexane (1:1) to afford the 




The title compound was prepared according to General Procedure A from 4-
bromochlorobenzene (21.3 g, 111 mmol) to give an off-white solid (6.05 g, 
73%). 1H NMR (500 MHz, C3DOD) δ 7.17-7.13 (8H, m, ArH), 6.98 (8H, d, J = 8.2 Hz, 
ArH); 13C NMR (125.8 MHz, C3DOD) δ 162.9 (4 x C, J11B-H = 49.7 Hz, J10B-H = 16.6 Hz), 




To a solution of NaBF4 (2.20 g, 20 mmol) in Et2O (100 mL) was added 4-
methoxyphenyl magnesium bromide (100 mL, 1M in THF) over 5 minutes. 
After 40 hours of stirring at room temperature, the reaction mixture was poured into sodium 
carbonate solution (500 mL, 1M) and stirred for a further 15 minutes. The mixture was 
filtered through a celite layer, the organic layer was separated and the aqueous layer was 
extracted with Et2O (2 x 100 mL). The combined organic layers were dried (MgSO4) and the 
solvent removed under reduced pressure. The solid obtained was washed with CHCl3 and 
hexane (1:1) to afford an off-white solid (3.81 g, 43%). 1H NMR (500 MHz, C3DOD) δ 7.23 
(8H, br, ArH), 6.65 (8H, d, J = 7.9 Hz, ArH), 3.73 (12H, s, OCH3); 






C3DOD) δ 158.1 (4 x C, J11B-H = 50.0 Hz, J10B-H = 16.6 Hz), 157.3 (4 x C), 138.5 (8 x CH),  




The title compound was prepared according to General Procedure A from 
bromotoluene (13.5 mL, 111 mmol) to give an off-white solid (3.15 g, 42%). 
1H NMR (500 MHz, C3DOD) δ 7.18 (4H, br, ArH), 7.11 (4H, app s, ArH), 6.90 (4H, t, J = 
7.4 Hz, ArH), 6.69 (4H, d, J = 7.3 Hz, ArH), 2.19 (12H, s, ArCH3); 
13C NMR (125.8 MHz, 
C3DOD) δ 166.4 (4 x C, J11B-H = 49.4 Hz, J10B-H = 16.5 Hz), 139.0 (4 x CH, J11B-H = 1.4 Hz), 
135.5 (4 x CH, J11B-H = 2.8 Hz), 135.4 (4 x CH, J11B-H = 1.1 Hz), 127.0 (4 x CH, J11B-H = 2.9 




The title compound was prepared using a reported procedure.171 One-fifth 
of a solution of 2-bromonaphthalene (3.40 g, 16.4 mmol) in THF (20 mL)  
was added to magnesium turnings (0.39 g, 16 mmol) and a flake of iodine. The mixture was 
heated until Grignard formation began. The remaining solution was then added slowly. After 
90 minutes of stirring at room temperature, a solution of boron trifluoride diethyl etherate 
(1.64 mL, 13.3 mL) in THF (10 mL) was added slowly. The reaction was stirred for 45 
minutes and then poured into sodium carbonate solution (40mL, 0.4 M). After 15 minutes 
stirring, the mixture was extracted with Et2O (20 mL x 3) and the combined organic layers 
were combined, dried (MgSO4) and solvent removed under reduced pressure to give an off-
white solid (1.43 g, 66%). 1H NMR (500 MHz, CD3OD) δ 7.90-7.88 (4H, m, ArH), 7.76-7.73 
(8H, m, ArH), 7.61-7.57 (8H, m, ArH), 7.29-7.25 (8H, m, ArH); 13C NMR (126 MHz, 
CD3OD) δ 163.7 (4 x C, J11B-H = 49.5 Hz, J10B-H = 16.4 Hz), 138.3 (4 x CH), 135.2 (4 x C, J11B-
H = 2.9 Hz), 134.3 (4 x CH), 132.7 (4 x C), 128.5 (4 x CH), 128.1 (4 x CH), 124.7 (4 x CH), 
124.7 (4 x CH, J11B-H = 2.6 Hz), 123.8 (4 x CH).  
 











MeOH (10 equiv), dioxane











To a solution of [Rh(cod)Cl]2 (6.2 mg, 0.013 mmol), the appropriate sodium tetraarylborate 
salt (0.75 mmol), and the appropriate α,β-unsaturated ketone (0.50 mmol) in 1,4-dioxane (1.8 
mL) was added MeOH (0.2 mL). The reaction mixture was then heated under microwave 
irradiation at 80 °C for 30 minutes. The mixture was filtered through a short plug of SiO2 
eluting with CHCl3 and the filtrate was concentrated in vacuo. Purification of the residue by 
column chromatography afforded the desired alcohol. 
 
(3E)-5,5,5-trifluoro-2,4-diphenylpent-3-en-2-ol (235a)  
The title compound was prepared according to General Procedure B from 129a 
(107 mg, 0.50 mmol) and sodium tetraphenylborate (257 mg, 0.75 mmol) and purified by 
column chromatography (2% EtOAc/hexane) to give a pale yellow oil (72 mg, 49%). Rf = 
0.37 (20% EtOAc/hexane); IR (film) 3435 (OH), 1283, 1227, 1173, 1117, 1072, 766, 756, 
698, 579 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.25-7.36 (8H, m, ArH), 7.09 (2H, d, J = 7.2 
Hz, ArH), 6.85 (1H, q, J = 1.5 Hz, =CH), 1.80 (1H, s, OH), 1.61 (3H, s, CCH3); 
13C NMR 
(125.8 MHz, CDCl3) δ 146.7 (C), 141.6 (CH, q, J = 5.2 Hz), 131.4 (C), 129.8 (2 x CH), 129.8 
(C, q, J = 29.7 Hz), 128.8 (CH), 128.4 (2 x CH), 128.3 (2 x CH), 127.3 (CH), 124.8 (2 x CH), 
123.2 (C, q, J = 273.8 Hz), 74.4 (C), 31.1 (CH3); 
19F NMR (376 MHz, CDCl3) δ –67.0 (3F, 
s); HRMS (EI) Exact mass calcd for C17H15F3O [M




The title compound was prepared according to General Procedure B from 
129a (107 mg, 0.50 mmol) and 245b (330 mg, 0.75 mmol) and purified by column 
chromatography (2→10% EtOAc/hexane) to give a pale yellow oil (93 mg, 58%). IR (film) 
3420 (OH), 1510, 1283, 1250, 1231, 1173, 1115, 1030, 831, 702 cm-1; Rf = 0.28 (20% 
EtOAc/hexane); 1H NMR (500 MHz, CDCl3) δ 7.29-7.37 (3H, m, ArH), 7.24 (2H, dt, J = 
9.0, 2.8 Hz, ArH), 7.11 (2H, d, J = 7.1 Hz, ArH), 6.85 (2H, dt, J = 9.0, 2.5 Hz, ArH), 6.83 
(1H, q, J = 1.5 Hz, =CH), 3.82 (3H, s, OCH3), 1.74 (1H, s, OH), 1.59 (3H, s, CCH3); 
13C 
NMR (125.8 MHz, CDCl3) δ 158.8 (C), 141.8 (CH, q, J = 5.1 Hz), 138.9 (C), 131.5 (C), 
129.8 (2 x CH), 129.5 (C, q, J = 29.7 Hz), 128.8 (CH), 128.3 (2 x CH), 126.2 (2 x CH), 123.2 
(C, q, J = 273.8 Hz), 113.7 (2 x CH), 74.1 (C), 55.3 (CH3), 30.9 (CH3); 
19F NMR (376 MHz, 
CDCl3) δ –66.9 (3F, s); HRMS (EI) Exact mass calcd for C18H17F3O2 [M













(3E)-2-(4-chlorophenyl)-5,5,5-trifluoro-4-phenylpent-3-en-2-ol (235c)  
The title compound was prepared according to General Procedure B from 
129a (107 mg, 0.50 mmol) and 245a (360 mg, 0.75 mmol) and purified by 
column chromatography (5% EtOAc/hexane) to give a pale yellow oil (36 mg, 22%). Rf = 
0.32 (20% EtOAc/hexane); IR (film) 3393 (OH), 1287, 1236, 1215, 1173, 1117, 1094, 829, 
702, 573 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.22-7.37 (7H, m, ArH), 7.06 (2H, d, J = 7.3 
Hz, ArH), 6.81 (1H, q, J = 1.5 Hz, =CH), 1.85 (1H, s, OH), 1.59 (3H, s, CH3); 
13C NMR 
(125.8 MHz, CDCl3) δ 145.2 (C), 141.1 (CH, q, J = 5.1 Hz), 133.2 (C), 131.1 (C), 130.4 (C, 
q, J = 30.0 Hz), 129.7 (2 x CH), 128.9 (CH), 128.5 (2 x CH), 128.4 (2 x CH), 126.4 (2 x CH), 
122.8 (C, q, J = 274.4 Hz), 73.9 (C), 31.2 (CH3); 
19F NMR (376 MHz, CDCl3) δ –67.1 (3F, 
s); HRMS (CI) Exact mass calcd for C17H18F3NOCl [M+NH4]




The title compound was prepared according to General Procedure B 
from 129e (158 mg, 0.50 mmol) and sodium tetraphenylborate (257 mg, 0.75 mmol) and 
purified by column chromatography (2% EtOAc/hexane) to give a pale yellow oil (113 mg, 
58%).  Rf = 0.43 (20% EtOAc/hexane); IR (film) 3570 (OH), 1285, 1273, 1229, 1173, 1123, 
1094, 775, 698, 625 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.23-7.37 (12H, m, ArH), 7.16 (2H, 
d, J = 6.9 Hz, ArH), 7.07 (1H, q, J = 1.5 Hz, =CH), 2.07 (1H, s, OH); 13C NMR (125.8 MHz, 
CDCl3) δ 145.6 (C), 144.4 (C), 139.9 (CH, q, J = 5.2 Hz), 133.5 (C), 131.4 (C), 130.5 (C, q, J 
= 29.8 Hz), 129.5 (2 x CH), 129.0 (CH), 128.58 (2 x CH), 128.56 (2 x CH), 128.5 (2 x CH), 
127.90 (2 x CH), 127.89 (CH), 124.4 (2 x CH), 123.1 (C, q, J = 274.7 Hz), 78.6 (C); 19F 
NMR (250 MHz, CDCl3) δ –66.7 (3F, s); HRMS (ES) Exact mass calcd for C22H15ClF3O [M-
H]+: 387.0769, found: 387.0766. 
 
(2E)-1-(4-Chlorophenyl)-4,4,4-trifluoro-1-(4-methoxyphenyl)-3-
phenylbut-2-en-1-ol (235e)  
The title compound was prepared according to General Procedure B 
from 129e (158 mg, 0.50 mmol) and 245b (330 mg, 0.75 mmol) and 
purified by column chromatography (2→5% EtOAc/hexane) to give a yellow oil (154 mg, 














1092, 827, 700, 588 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.32-7.39 (3H, m, ArH), 7.27-7.30 
(2H, m, ArH), 7.20-7.26 (4H, m, ArH), 7.17-7.18 (2H, m, ArH), 7.03 (1H, q, J = 1.5 Hz, 
=CH), 6.85-6.88 (2H, m, ArH), 3.82 (3H, s, OCH3), 2.01 (1H, s, OH); 
13C NMR (125.8 
MHz, CDCl3) δ 159.1 (C), 144.6 (C), 140.1 (CH, q, J = 5.1 Hz), 137.9 (C), 133.4 (C), 131.5 
(C), 130.1 (C, q, J = 29.9 Hz), 129.5 (2 x CH), 129.0 (CH), 128.52 (2 x CH), 128.46 (2 x 
CH), 127.8 (2 x CH), 127.7 (2 x CH), 123.2 (C, q, J = 274.7 Hz), 113.9 (2 x CH), 78.4 (C), 
55.3 (CH3); 
19F NMR (376 MHz, CDCl3) δ –66.6 (3F, s); HRMS (EI) Exact mass calcd for 
C23H17F3O2Cl [M-H]
+: 417.0864, found: 417.0864. 
 
(2E)-1-(4-chlorophenyl)-4,4,4-trifluoro-1-(3-methylphenyl)-3-
phenylbut-2-en-1-ol (235f)  
The title compound was prepared according to General Procedure B 
from 129e (158 mg, 0.50 mmol) and 245c (282 mg, 0.75 mmol) and 
purified by column chromatography (2% EtOAc/hexane) to give a yellow oil (96 mg, 48%). 
Rf = 0.53 (20% EtOAc/hexane); IR (film) 3572 (OH), 1283, 1271, 1173, 1123, 1092, 1015, 
835, 785, 700 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.21-7.37 (8H, m, ArH), 7.16 (2H, app d, 
J = 7.1 Hz, ArH), 7.09-7.11 (3H, m, ArH), 7.06 (1H, q, J = 1.5 Hz, =CH), 2.33 (3H, s, 
ArCH3), 2.05 (1H, s, OH); 
13C NMR (125.8 MHz, CDCl3) δ 145.6 (C), 144.5 (C), 140.0 (CH, 
q, J = 5.1 Hz), 138.3 (C), 133.5 (C), 131.4 (C), 130.3 (C, q, J = 29.8 Hz), 129.5 (2 x CH), 
129.0 (CH), 128.7 (CH), 128.51 (2 x CH), 128.49 (2 x CH), 128.4 (CH), 127.9 (2 x CH), 
127.0 (CH), 123.4 (CH), 123.2 (C, q, J = 286.9 Hz), 78.6 (C), 21.6 (CH3); 
19F NMR (376 
MHz, CDCl3) δ –66.7 (3F, s); HRMS (ES) Exact mass calcd for C23H17F3OCl [M-H]
+: 




The title compound was prepared according to General Procedure B from 
129b (107 mg, 0.50 mmol) and 245b (330 mg, 0.75 mmol) and purified by column 
chromatography (2→10% EtOAc/hexane) to give a yellow oil (88 mg, 53%). Rf = 0.34 (20% 
EtOAc/hexane); IR (film) 3363 (OH), 1510, 1298, 1248, 1175, 1111, 1032, 1015, 831, 700 
cm-1; 1H NMR (500 MHz, CDCl3) δ 7.26-7.39 (7H, m, ArH), 6.85-6.88 (2H, m, ArH), 6.75 
(1H, qq, J = 1.5, 1.4 Hz, =CH), 3.80 (1H, s, OCH3), 2.39 (1H, s, OH), 1.80 (3H, d, J = 1.4 
Hz, CCH3); 











J = 5.9 Hz), 128.6 (C, q, J = 28.8 Hz), 128.4 (2 x CH), 127.6 (2 x CH), 127.5 (CH), 126.2 (2 
x CH), 123.2 (C, q, J = 274.0 Hz), 113.8 (2 x CH), 78.2 (C), 55.3 (CH3), 11.9 (CH3); 
19F 
NMR (376 MHz, CDCl3) δ –69.8 (3F, s); HRMS (EI) Exact mass calcd for C18H17F3O2 [M
+]: 
322.1175, found: 322.1173. 
 
(2E)-4,4,4-trifluoro-1-(4-methoxyphenyl)-3-methyl-1-phenylbut-2-
en-1-ol (235g)  
The title compound was also prepared according to General Procedure 
B from 129d (107 mg, 0.50 mmol) and sodium tetraphenylborate (257 mg, 0.75 mmol), and 
purified by column chromatography (2% EtOAc/hexane) to give a yellow oil (30 mg, 19%). 
Spectral data was consistent with that above. 
 
(3E)-5,5,6,6,7,7,7-heptafluoro-2,4-diphenylhept-3-en-2-ol (235h)  
The title compound was prepared according to General Procedure B from 
129f (157 mg, 0.50 mmol) and sodium tetraphenylborate (257 mg, 0.75 mmol) and purified 
by column chromatography (5% EtOAc/hexane) to give a yellow oil (107 mg, 55%). Rf = 
0.41 (20% EtOAc/hexane); IR (film) 3379 (OH), 1229, 1209, 1179, 1111, 1099, 984, 768, 
723, 696 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.25-7.34 (8H, m, ArH), 7.03 (2H, d, J = 7.3 
Hz, ArH), 6.88 (1H, s, =CH), 1.78 (1H, s, OH), 1.61 (3H, s, CCH3); 
13C NMR (125.8 MHz, 
CDCl3) δ 147.0 (C), 145.7 (CH, t, J = 8.0 Hz), 131.3 (C), 130.2 (2 x CH), 129.3 (C, t, J = 
21.5 Hz), 128.8 (CH), 128.4 (2 x CH), 128.1 (2 x CH), 127.3 (CH), 124.8 (2 x CH), 117.9 (C, 
qt, J = 288.5, 34.4 Hz), 114.1 (C, tt, J = 256.7, 31.3 Hz), 109.3 (C, tqt, J = 265.7, 34.4, 31.3 
Hz), 74.7 (C), 31.2 (CH3); 
19F NMR (376 MHz, CDCl3) δ –80.4 (3F, t, J = 10.6 Hz), –(110.0-
110.2) (2F, m), –(124.1-124.2) (2F, m); HRMS (CI) Exact mass calcd for C19H19F7NO 
[M+NH4]
+: 410.1349, found: 410.1352. 
 
Preparation of Substrates for Ruthenium-Catalysed Arylation of β-Perfluoroalkyl-α,β-
Unsaturated Aldehydes 
 
(2E, 4E)-6,6,6-trifluoro-5-phenylhexa-2,4-dienal (249) 
Trifluoroacetophenone (1.6 mL, 10 mmol) was added in one portion to a 
solution of (formylmethylene)triphenylphosphorane (3.35 g, 11 mmol) in THF (0.2 M 















the ketone as observed by TLC analysis. The reaction was concentrated in vacuo and the 
residue was triturated thoroughly with hexane. After removal of the hexane in vacuo, 
purification of the residue by column chromatography (5% EtOAc/hexane) gave 249 as a 
yellow oil (361 mg, 18%) and the title compound as a yellow oil (297 mg, 13%). Rf = 0.38 
(20% EtOAc/hexane); IR (solid) 1688 (C=O), 1296, 1221, 1188, 1175, 1117, 1094, 978, 775, 
706 cm-1; 1H NMR (360 MHz, CDCl3) δ 9.52 (1H, d, J = 7.7 Hz, HC=O), 7.48-7.51 (3H, m, 
ArH), 7.32-7.34 (2H, m, ArH), 6.98-7.09 (2H, m, =CH), 6.42 (1H, dd, J = 15.1, 7.5 Hz, 
=CH); 13C NMR (125 MHz, CDCl3) δ 192.9 (C), 144.5 (CH), 139.0 (C, q, J = 30.4 Hz), 
136.9 (CH), 130.7 (C), 130.2 (CH, q, J = 5.9 Hz), 129.7 (CH), 129.6 (2 x CH), 128.8 (2 x 
CH), 122.8 (C, q, J = 273.7 Hz);19F NMR (376 MHz, CDCl3) δ –66.0; HRMS (CI) Exact 
mass calcd for C12H10F3O [M+H]
+: 227.0678, found: 227.0682.  
Determination of the fluorinated alkene stereochemistry was achieved using a 1H–19F 











The title compound was prepared using an adapted literature procedure. 2-
Phenylethylmagnesium bromide was prepared from 2-bromoethylbenzene (20.5 mL, 150 
mmol) and magnesium (3.65 g, 159 mmol) in Et2O (60 mL). At 0 °C, a solution of 
trifluoroacetic acid (3.8 mL, 50 mmol) in Et2O (10 mL) was added dropwise. The mixture 
was allowed to warm to room temperature and stirred for 16 hours. The reaction was then 
cooled again to 0 °C before 2M HCl (50 mL) was added. The mixture was extracted with 
Et2O (x 3) and the combined layers were dried (MgSO4) and concentrated in vacuo. The 
crude mixture was purified by distillation under reduced pressure (84-86 °C at 15 mbar) to 
give the ketone as a colourless oil (7.33 g, 73%). Spectral data was consistent with that 
reported previously.164 Rf = 0.19 (20% EtOAc/hexane); 
1H NMR (360 MHz, CDCl3) δ 7.33-
7.29 (2H, m, ArH), 7.26-7.19 (3H, m, ArH), 3.08-3.04 (2H, m, CH2), 3.01-2.97 (2H, m, 
CH2); 
13C NMR (125.8 MHz, CDCl3) δ 190.6 (C, q, J = 35.3 Hz), 139.2 (C), 128.7 (2 x CH), 
128.2 (2 x CH), 126.7 (CH), 115.5 (C, q, J = 291.9 Hz), 38.1 (CH2), 28.3 (CH2); 
19F NMR 





General Procedure C: Wittig Reaction of Perfluoroalkyl Ketones 
 
 
The appropriate perfluoroalkyl ketone (1.0 equiv) was added in one portion to a solution of 
ethyl (triphenylphosphoranylidene) acetate (1.1 equiv) in THF (0.2 M solution) and the 
resulting mixture was heated under reflux until complete consumption of the ketone as 
observed by TLC analysis, or until no further reaction progress could be seen. The reaction 
was concentrated in vacuo and the residue was triturated thoroughly with hexane. After 
removal of the hexane in vacuo, purification of the residue by column chromatography gave 
the α,β-unsaturated ethyl ester.  
 
Ethyl (E)-4,4,4-trifluoro-3-phenyl-but-2-enoate (251a).101c) The title 
compound was prepared according to General Procedure C from ethyl 
(triphenylphosphoranylidene) acetate (11.5 g, 33.0 mmol) and trifluoroacetophenone (4.2 
mL, 30 mmol) for 6.5 h and purified by column chromatography (20% CH2Cl2/hexane) to 
give the major E-isomer (the unpurified mixture contained a 9:1 E:Z ratio of isomers) as a 
colourless oil (6.06 g, 83%). Rf = 0.57 (20% EtOAc/hexane); IR (film) 1728 (C=O), 1229, 
1209, 1182, 1134, 1115, 1101, 993, 746, 698 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.45-7.39 
(3H, m, ArH), 7.31-7.29 (2H, m, ArH), 6.62 (1H, q, J = 1.3 Hz, =CH), 4.05 (2H, q, J = 7.1 
Hz, CH2), 1.07 (3H, t, J = 7.1 Hz, CH3); 
13C NMR (125.8 MHz, CDCl3) δ 164.1 (C), 142.3 
(C, q, J = 30.9 Hz), 131.0 (C), 129.3 (CH), 128.6 (2 x CH), 128.2 (2 x CH), 124.5 (CH, q, J = 
5.5 Hz), 122.5 (C, q, J = 274.8 Hz), 61.1 (CH2), 13.7 (CH3); 
19F NMR (376 MHz, CDCl3) δ –
67.6 (3F, s); HRMS (EI) Exact mass calcd for C12H11F3O2 [M
+]: 244.0706, found: 244.0706. 
 
Ethyl (E)-4,4,5,5,6,6,6-heptafluoro-3-phenyl-hex-2-enoate (251b). The 
title compound was prepared according to General Procedure C from ethyl 
(triphenylphosphoranylidene) acetate (11.50 g, 33 mmol) and heptafluoropropyl phenyl 
ketone (5.6 mL, 30 mmol) for 2 h and purified by column chromatography (10% 
CH2Cl2/hexane) to give the major E-isomer (the unpurified mixture contained a 10:1 E:Z 
ratio of isomers) as a colourless oil (7.94 g, 77%). Rf = 0.58 (20% EtOAc/hexane); IR (film) 
1732 (C=O), 1340, 1282, 1230, 1182, 1115, 1028, 993, 746, 700 cm-1; 1H NMR (500 MHz, 






=CH), 4.03 (2H, q, J = 7.1 Hz, CH2), 1.04 (3H, t, J = 7.1 Hz, CH3); 
13C NMR (125.8 MHz, 
CDCl3) δ 163.9 (C), 141.8 (C, t, J = 21.6 Hz), 131.3 (C), 129.2 (CH), 129.0 (2 x CH), 128.1 
(CH, t, J = 8.7 Hz), 128.0 (2 x CH), 117.7 (C, qt, J = 289.8, 35.0 Hz), 113.9 (C, tt, J = 257.6, 
31.3 Hz), 109.0 (C, tq, J = 266.5, 38.2 Hz), 61.1 (CH2), 13.6 (CH3); 
19F NMR (376 MHz, 
CDCl3) δ –80.4 (3F, t, J = 10.2 Hz), –112.0 (2F, q, J = 10.2 Hz), –124.2 (2F, br s); HRMS 
(CI) Exact mass calcd for C14H12F7O2 [M + H]
+: 345.0720, found: 345.0725.  
Determination of the alkene stereochemistry was achieved using a 1H–19F HOESY 








Ethyl (E)-4,4,4-trifluoro-3-(4-fluorophenyl)but-2-enoate  (251c). The title 
compound was prepared according to General Procedure C from ethyl 
(triphenylphosphoranylidene) acetate (11.5 g, 33.0 mmol) and  2,2,2,4’-
tetrafluoroacetophenone (5.76 g, 30.0 mmol) for 16 h and purified by column 
chromatography (1% EtOAc/hexane) to give the major E-isomer (the unpurified mixture 
contained a 10:1 E:Z ratio of isomers) as a colourless oil (5.37 g, 68%). Rf = 0.33 (20% 
EtOAc/hexane); IR (film) 1732 (C=O), 1607, 1512, 1285, 1258, 1231, 1171, 1159, 1126, 839 
cm-1; 1H NMR (500 MHz, CDCl3) δ 7.29-7.26 (2H, m, ArH), 7.12-7.08 (2H, m, ArH), 6.62 
(1H, q, J = 1.5 Hz, =CH), 4.07 (2H, q, J = 7.1 Hz, CH2), 1.11 (3H, t, J = 7.1 Hz, CH3); 
13C 
NMR (125.8 MHz, CDCl3) δ 163.9 (C), 163.3 (C, d, J = 249.4 Hz), 141.4 (C, q, J = 31.1 Hz), 
130.7 (2 x CH, d, J = 8.5 Hz), 126.8 (C, d, J = 3.5 Hz), 124.9 (CH, q, J = 5.4 Hz), 122.4 (C, 
q, J = 274.6 Hz), 115.4 (2 x CH, d, J = 21.9 Hz), 61.2 (CH2), 13.8 (CH3); 
19F NMR (376 
MHz, CDCl3) δ –67.8 (3F, s), –111.6 (1F, s); HRMS (EI) Exact mass calcd for C12H10F4O2 
[M+]: 262.0611, found: 262.0615.  
Determination of the alkene stereochemistry was achieved using a 1H–19F HOESY 












Ethyl (Z)-4,4,4-trifluoro-3-(thiophen-2-yl)but-2-enoate  (251d). The title 
compound was prepared according to General Procedure C from ethyl 
(triphenylphosphoranylidene) acetate (13.41 g, 38.5 mmol) and  
trifluoroacetylthiophene (4.5 mL, 35 mmol) for 16 h and purified by column chromatography 
(1% acetone/hexane) to give the major Z-isomer (the unpurified mixture contained a 8:1 Z:E 
ratio of isomers) as a colourless oil (4.97 g, 57%). Rf = 0.54 (20% EtOAc/hexane); IR (film) 
1730 (C=O), 1433, 1281, 1258, 1231, 1180, 1132, 1026, 853, 706 cm-1; 1H NMR (500 MHz, 
CDCl3) δ 7.48 (1H, dd, J = 5.1, 1.2 Hz, ArH), 7.26 (1H, app d, J = 3.6 Hz, ArH), 7.08 (1H, 
dd, J = 5.1, 3.6 Hz, ArH), 6.61 (1H, q, J = 1.3 Hz, =CH), 4.18 (2H, q, J = 7.1 Hz, CH2), 1.20 
(3H, t, J = 7.1 Hz, CH3); 
13C NMR (125.8 MHz, CDCl3) δ 164.3 (C), 134.2 (C, q, J = 31.9 
Hz), 130.3 (CH), 130.0 (C), 128.7 (CH), 127.0 (CH), 124.5 (CH, q, J = 5.4 Hz), 122.1 (C, q, 
J = 275.3 Hz), 61.4 (CH2), 13.8 (CH3); 
19F NMR (376 MHz, CDCl3) δ –67.4 (3F, s); HRMS 
(EI) Exact mass calcd for C10H9F3O2S [M
+]: 250.0270, found: 250.0268.  
Determination of the alkene stereochemistry was achieved using a 1H–19F HOESY 








Ethyl (E)-5-phenyl-3-(trifluoromethyl)pent-2-enoate  (251e).101c) The title 
compound was prepared according to General Procedure C from ethyl 
(triphenylphosphoranylidene) acetate (5.37 g, 15.4 mmol) and  254 (2.83 g, 
14.0 mmol) for 2 h and purified by column chromatography (10% CH2Cl2/hexane) to give the 
major E-isomer (the unpurified mixture contained a 14:1 E:Z ratio of isomers) as a colourless 
oil (2.65 g, 70%). Rf = 0.67 (20% EtOAc/hexane); IR (film) 1726 (C=O), 1312, 1296, 1271, 
1207, 1165, 1126, 1030, 895, 698 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.33-7.28 (4H, m, 
ArH), 7.24-7.20 (1H, m, ArH), 6.38 (1H, q, J = 1.0 Hz, =CH), 4.23 (2H, q, J = 7.1 Hz, 
CH2CH3), 2.99-2.95 (2H, m, CH2CH2), 2.88-2.84 (2H, m, CH2CH2), 1.32 (3H, t, J = 7.1 Hz, 
CH2CH3); 
13C NMR (125.8 MHz, CDCl3) δ 164.4 (C), 145.2 (C, q, J = 29.1 Hz), 140.7 (C), 
128.5 (2 x CH), 128.4 (2 x CH), 126.3 (CH), 123.5 (C, q, J = 275.2 Hz), 122.7 (CH, q, J = 
6.0 Hz), 61.0 (CH2), 35.0 (CH2), 29.0 (CH2), 14.1 (CH3); 
19F NMR (376 MHz, CDCl3) δ –
69.1 (3F, s); HRMS (EI) Exact mass calcd for C14H15F3O2 [M













To a solution of the appropriate ester (1.0 equiv) in CH2Cl2 (0.4 M) at –78 °C was added 
DIBAL (1.0 M in hexane, 2.4 equiv) over 5 min. After stirring at –78 °C for 1.5 h, the 
mixture was allowed to warm to 0 °C over 1 h. After a further 30 min, the reaction was 
quenched carefully with 2.0 M HCl solution. The aqueous layer was separated and extracted 
with CH2Cl2 (2 x). The combined organic layers were dried (MgSO4), filtered, and 




101c) The title compound was 
prepared according to General Procedure D from ester 251a (7.77 g, 31.8 mmol) 
and purified by column chromatography (20% EtOAc/hexane) to give a colourless oil (4.37 
g, 68%). Rf = 0.19 (20% EtOAc/hexane); IR (film) 3327 (OH), 1292, 1169, 1117, 1042, 
1026, 907, 772, 702, 669 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.43-7.40 (3H, m, ArH), 7.26-
7.24 (2H, m, ArH), 6.57 (1H, tq, J = 6.3, 1.5 Hz, =CH), 4.16-4.15 (2H, m, CH2), 1.73 (1H, br 
s, OH); 13C NMR (125.8 MHz, CDCl3) δ 134.7 (CH, q, J = 5.4 Hz), 132.4 (C, q, J = 30.2 
Hz), 131.3 (C), 129.3 (2 x CH), 128.9 (CH), 128.5 (2 x CH), 123.0 (C, q, J = 273.3 Hz), 59.2 
(CH2); 
19F NMR (376 MHz, CDCl3) δ –66.2 (3F, s); HRMS (EI) Exact mass calcd for 
C10H9F3O [M
+]: 202.0600, found: 202.0598.  
 
(E)-4,4,5,5,6,6,6-Heptafluoro-3-phenylhex-2-en-1-ol (252b). The title 
compound was prepared according to General Procedure D from ester 251b 
(3.00 g, 8.72 mmol) and purified by column chromatography (10% EtOAc/hexane) to give a 
colourless oil (2.29 g, 87%). Rf = 0.35 (20% EtOAc/hexane); IR (film) 3341 (OH), 1227, 
1198, 1180, 1138, 1113, 1028, 745, 712, 700 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.41-7.38 
(3H, m, ArH), 7.22-7.20 (2H, m, ArH), 6.57 (1H, tt, J = 6.1, 1.4 Hz, =CH), 4.13-4.11 (2H, 
m, CH2), 1.91 (1H, br s, OH); 
13C NMR (125.8 MHz, CDCl3) δ 138.6 (CH, t, J = 8.3 Hz), 
131.6 (C), 131.5 (C, t, J = 21.7 Hz), 129.7 (2 x CH), 128.9 (CH), 128.4 (2 x CH), 117.9 (C, 







19F NMR (376 MHz, CDCl3) δ –80.4 (3F, t, J = 10.3 Hz), –111.0 (2F, q, J = 10.3 
Hz), –124.5 (2F, s); HRMS (ESI) Exact mass calcd for C12H13F7ON [M+NH4]
+: 320.0880, 
found: 320.0880.  
 
(E)-4,4,4-Trifluoro-3-(4-fluorophenyl)but-2-en-1-ol (252c). The title 
compound was prepared according to General Procedure D from ester 251c (5.20 
g, 19.8 mmol) and purified by column chromatography (10% EtOAc/hexane) to 
give a colourless oil (3.40 g, 78%). Rf = 0.22 (20% EtOAc/hexane); IR (film) 
3319 (OH), 1512, 1294, 1229, 1171, 1119, 1098, 1032, 839, 735 cm-1; 1H NMR (500 MHz, 
CDCl3) δ 7.24-7.21 (2H, m, ArH), 7.12-7.07 (2H, m, ArH), 6.56 (1H, tq, J = 6.2, 1.5 Hz, 
=CH), 4.38 (2H, dq, J = 6.2, 2.5 Hz, CH2), 1.70 (1H, br s, OH); 
13C NMR (125.8 MHz, 
CDCl3) δ 163.0 (C, d, J = 248.9 Hz), 135.1 (CH, q, J = 5.3 Hz), 131.5 (C, q, J = 30.4 Hz), 
131.2 (2 x CH, d, J = 8.3 Hz), 127.2 (C, d, J = 3.5 Hz), 122.9 (C, q, J = 273.2 Hz), 115.7 
(CH, d, J = 21.7 Hz), 59.0 (CH2); 
19F NMR (376 MHz, CDCl3) δ –66.5 (3F, s), –112.2 (1F, 
s); HRMS (EI) Exact mass calcd for C10H8F4O [M
+]: 220.0506, found: 220.0508.  
 
(Z)-4,4,4-Trifluoro-3-(thiophen-2-yl)but-2-en-1-ol (252d). The title compound 
was prepared according to General Procedure D from ester 251d (4.75 g, 19.0 
mmol) and purified by column chromatography (10% EtOAc/hexane) to give a 
colourless oil (2.74 g, 69%). Rf = 0.16 (20% EtOAc/hexane); IR (film) 3333 (OH), 1287, 
1229, 1175, 1121, 1086, 1028, 849, 837, 702 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.43 (1H, 
dd, J = 5.1, 1.2 Hz, ArH), 7.09 (1H, dd, J = 5.1, 3.4 Hz, ArH), 7.06 (1H, app d, J = 3.4 Hz, 
ArH), 6.61 (1H, tq, J = 6.1, 1.5 Hz, =CH), 4.38 (2H, dq, J = 6.1, 2.1 Hz, CH2), 1.84 (1H, br 
s, OH); 13C NMR (125.8 MHz, CDCl3) δ 136.4 (CH, q, J = 5.2 Hz), 130.9 (C), 129.4 (CH), 
127.6 (CH), 127.2 (CH), 125.3 (C, q, J = 31.3 Hz), 122.5 (C, q, J = 273.6 Hz), 59.4 (CH2); 
19F NMR (376 MHz, CDCl3) δ –66.6 (3F, s); HRMS (EI) Exact mass calcd for C8H7F3OS 
[M+]: 208.0164, found: 208.0160.  
 
(E)-5-Phenyl-3-(trifluoromethyl)pent-2-en-1-ol  (252e).101c) The title 
compound was prepared according to General Procedure D from ester 251e (2.54 
g, 9.33 mmol) and purified by column chromatography (10% EtOAc/hexane) to 
give a colourless oil (1.70 g, 79%). Rf = 0.21 (20% EtOAc/hexane); IR (film) 3337 (OH), 











7.34-7.31 (2H, m, ArH), 7.26-7.23 (1H, m, ArH), 7.20-7.19 (2H, m, ArH), 6.25-6.22 (1H, m, 
=CH), 3.83 (2H, d, J = 5.0 Hz, CH2), 2.80 (2H, t, J = 7.5 Hz, CH2CH2), 2.53 (2H, t, J = 7.5 
Hz, CH2CH2), 1.09 (1H, br s, OH); 
13C NMR (125.8 MHz, CDCl3) δ 140.4 (C), 133.9 (CH, 
q, J = 5.9 Hz), 129.3 (C, q, J = 28.3 Hz), 128.9 (2 x CH), 128.5 (2 x CH), 126.4 (CH), 124.2 
(C, q, J = 273.8 Hz), 58.2 (CH2), 34.6 (CH2), 27.9 (CH2); 
19F NMR (376 MHz, CDCl3) δ –
67.0 (3F, s); HRMS (EI) Exact mass calcd for C12H13F3O [M
+]: 230.0913, found: 230.0914. 
 
General Procedure E: Oxidation of β-Perfluoroalkyl Allylic Alcohols 
 
 
To a solution of the appropriate allylic alcohol (1.0 equiv) in CHCl3 (0.3 M) was added MnO2 
(4.0 equiv) in one portion. The mixture was heated under reflux until complete consumption 
of the allylic alcohol as observed by TLC analysis. After cooling to room temperature, the 
reaction mixture was filtered through a pad of celite, washing with the pad with CHCl3. 
Removal of the solvent under reduced pressure gave the enal of sufficient purity for use in 
enantioselective arylations. 
 
(E)-4,4,4-Trifluoro-3-phenylbut-2-enal (248a). The title compound was 
prepared according to General Procedure E from allylic alcohol 252a (1.82 g, 
9.00 mmol) for 5.5 h to give a yellow oil (1.24 g, 69%). Rf = 0.56 (20% EtOAc/hexane); IR 
(film) 1692 (C=O), 1356, 1271, 1256, 1180, 1134, 1105, 756, 708, 683 cm-1; 1H NMR (500 
MHz, CDCl3) δ 9.56 (1H, d, J = 7.5 Hz, CH=O), 7.56-7.48 (3H, m, ArH), 7.40 (2H, d, J = 
7.3 Hz, ArH), 6.65 (1H, dq, J = 7.5, 1.1 Hz, =CH); 13C NMR (125.8 MHz, CDCl3) δ 191.7 
(CH), 147.9 (C, q, J = 31.6 Hz), 130.8 (CH, q, J = 4.9 Hz), 130.5 (CH), 129.9 (2 x CH), 
128.8 (2 x CH), 128.7 (C), 122.7 (C, q, J = 275.1 Hz); 19F NMR (376 MHz, CDCl3) δ –67.4 
(3F, s); HRMS (CI) Exact mass calcd for C10H8F3O [M+H]
+: 201.0522, found: 201.0524.  
 
(E)-4,4,5,5,6,6,6-Heptafluoro-3-phenylhex-2-enal (248b). The title 
compound was prepared according to General Procedure E from allylic 
alcohol 252b (5.09 g, 16.9 mmol) for 2 h to give a yellow oil (4.18 g, 83%). Rf = 0.69 (20% 
EtOAc/hexane); IR (film) 1692 (C=O), 1231, 1200, 1182, 1159, 1117, 1101, 976, 731, 702 










ArH), 7.37 (2H, app d, J = 6.9 Hz, ArH), 6.65 (1H, dt, J = 7.4, 1.1 Hz, =CH); 13C NMR 
(125.8 MHz, CDCl3) δ 191.2 (CH), 147.8 (C, t, J = 22.2 Hz), 134.2 (CH, t, J = 7.6 Hz), 130.4 
(CH), 130.3 (2 x CH), 129.0 (C), 128.6 (2 x CH), 117.6 (C, qt, J = 286.1, 33.8 Hz), 114.0 (C, 
tt, J = 256.6, 31.1 Hz), 108.9 (C, tq, J = 264.5, 37.8 Hz); 19F NMR (376 MHz, CDCl3) δ –
80.3 (3F, t, J = 10.6 Hz), –113.1 (2F, t, J = 10.6 Hz), –124.5 (2F, app s); HRMS (CI) Exact 
mass calcd for C12H8F7O [M+H]
+: 301.0458, found: 301.0461.  
 
(E)-4,4,4-Trifluoro-3-(4-fluorophenyl)but-2-enal (248c). The title compound 
was prepared according to General Procedure E from allylic alcohol 252c (3.27 
g, 14.9 mmol) for 2.5 h to give a yellow oil (2.74 g, 85%). Rf = 0.64 (20% 
EtOAc/hexane); IR (film) 1694 (C=O), 1607, 1512, 1275, 1233, 1184, 1169, 
1132, 1103, 843 cm-1; 1H NMR (500 MHz, CDCl3) δ 9.56 (1H, d, J = 6.9 Hz, CH=O), 7.41 
(2H, dd, J = 8.1, 5.4 Hz, ArH), 7.22-7.18 (2H, m, ArH), 6.65 (1H, d, J = 6.9 Hz, =CH); 13C 
NMR (125.8 MHz, CDCl3) δ 191.2 (CH), 164.0 (C, d, J = 252.2 Hz), 146.7 (C, qd, J = 32.0, 
3.3 Hz), 132.0 (2 x CH, d, J = 8.6 Hz), 131.1 (CH, q, J = 4.8 Hz), 124.7 (C, d, J = 3.5 Hz), 
122.6 (C, q, J = 275.0 Hz), 116.2 (2 x CH, d, J = 22.1 Hz); 19F NMR (376 MHz, CDCl3) δ –
67.6 (3F, s), –109.1 (1F, s); HRMS (EI) Exact mass calcd for C10H5F4O [M–H]
+: 217.0271, 
found: 217.0274.  
 
(Z)-4,4,4-Trifluoro-3-(thiophen-2-yl)but-2-enal (248d). The title compound 
was prepared according to General Procedure E from allylic alcohol 252d (2.64 
g, 12.7 mmol) for 1.5 h to give a red oil (2.22 g, 85%). Rf = 0.55 (20% 
EtOAc/hexane); IR (film) 1682 (C=O), 1271, 1231, 1182, 1128, 1098, 870, 853, 845, 710 
cm-1; 1H NMR (500 MHz, CDCl3) δ 9.86 (1H, dq, J = 7.2, 0.6 Hz, CH=O), 7.64 (1H, dd, J = 
5.1, 1.0 Hz, ArH), 7.32 (1H, dd, J = 3.6, 1.0 Hz, ArH), 7.18 (1H, dd, J = 5.1, 3.6 Hz, ArH), 
6.65 (1H, dq, J = 7.2, 1.0 Hz, =CH); 13C NMR (125.8 MHz, CDCl3) δ 191.2 (CH), 140.3 (C, 
q, J = 32.7 Hz), 133.2 (CH), 131.0 (CH), 130.5 (CH, q, J = 4.8 Hz), 128.7 (C), 127.9 (CH), 
122.3 (C, q, J = 275.6 Hz); 19F NMR (376 MHz, CDCl3) δ –67.6 (3F, s); HRMS (EI) Exact 
mass calcd for C8H4F3OS [M–H]
+: 204.9929, found: 204.9927.  
 
(E)-5-Phenyl-3-(trifluoromethyl)pent-2-enal (248e). The title compound was 
prepared according to General Procedure E from allylic alcohol 252e (1.61 g, 














EtOAc/hexane); IR (film) 1690 (C=O), 1310, 1275, 1190, 1167, 1155, 1119, 872, 748, 700 
cm-1; 1H NMR (500 MHz, CDCl3) δ 9.49 (1H, d, J = 7.1 Hz, CH=O), 7.34-7.30 (2H, m, 
ArH), 7.27-7.23 (1H, m, ArH), 7.18-7.15 (2H, m, ArH), 6.38 (1H, dq, J = 7.1, 1.3 Hz, =CH), 
2.96-2.94 (4H, m, CH2CH2); 
13C NMR (125.8 MHz, CDCl3) δ 189.1 (CH), 145.6 (C, q, J = 
29.7 Hz), 138.8 (C), 130.4 (CH, q, J = 5.4 Hz), 128.8 (4 x CH), 126.9 (CH), 123.6 (C, q, J = 
273.8 Hz), 35.2 (CH2), 28.0 (CH2); 
19F NMR (376 MHz, CDCl3) δ –68.8 (3F, s); HRMS (EI) 
Exact mass calcd for C12H11F3O [M
+]: 228.0757, found: 228.0760. 
 




The title compound was made according to a literature 
procedure.171 To a solution of 3,3’’-(Oxydimethylene)-
di-1,1’-bi-2-naphthol (123 mg, 0.20 mmol) and NH4Cl 
(5 mg) in toluene was added hexamethylphosphoramide (0.10 mL, 0.56 mmol). The mixture 
was heated at reflux for 16 h. After cooling to rt, the solvent was removed and the residue 
was recrystallised from hexane/CH2Cl2 to give an off-white solid (109 mg, 72 %). [α]
24
D  –
574.9 (c 0.48, CHCl3); 
1H NMR (500 MHz, CDCl3) δ 8.25 (2H, s, ArH), 7.99-7.91 (6H, m, 
ArH), 7.52-7.23 (14H, m, ArH), 5.14 (2H, d, J = 13.6 Hz, CH2), 4.95 (2H, d, J = 13.6 Hz, 
CH2), 2.48 (12H, d, J = 8.9 Hz, NCH3); 
13C NMR (125.8 MHz, CDCl3) δ 150.8 (2 x C), 
150.1 (2 x C), 149.3 (2 x C), 132.8 (2 x C), 132.0 (2 x C), 131.4 (2 x C), 130.3 (2 x CH), 
128.34 (2 x CH), 128.33 (2 x CH), 128.2 (2 x C), 126.93 (2 x CH), 126.89 (2 x C), 126.8 (2 x 
CH), 126.1 (2 x CH), 125.9 (2 x CH), 124.81 (2 x CH), 124.79 (2 x CH), 124.6 (2 x C), 122.0 
(2 x CH), 121.8 (2 x CH), 68.9 (2 x CH2), 34.7 (4 x CH3); 
31P NMR (161.9 MHz, CDCl3) δ 




The title compound was made according to a literature 
procedure.172 To a solution of 3,3’’-(Oxydimethylene)-
di-1,1’-bi-2-naphthol (123 mg, 0.20 mmol) and NH4Cl 
(10 mg) in toluene was added hexaethylphosphoramide 
(0.15 mL, 0.56 mmol). The mixture was heated at reflux for 16 h. After cooling to rt, the 














EtOAc/hexane) to give a white solid (112 mg, 69 %). 1H NMR (400 MHz, CDCl3) δ 8.24 
(2H, d, J = 4.1 Hz, ArH), 7.97 (4H, dd, J = 8.8, 4.1 Hz, ArH), 7.92 (2H, d, J = 8.8 Hz, ArH), 
7.51 (2H, dd, J = 8.8, 0.7 Hz, ArH), 7.45-7.36 (6H, m, ArH), 7.33-7.21 (6H, m, ArH), 5.16 
(2H, d, J = 13.9 Hz, OCH2), 5.02 (2H, d, J = 13.9 Hz, OCH2), 2.92 (8H, dm, J = 69.6 Hz, 
PNCH2), 1.04-0.86 (12H, m, CH2CH3). 
 
General Procedure F: Enantioselective Arylation of β-Perfluoroalkyl-α,β-Unsaturated 
Aldehydes 
 
A solution of [RuCl2(p-cymene)]2 (2.5 mg, 0.004 mmol) and 228 (8.4 mg, 0.011 mmol) in 
toluene (1.2 mL) was stirred at room temperature for 30 min. To this solution was added a 
solution of the appropriate enal (0.50 mmol), K2CO3 (69.1 mg, 0.50 mmol) and the 
appropriate boronic acid (0.75 mmol) in toluene (1.2 mL) and H2O (0.6 mL) via cannula and 
the mixture was heated at 90 °C for 16 h. After cooling to room temperature, the mixture was 
partitioned between saturated aqueous NH4Cl solution (30 mL) and CH2Cl2 (30 mL). The 
aqueous layer was separated and extracted with CH2Cl2 (2 x 30 mL). The combined organic 
extracts were dried (MgSO4), filtered, and concentrated in vacuo. Purification of the residue 
by column chromatography (5% EtOAc/hexane) gave the allylic alcohol.  
 
(R)-(E)-4,4,4-Trifluoro-1,3-diphenylbut-2-en-1-ol (255a).57 The title 
compound was prepared according to General Procedure F from enal 248a 
(100 mg, 0.50 mmol) and phenylboronic acid (91 mg, 0.75 mmol) to give a colourless oil (93 
mg, 66%). Spectral data were consistent with those reported previously.57 [α] 24D  –134.0 (c 
0.99, CHCl3), Lit
57 [α] 20D  +136.0 (c 1.6, CHCl3) for (S)-isomer of 76% ee; Rf = 0.45 (20% 
EtOAc/hexane); 1H NMR (500 MHz, CDCl3) δ 7.45-7.43 (3H, m, ArH), 7.39-7.26 (7H, m, 





= 3.4 Hz, OH); 13C NMR (125.8 MHz, CDCl3) δ 141.5 (C), 136.5 (CH, q, J = 5.2 Hz), 132.1 
(C, q, J = 30.3 Hz), 131.3 (C), 129.6 (2 x CH), 129.0 (CH), 128.9 (2 x CH), 128.6 (2 x CH), 
128.4 (CH), 126.2 (2 x CH), 123.1 (C, q, J = 273.5 Hz), 70.4 (CH); 19F NMR (376 MHz, 
CDCl3) δ –66.6 (3F, s); Enantiomeric excess was determined by HPLC with a Chiralcel OD-
H column (95:5 hexane:i-PrOH, 0.8 mL/min, 230 nm); tr (major) = 8.5 min; tr (minor) = 10.2 
min, 84% ee.  
 
(R)-(E)-4,4,4-Trifluoro-1-(3-methylphenyl)-3-phenylbut-2-en-1-ol 
(255b). The title compound was prepared according to General 
Procedure F from enal 248a (100 mg, 0.50 mmol) and 3-tolylboronic 
acid (102 mg, 0.75 mmol) to give a colourless oil (94 mg, 64%). [α] 24D  –120.2 (c 0.87, 
CHCl3); Rf = 0.39 (20% EtOAc/hexane); IR (film) 3360 (OH), 1283, 1233, 1171, 1121, 1074, 
1024, 791, 752, 700 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.44-7.42 (3H, m, ArH), 7.29 (2H, 
dd, J = 6.4, 2.9 Hz, ArH), 7.25 (1H, t, J = 7.6 Hz, ArH), 7.13 (1H, d, J = 7.6 Hz, ArH), 7.09 
(1H, s, ArH), 7.04 (1H, d, J = 7.6 Hz, ArH), 6.62 (1H, dq, J = 9.3, 1.4 Hz, =CH), 5.10 (1H, 
dd, J = 9.3, 3.4 Hz, CHOH), 2.36 (3H, s, CH3), 1.94-1.93 (1H, m, OH); 
13C NMR (125.8 
MHz, CDCl3) δ 141.5 (C), 138.7 (C), 136.6 (CH, q, J = 5.3 Hz), 132.0 (C, q, J = 30.3 Hz), 
131.4 (C), 129.7 (2 x CH), 129.1 (CH), 129.0 (CH), 128.8 (CH), 128.5 (2 x CH), 126.8 (CH), 
123.2 (CH), 123.1 (C, q, J = 273.5 Hz), 70.4 (CH), 21.4 (CH3); 
19F NMR (376 MHz, CDCl3) 
δ –66.6 (3F, s); HRMS (EI) Exact mass calcd for C17H15F3O [M
+]: 292.1070, found: 
292.1063. Enantiomeric excess was determined by HPLC with a Chiralcel OD-H column 




ol (255c). The title compound was prepared according to General 
Procedure F from enal 248a (100 mg, 0.50 mmol) and 3,5-
dimethylphenylboronic acid (112 mg, 0.75 mmol) to give a pale yellow 
solid (95 mg, 62%). m.p. 48-50 °C; [α] 24D  –183.3 (c 0.72, CHCl3); Rf = 0.42 (20% 
EtOAc/hexane); IR (film) 3337 (OH), 1512, 1315, 1269, 1236, 1173, 1123, 1011, 845, 704 
cm-1; 1H NMR (500 MHz, CDCl3) δ 7.46-7.43 (3H, m, ArH), 7.30-7.29 (2H, m, ArH), 6.97 
(1H, s, ArH), 6.87 (2H, s, ArH), 6.63 (1H, dq, J = 9.2, 1.4 Hz, =CH), 5.06 (1H, dd, J = 9.2, 
3.4 Hz, CHOH), 2.32 (6H, s, ArCH3), 1.90 (1H, d, J = 3.4 Hz, OH); 











CDCl3) δ 141.5 (C), 138.5 (2 x C), 136.7 (CH, q, J = 5.3 Hz), 131.9 (C, q, J = 30.3 Hz), 
131.4 (C), 130.0 (CH), 129.7 (2 x CH), 129.0 (CH), 128.5 (2 x CH), 123.9 (2 x CH), 123.1 
(C, q, J = 273.6 Hz), 70.4 (CH), 21.3 (2 x CH3); 
19F NMR (376 MHz, CDCl3) δ –66.5 (3F, s); 
HRMS (EI) Exact mass calcd for C18H17F3O [M
+]: 306.1226, found: 306.1227. Enantiomeric 
excess was determined by HPLC with a Chiralpak AD-H column (95:5 hexane:isopropanol, 
0.8 mL/min, 230 nm); tr (minor) = 9.8 min; tr (major) = 13.3 min, 84% ee. 
 
(R)-(E)-1-(4-Chlorophenyl)-4,4,4-trifluoro-3-phenylbut-2-en-1-ol 
(255d). The title compound was prepared according to General 
Procedure F from enal 248a (100 mg, 0.50 mmol) and 4-
chlorophenylboronic acid (117 mg, 0.75 mmol) to give a colourless oil which solidified upon 
standing to give a white amorphous solid (105 mg, 66%). [α] 24D  –216.6 (c 0.91, CHCl3); Rf = 
0.48 (20% EtOAc/hexane); IR (film) 3279 (OH), 1491, 1312, 1279, 1240, 1171, 1126, 1028, 
1013, 700 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.45-7.43 (3H, m, ArH), 7.34-7.32 (2H, m, 
ArH), 7.27-7.25 (2H, m, ArH), 7.20-7.18 (2H, m, ArH), 6.55 (1H, dq, J = 9.1, 1.4 Hz, =CH), 
5.12 (1H, dd, J = 9.1, 2.8 Hz, CHOH), 1.99 (1H, d, J = 2.8 Hz, OH); 13C NMR (125.8 MHz, 
CDCl3) δ 140.0 (C), 136.1 (CH, q, J = 5.3 Hz), 134.1 (C), 132.5 (C, q, J = 30.5 Hz), 131.1 
(C), 129.5 (2 x CH), 129.2 (CH), 129.0 (2 x CH), 128.7 (2 x CH), 127.5 (2 x CH), 122.9 (C, 
q, J = 273.6 Hz), 69.8 (CH); 19F NMR (376 MHz, CDCl3) δ –66.4 (3F, s); HRMS (CI) Exact 
mass calcd for C16H11F3OCl [M–H]
+: 311.0445, found: 311.0444. Enantiomeric excess was 
determined by HPLC with a Chiralcel OD-H column (95:5 hexane:i-PrOH, 0.8 mL/min, 230 
nm); tr (major) = 8.5 min; tr (minor) = 10.0 min, 87% ee.  
 
(R)-(E)-4,4,4-Trifluoro-1-(3-methoxyphenyl)-3-phenylbut-2-en-1-ol 
(255e). The title compound was prepared according to General 
Procedure F from enal 248a (100 mg, 0.50 mmol) and 3-
methoxyphenylboronic acid (114 mg, 0.75 mmol) to give a yellow oil (77 mg, 50%). [α] 24D  –
152.0 (c 1.00, CHCl3); Rf = 0.23 (20% EtOAc/hexane); IR (film) 3374 (OH), 1317, 1258, 
1171, 1119, 1036, 1026, 905, 779, 700 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.45-7.43 (3H, 
m, ArH), 7.30-7.26 (3H, m, ArH), 6.86-6.82 (3H, m, ArH), 6.59 (1H, dq, J = 9.2, 1.4 Hz, 
=CH), 5.11 (1H, d, J = 9.2 Hz, CHOH), 3.81 (3H, s, OCH3), 2.00 (1H, d, J = 1.8 Hz, OH); 
13C NMR (125.8 MHz, CDCl3) δ 159.9 (C), 143.1 (C), 136.4 (CH, q, J = 5.3 Hz), 132.1 (C, 










(C, q, J = 273.6 Hz), 118.3 (CH), 113.8 (CH), 111.7 (CH), 70.3 (CH), 55.2 (CH3); 
19F NMR 
(376 MHz, CDCl3) δ –66.6 (3F, s); HRMS (EI) Exact mass calcd for C17H15F3O2 [M
+]: 
308.1019, found: 308.1018. Enantiomeric excess was determined by HPLC with a Chiralpak 
AD-H column (95:5 hexane:isopropanol, 0.8 mL/min, 230 nm); tr (minor) = 21.3 min; tr 
(major) = 29.6 min, 79% ee.  
 
(R)-(E)-4,4,4-Trifluoro-1-(naphthalene-2-yl)-3-phenylbut-2-en-1-ol 
(255f). The title compound was prepared according to General 
Procedure F from enal 248a (100 mg, 0.50 mmol) and 2-
naphthyleneboronic acid (129 mg, 0.75 mmol) to give a pale yellow oil (107 mg, 64%). [α] 24D  
–163.6 (c 1.21, CHCl3); Rf = 0.37 (20% EtOAc/hexane); IR (film) 3319 (OH), 1310, 1271, 
1256, 1171, 1119, 858, 820, 752, 702 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.89-7.82 (3H, m, 
ArH), 7.69 (1H, s, ArH), 7.53-7.50 (2H, m, ArH), 7.47-7.45 (3H, m, ArH), 7.40 (1H, dd, J = 
8.5, 1.7 Hz, ArH), 7.32 (2H, dd, J = 6.5, 2.9 Hz, ArH), 6.72 (1H, dq, J = 9.2, 1.4 Hz, =CH), 
5.32 (1H, dd, J = 9.2, 2.0 Hz, CHOH), 2.08 (1H, d, J = 3.4 Hz, OH); 13C NMR (125.8 MHz, 
CDCl3) δ 138.9 (C), 136.4 (CH, q, J = 5.3 Hz), 133.3 (C), 133.2 (C), 132.3 (C, q, J = 30.3 
Hz), 131.4 (C), 129.7 (2 x CH), 129.1 (CH), 128.8 (CH), 128.6 (2 x CH), 128.0 (CH), 127.7 
(CH), 126.44 (CH), 126.37 (CH), 125.1 (CH), 124.0 (CH), 123.1 (C, q, J = 274.0 Hz), 70.6 
(CH); 19F NMR (376 MHz, CDCl3) δ –66.6 (3F, s); HRMS (EI) Exact mass calcd for 
C20H15F3O [M
+]: 328.1070, found: 328.1063. Enantiomeric excess was determined by HPLC 
with a Chiralpak OD-H column (95:5 hexane:isopropanol, 0.8 mL/min, 230 nm); tr (major) = 
21.0 min; tr (minor) = 33.4 min, 85% ee. 
 
(R)-(E)-4,4,5,5,6,6,6-Heptafluoro-1,3-diphenylhex-2-en-1-ol (255g). The 
title compound was prepared according to General Procedure F from enal 
248b (150 mg, 0.50 mmol) and phenylboronic acid (91 mg, 0.75 mmol) to give a yellow oil 
(114 mg, 66%). [α] 24D  –106.3 (c 1.43, CHCl3); Rf = 0.49 (20% EtOAc/hexane); IR (film) 
3332 (OH), 1344, 1227, 1180, 1138, 1113, 1016, 976, 718, 698 cm-1; 1H NMR (500 MHz, 
CDCl3) δ 7.45-7.30 (6H, m, ArH), 7.26-7.23 (4H, m, ArH), 6.65 (1H, dt, J = 9.1, 1.0 Hz, 
=CH), 5.12 (1H, dd, J = 9.1, 3.7 Hz, CHOH), 1.95 (1H, d, J = 3.7 Hz, OH); 13C NMR (125.8 
MHz, CDCl3) δ 141.5 (C), 140.3 (CH, t, J = 8.1 Hz), 131.5 (C), 131.3 (C, t, J = 21.7 Hz), 
130.1 (2 x CH), 128.94 (CH), 128.86 (2 x CH), 128.39 (2 x CH), 128.35 (CH), 126.2 (2 x 








265.7, 37.9), 70.5 (CH); 19F NMR (376 MHz, CDCl3) δ –80.4 (3F, t, J = 10.6 Hz), –(110.2-
111.8) (2F, m), –124.4 (2F, app s); HRMS (EI) Exact mass calcd for C18H13F7O [M
+]: 
378.0849, found: 378.0852. Enantiomeric excess was determined by HPLC with a Chiralpak 
IA-3 column (99:1 hexane:i-PrOH, 1.0 mL/min, 230 nm); tr (major) = 13.9 min; tr (minor) = 
14.5 min, 86% ee. 
 
(R)-(E)-4,4,5,5,6,6,6-Heptafluoro-1-(naphthalen-2-yl)-3-
phenylhex-2-en-1-ol (255h). The title compound was prepared 
according to General Procedure F from enal 248b (150 mg, 0.50 
mmol) and 2-naphthylboronic acid (129 mg, 0.75 mmol) to give a pale yellow oil (112 mg, 
52%). [α] 24D  –176.2 (c 0.97, CHCl3); Rf = 0.49 (20% EtOAc/hexane); IR (film) 3337 (OH), 
1342, 1227, 1211, 1180, 1113, 980, 745, 710, 700 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.86-
7.81 (3H, m, ArH), 7.65 (1H, br s, ArH), 7.52-7.50 (2H, m, ArH), 7.45-7.37 (4H, m, ArH), 
7.28-7.26 (2H, m, ArH), 6.74 (1H, dt, J = 9.0, 1.4 Hz, =CH), 5.29 (1H, d, J = 9.0 Hz, 
CHOH), 2.07 (1H, br s, OH); 13C NMR (125.8 MHz, CDCl3) δ 140.2 (CH, t, J = 8.1 Hz), 
138.8 (C), 133.21 (C), 133.15 (C), 131.6 (C), 131.4 (C, t, J = 21.5 Hz), 130.1 (2 x CH), 129.0 
(CH), 128.8 (CH), 128.4 (2 x CH), 128.0 (CH), 127.7 (CH), 126.41 (CH), 126.36 (CH), 
125.2 (CH), 124.0 (CH), 117.9 (C, qt, J = 288.4, 34.7 Hz), 114.2 (C, tt, J = 257.0, 30.7 Hz), 
109.2 (C, tq, J = 265.9, 38.1 Hz), 70.7 (CH); 19F NMR (376 MHz, CDCl3) δ –80.4 (3F, t, J = 
10.2 Hz), –(110.2-111.9) (2F, m), –124.4 (2F, app s); HRMS (EI) Exact mass calcd for 
C22H15F7O [M
+]: 428.1006, found: 428.1008. Enantiomeric excess was determined by HPLC 
with a Chiralcel OD-H column (95:5 hexane:i-PrOH, 0.8 mL/min, 230 nm); tr (major) = 20.2 
min; tr (minor) = 30.5 min, 76% ee. 
 
(R)-(E)-4,4,4-Trifluoro-3-(4-fluorophenyl)-1-phenyl-but-2-en-1-ol (255i). 
The title compound was prepared according to General Procedure F from enal 
248c (109 mg, 0.50 mmol) and phenylboronic acid (91 mg, 0.75 mmol) to give 
a colourless oil which solidified upon standing to give a beige amorphous solid 
(90 mg, 60%). [α] 24D  –168.9 (c 1.13, CHCl3); Rf = 0.31 (20% EtOAc/hexane); IR (film) 3341 
(OH), 1512, 1310, 1229, 1171, 1121, 1015, 841, 737, 698 cm-1; 1H NMR (500 MHz, CDCl3) 
δ 7.40-7.32 (3H, m, ArH), 7.28-7.25 (4H, m, ArH), 7.16-7.11 (2H, m, ArH), 6.65 (1H, dq, J 
= 9.1, 1.4 Hz, =CH), 5.11 (1H, br d, J = 9.1 Hz, CHOH), 2.03 (1H, br m, OH); 13C NMR 







x CH, d, J = 8.3 Hz), 131.1 (C, q, J = 30.5 Hz), 129.0 (2 x CH), 128.5 (CH), 127.2 (C, d, J = 
3.5 Hz), 126.2 (2 x CH), 122.9 (C, q, J = 274.3 Hz), 115.7 (2 x CH, d, J = 21.7 Hz), 70.5 
(CH); 19F NMR (376 MHz, CDCl3) δ –66.7 (3F, s), –112.1 (1F, s); HRMS (EI) Exact mass 
calcd for C16H12F4O [M
+]: 296.0819, found: 296.0815. Enantiomeric excess was determined 
by HPLC with a Chiralcel OD-H column (95:5 hexane:i-PrOH, 0.8 mL/min, 230 nm); tr 
(major) = 10.7 min; tr (minor) = 13.1 min, 81% ee. 
 
(R)-(E)-1-(4-Bromophenyl)-4,4,4-trifluoro-3-(4-fluorophenyl)but-2-
en-1-ol (255j). The title compound was prepared according to General 
Procedure F from enal 248c (109 mg, 0.50 mmol) and 4-
bromophenylboronic acid (151 mg, 0.75 mmol) to give a pale yellow oil 
(115 mg, 61%). [α] 24D –208.6 (c 0.58, CHCl3); Rf = 0.29(20% 
EtOAc/hexane); IR (film) 3335 (OH), 1512, 1229, 1171, 1123, 1009, 928, 841, 814, 739 cm-
1; 1H NMR (500 MHz, CDCl3) δ 7.51-7.49 (2H, m, ArH), 7.26-7.23 (2H, m, ArH), 7.16-7.11 
(4H, m, ArH), 6.58 (1H, dq, J = 9.1, 1.5 Hz, =CH), 5.08 (1H, dd, J = 9.1, 3.5 Hz, CHOH), 
1.98 (1H, d, J = 3.5 Hz, OH); 13C NMR (125.8 MHz, CDCl3) δ 163.2 (C, d, J = 249.4 Hz), 
140.3 (C), 136.6 (CH, q, J = 5.1 Hz), 132.1 (2 x CH), 131.6 (C, q, J = 30.6 Hz), 131.5 (2 x 
CH, d, J = 8.3 Hz), 127.8 (2 x CH), 127.0 (C, d, J = 3.5 Hz), 122.8 (C, q, J = 273.8 Hz), 
122.5 (C), 115.9 (2 x CH, d, J = 21.7 Hz), 69.9 (CH); 19F NMR (376 MHz, CDCl3) δ –66.9 
(3F, s), –111.8 (1F, s); HRMS (EI) Exact mass calcd for C16H11F4OBr [M
+]: 373.9924, found: 
373.9918. Enantiomeric excess was determined by HPLC with a Chiralpak OD-H column 
(95:5 hexane:isopropanol, 0.8 mL/min, 230 nm); tr (major) = 10.3 min; tr (minor) = 12.7 min, 
84% ee.  
 
(R)-(Z)-4,4,4-Trifluoro-1-phenyl-3-(thiophen-2-yl)but-2-en-1-ol (255k). 
The title compound was prepared according to General Procedure F from enal 
248d (103 mg, 0.50 mmol) and phenylboronic acid (91 mg, 0.75 mmol) to give 
a pale yellow oil (101 mg, 71%). [α] 24D  –180.0 (c 1.00, CHCl3); Rf = 0.41 (20% 
EtOAc/hexane); IR (film) 3345 (OH), 1306, 1287, 1277, 1229, 1175, 1123, 1015, 764, 698 
cm-1; 1H NMR (500 MHz, CDCl3) δ 7.48-7.47 (1H, m, ArH), 7.42-7.33 (5H, m, ArH), 7.11 
(2H, d, J = 3.6 Hz, ArH), 6.69 (1H, dq, J = 9.2, 1.4 Hz, =CH), 5.46 (1H, d, J = 9.2 Hz, 
CHOH), 2.10 (1H, br s, OH); 13C NMR (125.8 MHz, CDCl3) δ 141.2 (C), 138.5 (CH, q, J = 









(2 x CH), 125.5 (C, q, J = 31.5 Hz), 122.6 (C, q, J = 273.8 Hz), 70.3 (CH); 19F NMR (376 
MHz, CDCl3) δ –66.9 (3F, s); HRMS (EI) Exact mass calcd for C14H11F3OS [M
+]: 284.0477, 
found: 284.0480. Enantiomeric excess was determined by HPLC with a Chiralcel OD-H 
column (95:5 hexane:i-PrOH, 0.8 mL/min, 230 nm); tr (major) = 10.9 min; tr (minor) = 13.3 
min, 85% ee. 
 
(R)-(Z)-4,4,4-Trifluoro-1-(4-fluorophenyl)-3-(thiophen-2-yl)but-2-en-
1-ol (255l). The title compound was prepared according to General 
Procedure F from enal 248d (103 mg, 0.50 mmol) and 4-
fluorophenylboronic acid (105 mg, 0.75 mmol) to give a pale brown oil 
(89 mg, 59%). [α] 24D  –149.8 (c 1.14, CHCl3); Rf = 0.34 (20% EtOAc/hexane); IR (film) 3345 
(OH), 1310, 1227, 1175, 1157, 1125, 1013, 835, 704, 563 cm-1; 1H NMR (500 MHz, CDCl3) 
δ 7.47 (1H, dd, J = 5.0, 1.4 Hz, ArH), 7.36-7.31 (2H, m, ArH), 7.12-7.06 (4H, m, ArH), 6.65 
(1H, dq, J = 9.1, 1.4 Hz, =CH), 5.45 (1H, d, J = 9.1 Hz, CHOH), 2.07 (1H, br s, OH); 13C 
NMR (125.8 MHz, CDCl3) δ 162.6 (C, d, J = 247.3 Hz), 138.3 (CH, q, J = 4.9 Hz), 137.0 (C, 
d, J = 3.1 Hz), 130.3 (C), 129.8 (CH), 128.1 (2 x CH, d, J = 8.2 Hz), 127.9 (CH), 127.3 (CH), 
125.7 (C, q, J = 31.7 Hz), 122.5 (C, q, J = 273.8 Hz), 115.8 (2 x CH, d, J = 21.6 Hz), 69.7 
(CH); 19F NMR (376 MHz, CDCl3) δ –67.0 (3F, s), –113.5 (1F, s); HRMS (EI) Exact mass 
calcd for C14H10F4OS [M
+]: 302.0383, found: 302.0381. Enantiomeric excess was determined 
by HPLC with a Chiralcel OD-H column (95:5 hexane:i-PrOH, 0.8 mL/min, 230 nm); tr 
(major) = 10.6 min; tr (minor) = 12.8 min, 87% ee.  
 
(R)-(E)-1,5-Diphenyl-3-(trifluoromethyl)pent-2-en-1-ol (255m). The title 
compound was prepared according to General Procedure F from enal 248e 
(114 mg, 0.50 mmol) and phenylboronic acid (91 mg, 0.75 mmol) to give a 
pale yellow oil (61 mg, 40%). [α] 24D  –60.7 (c 0.89, CHCl3); Rf = 0.47 (20% EtOAc/hexane); 
IR (film) 3370 (OH), 1325, 1186, 1163, 1113, 1003, 762, 746, 698, 552 cm-1; 1H NMR (500 
MHz, CDCl3) δ 7.38-7.23 (10H, m, ArH), 6.26 (1H, dq, J = 9.1, 1.3 Hz, =CH), 5.09 (1H, d, J 
= 9.1 Hz, CHOH), 2.86-2.83 (2H, m, CH2CH2), 2.74-2.63 (2H, m, CH2CH2), 1.28 (1H, br s, 
OH); 13C NMR (125.8 MHz, CDCl3) δ 141.1 (C), 140.6 (C), 136.5 (CH, q, J = 5.7 Hz), 129.0 
(C, q, J = 28.1 Hz), 128.9 (2 x CH), 128.7 (2 x CH), 128.6 (2 x CH), 128.1 (CH), 126.6 (CH), 
125.9 (2 x CH), 124.3 (C, q, J = 274.3 Hz), 69.5 (CH), 34.6 (CH2), 28.0 (CH2); 
19F NMR 










306.1226, found: 306.1229. Enantiomeric excess was determined by HPLC with a Chiralcel 
OD-H column (95:5 hexane:i-PrOH, 0.8 mL/min, 210 nm); tr (major) = 17.1 min; tr (minor) = 




 The title compound was prepared according to General Procedure F 
from enal 248e (114 mg, 0.50 mmol) and 4-tolylboronic acid (102 mg, 
0.75 mmol) to give a pale yellow oil (67 mg, 42%). [α] 24D  –119.2 (c 0.99, CHCl3); Rf = 0.46 
(20% EtOAc/hexane); IR (film) 3356 (OH), 1314, 1229, 1184, 1161, 1113, 1003, 818, 748, 
698 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.38-7.35 (2H, m, ArH), 7.29-7.23 (3H, m, ArH), 
7.17-7.13 (4H, m, ArH), 6.28 (1H, dq, J = 9.0, 1.1 Hz, =CH), 5.09 (1H, dd, J = 9.0, 2.8 Hz, 
CHOH), 2.83 (2H, t, J = 7.6 Hz, CH2CH2), 2.72-2.62 (2H, m, CH2CH2), 2.35 (3H, s, CH3), 
1.27 (1H, dd, J = 2.8, 1.5 Hz, OH); 13C NMR (125.8 MHz, CDCl3) δ 140.7 (C), 138.3 (C), 
138.0 (C), 136.7 (CH, q, J = 5.8 Hz), 129.4 (2 x CH), 128.9 (2 x CH), 128.8 (C, q, J = 27.9 
Hz), 128.6 (2 x CH), 126.6 (CH), 125.9 (2 x CH), 124.3 (C, q, J = 274.3 Hz), 69.4 (CH), 34.6 
(CH2), 28.0 (CH2), 21.1 (CH3); 
19F NMR (376 MHz, CDCl3) δ –66.6 (3F, s); HRMS (EI) 
Exact mass calcd for C19H19F3O [M
+]: 320.1383, found: 320.1382. Enantiomeric excess was 
determined by HPLC with a Chiralcel OD-H column (95:5 hexane:i-PrOH, 0.8 mL/min, 230 
nm); tr (major) = 13.7 min; tr (minor) = 16.1 min, 85% ee. 
 
(2E)-4,4,4-Trifluoro-3-phenyl-1-[4-(trifluoromethyl)phenyl]but-2-
en-1-ol (255q)  
The title compound was prepared according to General Procedure F 
from enal 248a (100 mg, 0.50 mmol) and 4-
trifluoromethylphenylboronic acid (142 mg, 0.75 mmol) to give a pale yellow oil which 
solidified upon standing to give a pale yellow amorphous solid (65 mg, 38%). Rf = 0.28 (20% 
EtOAc/hexane); IR (film) 3289 (OH), 1323, 1248, 1171, 1117, 1067, 1042, 1015, 849, 704 
cm-1; 1H NMR (500 MHz, CDCl3) δ 7.63 (2H, d, J = 8.2 Hz, ArH); 7.48-7.45 (3H, m, ArH), 
7.39 (2H, d, J = 8.2 Hz, ArH), 7.29 (2H, dd, J = 6.5, 2.9 Hz, ArH), 6.56 (1H, dq, J = 9.1, 1.4 
Hz, C=CH), 5.22 (1H, dd, J = 9.1, 2.5 Hz, CHOH), 2.11 (1H, d, J = 3.6 Hz, OH); 13C NMR 
(126 MHz, CDCl3) δ 145.2 (C), 135.8 (CH, q, J = 5.2 Hz), 133.1 (C, q, J = 30.5 Hz), 131.0 









125.8 (2 x CH, q, J = 3.8 Hz), 123.9 (C, q, J = 272.7 Hz), 122.9 (C, q, J = 274.3 Hz), 69.8 
(CH); 19F NMR (376 MHz, CDCl3) δ –62.7 (3F, s), –66.7 (3F, s); HRMS (EI) Exact mass 
calcd for C17H12F6O [M
+]: 346.07869, found: 346.07892. Enantiomeric excess was 
determined by HPLC with a Chiralcel OD-H column (95:5 hexane:i-PrOH, 0.8 mL/min, 210 
nm); tr = 7.9 min and 9.3 min, 0% ee. 
 
(R)-(2E)-4,4,4-Trifluoro-3-(4-fluorophenyl)-1-[4-
(trifluoromethyl)phenyl]but-2-en-1-ol (255r).  
The title compound was prepared according to General Procedure F 
from enal 248c (109 mg, 0.50 mmol) and 4-
trifluoromethylphenylboronic acid (142 mg, 0.75 mmol) to give a pale 
yellow oil (70 mg, 38%). Rf = 0.42 (20% EtOAc/hexane); IR (film) 3352 (OH), 1512, 1325, 
1236, 1171, 1121, 1067, 1016, 843, 814  cm-1; 1H NMR (500 MHz, CDCl3) δ 7.63 (2H, d, J = 
8.2 Hz, ArH), 7.37 (2H, d, J = 8.2 Hz, ArH), 7.25-7.28 (2H, m, ArH), 7.12-7.17 (2H, m, 
ArH), 6.58 (1H, dq, J = 9.1, 1.4 Hz, C=CH), 5.18 (1H, dd, J = 9.1, 1.5 Hz, CHOH), 2.15 
(1H, d, J = 3.5 Hz, OH); 13C NMR (126 MHz, CDCl3) δ 163.2 (C, d, J = 249.6 Hz), 145.1 
(C), 136.3 (CH, q, J = 5.1 Hz), 132.1 (C, q, J = 30.7 Hz), 131.5 (2 x CH, d, J = 8.4 Hz), 130.6 
(C, q, J = 32.6 Hz), 126.9 (C, d, J = 3.5 Hz), 126.5 (2 x CH), 125.9 (2 x CH, q, J = 3.8 Hz), 
123.9 (C, q, J = 270.5 Hz), 122.8 (C, q, J = 271.8 Hz), 116.0 (2 x CH, d, J = 21.7 Hz), 69.9 
(CH); 19F NMR (376 MHz, CDCl3) δ –62.8 (3F, s), –67.0 (3F, s), –111.6 (1F, s); HRMS (EI) 
Exact mass calcd for C17H11F7O [M
+]: 346.06926, found: 364.07025. Enantiomeric excess 
was determined by HPLC with a Chiralcel OD-H column (95:5 hexane:i-PrOH, 0.8 mL/min, 
210 nm); tr (major) = 10.0 min; tr (minor) = 11.9 min, 6% ee. 
 
(R)-(2E)-1-[3,5-bis(trifluoromethyl)phenyl]-4,4,4-trifluoro-3-
phenylbut-2-en-1-ol (255s)  
The title compound was prepared according to General Procedure B 
from enal 248a (100 mg, 0.50 mmol) and 3,5-
difluoromethylphenylboronic acid (310 mg, 0.75 mmol) to give a 
yellow solid (56 mg, 26%). [α] 24D  +93.7 (c 1.05, CHCl3); m.p. 59-61 °C; Rf = 0.50 (20% 
EtOAc/hexane); IR (film) 3350 (OH), 1277, 1167, 1126, 1109, 1086, 901, 889, 841, 704 cm-
1; 1H NMR (500 MHz, CDCl3) δ 7.83 (1H, app s, ArH), 7.68 (2H, app s, ArH), 7.49-7.47 










5.31 (1H, dd, J = 8.5, 3.6 Hz, CHOH), 2.28 (1H, d, J = 3.6 Hz, OH); 13C NMR (126 MHz, 
CDCl3) δ 143.9 (C), 135.4 (CH, q, J = 5.2 Hz), 134.0 (C, q, J = 30.8 Hz), 132.1 (2 x C, q, J = 
33.5 Hz), 130.8 (C), 129.5 (CH), 129.4 (2 x CH), 129.0 (2 x CH), 126.3 (2 x CH, q, J = 2.9 
Hz), 123.1 (2 x C, q, J = 273.3 Hz), 122.7 (C, q, J = 274.3 Hz), 122.1 (CH, sept, J = 3.8 Hz), 
69.4 (CH); 19F NMR (376 MHz, CDCl3) δ –63.0 (6F, s), –67.1 (3F, s); HRMS (EI) Exact 
mass calcd for C18H11F9O [M
+]: 414.06607, found: 414.06683. Enantiomeric excess was 
determined by HPLC with a Chiralcel AD-H column (95:5 hexane:i-PrOH, 0.8 mL/min, 210 
nm); tr (major) = 4.9 min; tr (minor) = 6.7 min, 54% ee. 
 
Stereochemical Determinations 
The absolute stereochemistry of 255a was assigned as (R) by comparison of the optical 
rotation with that reported for the (S)-isomer in the literature.57  
 
(R)-255a: [α] 24D  –134.0 (c 0.99, CHCl3)   
(S)-255a: [α] 20D  +136.0 (c 1.6, CHCl3) 
 
In addition, the sense of enantioinduction in the arylation reaction producing (R)-255a 
described herein is consistent with that reported in the literature for similar reactions using 
ligand 228. The absolute stereochemistries of the remaining products were assigned by 
analogy. 
 




Authentic racemic samples for chiral HPLC assay determinations were prepared using the 
following procedure: A solution of the appropriate enal (0.5 mmol, 1 equiv), [Rh(cod)Cl]2 
(6.2 mg, 0.0125 mmol), KOH (70.1 mg, 1.25 mmol) and the appropriate boronic acid (1.2 
mmol, 2.4 equiv) in 9:1 dioxane/H2O (3 mL) was heated under microwave irradiation at 70 










plug of SiO2 using CH2Cl2 as eluent and concentrated in vacuo. Purification of the residue by 




The title compound was prepared according to General Procedure G 
from enal 248a (100 mg, 0.50 mmol) and 4-methoxyphenylboronic acid (182 mg, 1.2 mmol) 
and purified by column chromatography (5→20% EtOAc/hexane) to give a yellow oil (117 
mg, 76%). Rf = 0.16 (20% EtOAc/hexane); IR (Neat) 3340 (OH), 1610, 1512, 1304, 1250, 
1171, 1121, 1032, 831, 702 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.42-7.45 (3H, m, ArH), 
7.26-7.28 (2H, m, ArH), 7.18-7.21 (2H, m, ArH), 6.88-6.91 (2H, m, ArH), 6.63 (1H, dq, J = 
9.2, 1.5 Hz, C=CH), 5.09 (1H, dd, J = 9.2, 3.1 Hz, CHOH), 3.82 (3H, s, OCH3), 1.88-1.91 
(1H, m, OH); 13C NMR (126 MHz, CDCl3) δ 159.6 (C), 136.7 (CH, q, J = 5.3 Hz), 133.8 (C), 
131.6 (C, q, J = 30.2 Hz), 131.4 (C), 129.7 (2 x CH), 129.0 (CH), 128.5 (2 x CH), 127.5 (2 x 
CH), 123.1 (C, q, J = 273.5 Hz), 114.3 (2 x CH), 70.0 (CH), 55.3 (CH3); 
19F NMR (376 




(2E)-4,4,4-trifluoro-1-(2-methylphenyl)-3-phenylbut-2-en-1-ol (255p).  
The title compound was prepared according to General Procedure G from 
enal 248a (100 mg, 0.50 mmol) and 2-tolylboronic acid (163 mg, 1.2 mmol) and purified by 
column chromatography (5% EtOAc/hexane) to give a yellow oil (99 mg, 68%). Rf = 0.32 
(20% EtOAc/hexane); IR (Neat) 3306 (OH), 1308, 1271, 1242, 1171, 1119, 1015, 745, 702, 
610 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.39-7.45 (4H, m, ArH), 7.24-7.28 (3H, m, ArH), 
7.22 (1H, td, J = 7.2, 1.6 Hz, ArH), 7.12 (1H, d, J = 7.2 Hz, ArH), 6.68 (1H, dq, J = 9.0, 1.5 
Hz, C=CH), 5.32 (1H, dd, J = 9.0, 3.0 Hz, CHOH), 2.00 (3H, s, ArCH3), 1.87 (1H, d, J = 3.0 
Hz, OH); 13C NMR (126 MHz, CDCl3) δ 139.9 (C), 136.4 (CH, q, J = 5.3 Hz), 135.4 (C), 
132.3 (C, q, J = 30.3 Hz), 131.4 (C), 130.8 (CH), 129.5 (2 x CH), 129.0 (CH), 128.5 (2 x 
CH), 128.2 (CH), 126.6 (CH), 126.1 (CH), 123.1 (C, q, J = 273.6 Hz), 67.6 (CH), 18.8 
(CH3); 
19F NMR (376 MHz, CDCl3) δ –66.3 (3F, s); HRMS (EI) Exact mass calcd for 
C17H15F3O [M















The title compound was isolated from the reaction mixture when 255i was synthesised as 
above. To the combined aqueous layers was added 2 M HCl (20 mL) and CH2Cl2 (20 mL). 
The organic layer was separated and the aqueous was extracted with CH2Cl2 (2 x 20 mL). 
The combined organic layers were dried (MgSO4) and concentrated in vacuo to give a white 
solid. 1H NMR (500 MHz, CDCl3) δ 7.29-7.26 (2H, m, ArH), 7.10 (2H, t, J = 8.7 Hz, ArH), 
6.61 (1H, br, =CH); 13C NMR (125.8 MHz, CDCl3) δ 167.8 (C), 163.5 (C, d, J = 249.9 Hz), 
143.7 (C, q, J = 30.9 Hz), 130.6 (2 x CH, d, J = 8.5 Hz), 126.2 (C, d, J = 3.5 Hz), 123.5 (CH, 
q, J = 3.4 Hz), 122.1 (C, q, J = 275.6 Hz), 115.6 (2 x CH, d, J = 22.0 Hz); 19F NMR (376 
MHz, CDCl3) δ –67.8 (3F, s), –110.9 (1F, s). 
 
Further Manipulation Reactions 
 
(R)-(E)-1-(4-chlorophenyl)-4,4,4-trifluoro-3-phenylbut-2-en-1-yl acetate (262) 
 
 
To a solution of 255d (156 mg, 0.50 mmol) in CH2Cl2 (1 mL) at 0 °C was added acetyl 
chloride (43 µL, 0.60 mmol) dropwise followed by pyridine (49 µL, 0.60 mmol). The 
mixture was then warmed to room temperature and stirred for 16 h. The reaction was 
partitioned between CH2Cl2 (20 mL) and H2O (20 mL), and the aqueous layer was separated 
and extracted with CH2Cl2 (2 x 20 mL). The combined organic layers were washed with brine 
(20 mL), dried (MgSO4), filtered, and concentrated in vacuo to leave the acetate ester 262 as 
a colourless oil (133 mg, 73%) which was used immediately in the next step without 
purification. 1H NMR (400 MHz, CDCl3) δ 7.45-7.43 (3H, m, ArH), 7.34-7.31 (2H, m, ArH), 
7.24-7.22 (2H, m, ArH), 7.13 (2H, d, J = 8.4 Hz, ArH), 6.57 (1H, d, J = 8.9 Hz, =CH), 6.09 
(1H, d, J = 8.9 Hz, CHOAc), 2.05 (3H, s, CH3C=O);
 13C NMR (125.8 MHz, CDCl3) δ 169.4 
(C), 136.6 (C), 134.6 (C), 133.6 (C, q, J = 30.6 Hz), 132.8 (CH, q, J = 5.5 Hz), 130.8 (C), 
129.4 (2 x CH), 129.3 (CH), 129.0 (2 x CH), 128.6 (2 x CH), 128.3 (2 x CH), 122.8 (C, q, J = 
273.8 Hz), 71.6 (CH), 20.9 (CH3); 
19F NMR (376 MHz, CDCl3) δ –67.0 (3F, s). 
 




The title compound was prepared following a literature procedure for a similar 
transformation.57 To a solution of Pd2(dba)3·CHCl3 (5.2 mg, 0.005 mmol) and PPh3 (5.2 mg, 
0.02 mmol) in DMF (1 mL) at 0 °C was added a solution of the allylic acetate 262 (71 mg, 
0.20 mmol) in DMF (0.5 mL) via cannula. After stirring at room temperature for 20 min, a 
solution of HCO2H (9 µL, 0.24 mmol) and Et3N (39 µL, 0.28 mmol) in DMF (0.5 mL) was 
added dropwise and the reaction was then heated at 80 °C for 3.5 h. After cooling to room 
temperature, saturated aqueous NH4Cl solution (10 mL) was added and the mixture was 
extracted with Et2O (3 x 10 mL). The combined organic extracts were washed with brine (20 
mL), dried (MgSO4), filtered, and concentrated in vacuo. Purification of the residue by 
column chromatography (hexane) gave the alkene 263 (39 mg, 66%) as a colourless oil. 
[α] 24D  +63.6 (c 0.22, CHCl3); IR (film) 1491, 1248, 1161, 1105, 1092, 1013, 964, 799, 758, 
700 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.44-7.36 (5H, m, ArH), 7.33-7.29 (4H, m, ArH), 
6.55 (1H, d, J = 15.9 Hz, =CHAr), 6.44 (1H, dd, J = 15.9, 7.9 Hz, CH=CHAr), 4.16 (1H, qd, 
J = 8.8, 7.9 Hz, CHCF3); 
13C NMR (125.8 MHz, CDCl3) δ 134.6 (C), 134.5 (C, q, J = 1.3 
Hz), 134.3 (CH), 133.9 (C), 129.0 (2 x CH), 128.9 (2 x CH), 128.8 (2 x CH), 128.3 (CH), 
127.8 (2 x CH), 126.0 (C, q, J = 280.3 Hz), 123.4 (CH, q, J = 2.4 Hz), 53.4 (CH, q, J = 27.9 
Hz); 19F NMR (376 MHz, CDCl3) δ –69.0 (3F, s); HRMS (EI) Exact mass calcd for 
C16H12F3Cl [M
+]: 296.0574, found: 296.0575. Enantiomeric excess was determined by HPLC 
with a Chiralpak OD-H column (98:2 hexane:i-PrOH, 0.8 mL/min, 230 nm); tr (minor) = 6.2 
min; tr (major) =  7.4 min, 64% ee. 
 





The title compound was synthesised according to a literature procedure.174 
To a solution of benzaldehyde (1.70 g, 16 mmol) and tbutanesulfinamide 
(2.00 g, 16.5 mmol) in dichloromethane (100 mL) was added titanium tetraethoxide (20 mL, 
80 mmol). The mixture was stirred at room temperature for 17 hours, then distilled water 
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(100 mL) was added. The mixture was filtered through celite (~20 g) eluting with 
dichloromethane (100 mL). The organic layer was separated and the aqueous layer was 
extracted with dichloromethane (2 x 50 mL). The combined organic layers were combined, 
dried (MgSO4) and concentrated in vacuo to give colourless oil (2.96 g, 88%), which was 
used without further purification. 1H NMR (400 MHz, CDCl3) δ 8.60 (1H, s, HC=N), 7.89-





The title compound was synthesised according to a literature 
procedure.133b) To vinyl magnesium bromide (1.0 M in THF, 3.8 mL, 3.75 
mmol) was added dimethylzinc (1.2 M in toluene, 3.5 mL, 4.25 mmol) and the mixture was 
stirred at room temperature for 15 minutes. The mixture was then added dropwise to a 
solution of 265 (523 mg, 2.5 mmol) in THF (15 mL) at −78 °C. After 45 minutes stirring at 
−78 °C , the reaction was quenched with saturated ammonium chloride solution (30 mL), 
extracted with diethyl ether (3 x 30 mL). The combined organic layers were washed with 
saturated sodium chloride solution (30 mL), dried (MgSO4) and concentrated in vacuo. The 
residue was purified by column chromatography (5% EtOAc/hexane) to give a colourless oil 
(430 mg, 73%). 1H NMR (500 MHz, CDCl3) δ 7.38-7.36 (4H, m, ArH), 7.33-7.29 (1H, m, 
ArH), 5.94 (1H, ddd, J = 17.3, 10.1, 7.5 Hz, =CH), 5.39 (1H, dt, J = 17.3, 1.2 Hz, =CH), 5.25 
(1H, dt, J = 10.1, 1.2 Hz, =CH), 4.99 (1H, dd, J = 7.5, 2.7 Hz, CHNH), 2.27 (1H, br, NH), 
1.26 (9H, s, (CH3)3); 
13C NMR (125.8 MHz, CDCl3) δ 141.5 (CH), 138.3 (CH), 128.9 (2 x 
CH), 128.1 (CH), 127.2 (2 x CH), 117.5 (CH2), 61.5 (CH), 55.7 (C), 22.7 (3 x CH3). 
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